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Abstract 
 
 
Chlamydiae are obligate intracellular bacterial pathogens with medical and veterinary 
importance.  Their principal virulence mechanism is their ability to invade different 
cell types both in vivo and in vitro.  Whilst the human species, Chlamydia trachomatis 
and Chlamydia pneumoniea, are limited to infection of mucosal epithelium, the 
veterinary species of Chlamydia caviae, Chlamydia psittaci, Chlamydia abortus, 
amongst others, tend to establish a more systemic infection causing organ failure, 
reproductive defects, and spontaneous abortion.   
The cell invasion mechanism of Chlamydia trachomatis is the best studied, 
implicating the chlamydial protein TarP and, specifically, the N-terminal domain that 
is phosphorylated by the Src-family of non-receptor tyrosine kinases.  The veterinary 
species also possess their respective TarP homologues, but they differ from the 
Chlamydia trachomatis version by lacking the N-terminal phosphodomain.  To 
resolve this issue, and begin to elucidate the alternative invasion mechanism 
exhibited by the non-trachomatis species, a bioinformatics-based search of potential 
signalling motif within the highly conserved C-terminal half of TarP was performed.  A 
candidate Vinculin Binding Domain (VBD) and Focal Adhesion Kinase (FAK)-binding 
motif (LD) were indentified, which were determined to function in recruiting vinculin 
and FAK to the sites of invasion, respectively.  In addition, the VBD positively 
influenced the actin-recruiting function of the LD motif.  Structural modelling revealed 
the formation of the hydrophobic interface in VBD/vinculin or LD/FAK interaction. 
Finally, knockout mouse embryonic fibroblasts confirmed a role for vinculin and FAK 
in invasion.  
 
 
 
 
5 
Altogether, the data indicate that TarP-mediated exploitation of focal adhesion 
signalling represents a pan-chlamydial invasion mechanism. Interestingly, this 
signalling mechanism was found to have a post-invasion function. Chlamydia 
infection led to changes in focal adhesions and adherens junctions, which may be 
important in apoptosis resistance, counteracting the exfoliation cues provided by 
neighbouring cells, or cell motility and dissemination of infection within the host. 
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1.1 Background 
 
Bacteria within the Chlamydiaceae family are obligate intracellular parasites that 
infect a wide range of cell types but replicate primarily in epithelial cells. These 
Gram-negative bacteria are responsible for inducing acute and chronic diseases in a 
variety of vertebrates, including humans, and are of major importance with relation to 
public health. Critical to successful infection are unique and complex host-pathogen 
interactions that facilitate host cell entry, establishment of an intracellular niche for 
replication, and host cell exit. Through advances in understanding of Chlamydia 
pathogenesis and biology, a clearer picture of the extent to which chlamydiae 
manipulate mammalian cellular processes is beginning to emerge.  
 
1.2 Chlamydiae and associated diseases 
 
The DNA-based classification system introduced in 1999 redefined the order 
Chlamydiales based on 16S and 23S rRNA sequence relatedness, recognizing 9 
species within the Chlamydiaceae family that were divided into two genera: 
Chlamydia and Chlamydophila (Figure 1.1). The genus Chlamydia includes 
Chlamydia trachomatis, C. muridarum, and C. suis, whereas the Chlamydophila 
genus is larger and more diverse, with six species including Chlamydophila 
pneumoniae, C. caviae (formerly Chlamydophila psittaci guinea pig conjunctivitis 
strain), C. psittaci, C. abortus, C. felis and C. percorum. However, the revisions have 
not been widely adopted with researchers accepting the introduction of nine species, 
but not the two genera.   
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They argued that there is not sufficient enough sequence difference to separate 
Chlamydiaceae into two distinct genera and that the introduction of the new word 
“Chlamydophila” would create confusion (Schachter et al., 2001). For clarity, all 
Chlamydia or Chlamydophila genera will be abbreviated for the purposes of this 
study.    
 
The main species pathogenic in humans include Chlamydia psittaci, a zoonotic agent 
that causes rare but severe pneumonia, and Chlamydia pneumoniae, the causative 
agent of community-acquired pneumonia that has been linked to cardiovascular 
disease (Campbell et al., 1998). Variations within the species of the most significant 
human pathogen, C. trachomatis, have led to further classifications based on 
differences in serological (serovar) properties into distinct biovars.  There are two 
biovars important in humans: the trachoma (serovars A, B, Ba, C and D-K) and 
lymphogranuloma venereum (LGV; L1, L2, L3) biovars. Despite small genomic 
differences, there is considerable diversity in clinical syndrome between the C. 
trachomatis biovars. Serovars A, B, Ba, and C are associated with trachoma, an 
infection of the conjunctival epithelium causing acute inflammation. Recurrent 
episodes of reinfection and associated chronic inflammation results in the conjuctival 
scarring that ultimately lead to irreversible blindness. Thriving in unhygienic 
conditions and spread by close physical contact, trachoma is endemic in many parts 
of the developing world. The World Health Organisation (WHO) estimates that 
ocular-specific serovars affect more than 500 million people worldwide, with 
approximately 1.3 million blind as a result (WHO, 2001, WHO, 2008).  Although 
serovars D-K can occasionally cause eye disease in infants and adults in trachoma 
endemic areas, they are primarily recognised as the causative agents of sexually 
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transmitted infection (STI).  Unlike serovars A-K of the trachoma biovar, the LGV 
strains are invasive and are not locally restricted to mucosal epithelial cells. 
Transmitted sexually, the infection is characterised by penetration of the epithelial 
barrier and infection of regional lymph nodes (Schachter, 1978). International 
estimates show around 92 million new cases of Chlamydia STI every year ((WHO, 
2001)).  
 
Because a large percentage of C. trachomatis genital infection is asymptomatic, 
infected individuals usually do not seek treatment despite the availability of effective 
antibiotics. Left untreated, acute infection in women can develop further into more 
serious sequelae such as pelvic inflammatory disease (PID), ectopic pregnancy, and 
infertility. The WHO estimates the cost for treating Chlamydia-infected patients to be 
$10 billion annually (WHO, 2011).  
 
1.3 Chlamydia Biology 
 
1.3.1 Structure 
 
All chlamydial species undergo a unique biphasic developmental cycle that requires 
the adoption of two distinct forms: the elementary body (EBs) and reticulate body 
(RBs). The EBs are small, circular, electron dense organisms approximately 0.3µm in 
diameter. They constitute the highly infectious, metabolically quiescent stage of the 
organism; a spore-like form suited for extracellular survival. The metabolically active 
RBs are larger in comparison, about 1µm in diameter, and are characterised by loss 
of infectivity (Figure 1.2). 
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Extraction of the Chlamydia outer-membrane complex (COMC) revealed the 
presence of genus-specific lipopolysaccharide (LPS) in addition to three dominant 
proteins: the major outer membrane protein (MOMP) and two cysteine-rich outer 
membrane proteins OmcA and OmcB (Mygind et al., 1998). Like Gram-negative 
bacteria, LPS is a major constituent of the Chlamydia outer membrane. However, 
whilst chlamydial LPS resembles that of enterobacterial LPS, it only shows weak 
endotoxic activity (Ingalls et al., 1995, Heine et al., 2003). This has been attributed to 
lipid A, the hydrophobic membrane anchor for LPS, containing longer, 
nonhydroxylated fatty acids in chlamydial LPS (Heine et al., 2007). Chlamydiae also 
lack detectable amounts of peptidoglycan, a major cell wall component in bacteria. 
Instead, disulfide cross-linking of OmcA and OmcB is thought to contribute to cell 
wall rigidity and osmotic stability of EBs (Newhall, 1987, Everett and Hatch, 1995). 
Finally, chlamydial MOMP is the most abundant surface protein present in both EBs 
and RBs. Widely accepted to function as a porin (Bavoil et al., 1984, Wyllie et al., 
1998, Jones et al., 2000), published data have also indicated roles as a structural 
protein (Hatch, 1996) and adhesin (Su et al., 1990, Swanson and Kuo, 1994). Due to 
its ability to induce both neutralizing antibodies (Brunham and Peeling, 1994, Zhang 
et al., 1989, Su et al., 1990) and a T-cell mediated immune response (Kim et al., 
2000, Ortiz et al., 2000), MOMP has also been subject to significant immunological 
interest as a vaccine candidate, although success was limited.   
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1.3.2 Development 
 
Chlamydiae infect and replicate in a broad range of eukaryotic cells including 
macrophages, fibroblasts, epithelial, endothelial and dendritic cells. Invasion initiates 
when the EB attaches to host cells via a weak and reversible electrostatic interaction 
mediated through heparan sulphate proteoglycans. Following this, EBs irreversibly 
attach in a temperature-dependent fashion to an as yet unidentified secondary host 
receptor (Carabeo and Hackstadt, 2001), which will be discussed in further detail 
later on.  
 
Stable attachment to the host cell triggers type-III secretion of pre-packaged 
immediate-early virulence proteins (effectors) required for host cell invasion. A rapid 
localised recruitment of actin then follows accompanied with the appearance of 
hypertrophic microvilli and pedestal-like structures at the site of attachment (Carabeo 
et al., 2002). This transient recruitment of actin is required for chlamydial invasion 
and eventually leads to the uptake of the EB in a membrane-bound vesicle termed 
inclusion (Carabeo et al., 2002, Coombes and Mahony, 2002). Soon after, the EBs 
begin to differentiate into metabolically active RBs. Bacterial transcription and 
translation starts almost immediately within the differentiated RBs, with newly 
synthesised proteins detected as early as 15 min post infection (p.i.) (Plaunt and 
Hatch, 1988). Upon primary differentiation, RBs undergo binary fission as a means of 
replication. The inclusion, acting as a barrier between host and multiplying bacteria, 
is segregated from the endocytic pathway and fails to fuse with phagolysosomal 
compartments (Eissenberg and Wyrick, 1981). Instead the inclusion recruits dynein 
and is trafficked along microtubules to the microtubule-organising centre (MTOC)  
 
 
 
 
24 
(Grieshaber et al., 2003, Scidmore et al., 2003). During this process, the inclusion is 
also decorated with a subset of Rab GTPases, which are important regulators of 
membrane trafficking (Rzomp et al., 2006, Jordens et al., 2005). As the 
developmental cycle progresses, the inclusion expands to accommodate the 
increasing number of progeny. Chlamydial replication also becomes asynchronous 
as RBs begin secondary differentiation back into EBs. The chlamydial inclusion 
becomes fusogenic with Golgi-derived exocytic vesicles (Hackstadt et al., 1996, 
Scidmore et al., 2003), allowing the inclusion to acquire sphingolipids (Hackstadt et 
al., 1995) and cholesterol (Carabeo et al., 2003). In turn, this provides a mechanism 
for energy acquisition by replicating bacteria and lipid acquisition for inclusion 
expansion. At 30-84 hours p.i. depending on the chlamydial species, host, and 
environmental conditions, infectious EBs exit the cell via protease-dependent lysis or 
extrusion, an exocytic-like mechanism that leaves both host cell and inclusion intact.  
Once released, EBs may go on to initiate a secondary infection, restarting the cycle 
(Figure 1.3).  
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1.3.3 Genomics 
 
One of the major obstacles in the Chlamydia field is the genetic intractability of 
Chlamydia, a consequence of its obligate intracellular lifestyle and complex 
developmental cycle. To date, several chlamydial genomes have been sequenced, 
with genomic data providing significant insights in metabolic pathways, protein 
secretion, and signal transduction. The emerging picture inferred from the sequenced 
Chlamydia genomes is one of genomic stability, with few gene rearrangements 
(Bavoil et al., 2000). However, the limited homology of the chlamydial genome to 
other eubacteria still presents some difficulties, particularly in determining the 
functional significance of Chlamydia-specific proteins. Additionally, the different 
pathogenic mechanisms involved in chlamydial infection of the host cell remain 
poorly understood. 
 
Like other invasive bacteria, residing in a protective intracellular niche supplemented 
with nutrients has allowed for genomic reduction in chlamydiae. Indeed, C. 
trachomatis lacks coding for essential metabolic pathways including biosynthesis of 
most amino acids and nucleotides (Stephens et al., 1998). To overcome this, 
chlamydiae have several outer (porins) and inner membrane transport systems that 
have been suggested to play a role in acquiring metabolites and nutrients from the 
host cell. For instance, a chlamydial porin, PorB, has been empirically shown to feed 
the incomplete tricarboxylic acid (TCA) cycle with carbon and energy production 
intermediates (Kubo and Stephens, 2001).  
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Finally, efforts to introduce exogenous DNA or chromosonal deletions into Chlamydia 
have been notoriously restricted. Despite harbouring DNA repair machinery, 
homologues for proteins involved in transformation or competence were not identified 
in C. trachomatis (Stephens et al., 1998). Of great significance, however, has been 
the very recent success in stable transformation of C. trachomatis (Wang et al., 2011, 
Wang et al., 2013). Coupled with success in forward and reverse genetic approaches 
(Kari et al., 2011, Nguyen and Valdivia, 2012), it is becoming clear that the term 
“genetically intractable” may no longer be applicable to Chlamydia.  
 
1.3.4 Type III secretion 
 
In recent years, research striving to dissect the complex interactions between 
pathogenic bacteria and their eukaryotic host has benefited from significant 
advances in molecular technology.  Much of this work has focused on the 
mechanisms of how pathogens subvert host signal transduction pathways and 
cytoskeletal membrane components for their own benefit. Appropriately, the bacterial 
type-III secretion system (T3SS), a protein channel for delivery of effectors into the 
host, has been at the focal point of this research. Found in many Gram-negative 
bacteria with animal or plant hosts including Salmonella, Shigella, E. coli, Yersinia, 
Pseudomonas, and Chlamydia (reviewed in: Hueck, 1998), the T3SS is a major 
bacterial virulence factor. Made up of more that 20 proteins, the T3SS comprises two 
central components: a basal body and needle complex. Secretion of T3S effectors 
allows for manipulation of a vast array of cellular functions, where ‘mimicry’ of host 
protein functions as a central strategy (Galan, 2009, Stebbins and Galan, 2001).  
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Although there is a great deal of effector diversity amongst pathogenic bacteria, the 
type III secretion apparatus is generally conserved.  
 
Before the discovery of the T3SS, electron microscopic studies revealed the 
presence of needle-like projections protruding from the inclusion membrane 
(Matsumoto, 1982a, Matsumoto, 1982b) (Figure 1.4). The initial isolation of T3S-
related genes from C. psittaci (Hsia et al., 1997) lead to speculation that the needle-
like projections identified many years ago could correspond to chlamydial T3SS. 
Indeed, the structures were found to strongly resemble the needle complexes of 
Shigella (Tamano et al., 2000) and Salmonella (Kubori et al., 2000). Although much 
progress has been made to resolve the chlamydial T3SS, initial efforts to 
characterise chlamydial effectors were of limited success due to genetic intractability 
and effector diversity amongst T3SS-bearing pathogens.  In recent years, however, 
progress has been made through the use of heterologous expression systems, 
taking advantage of the relative promiscuity of T3S. Translocated chlamydial proteins 
are identified by their ability to be secreted by Yersinia, Shigella, and Salmonella 
T3SS’s (Subtil et al., 2005, Fields et al., 2003, Ho and Starnbach, 2005). One such 
chlamydial effector is the translocated actin recruiting protein (TarP); the first EB-
associated effector described (Clifton et al., 2004). The direct role for TarP in 
chlamydial pathogenesis will be discussed in further detail later in this chapter. 
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The continued presence of T3S machinery throughout infection suggests that is has 
functions in addition to its role in host cell invasion. Initial research proposed that the 
T3S machinery may serve as a conduit to the cytoplasm (Heinzen and Hackstadt, 
1997) or acts to regulate development through contact between RB and inclusion 
(Wilson et al., 2006, Wilson et al., 2009). Indeed, T3S chlamydial effectors CADD 
(Stenner-Liewen et al., 2002, Subtil et al., 2005) and CT847 (Chellas-Gery et al., 
2007) have been shown to localise to the host cell cytosol during the course of 
infection, where they modulate apoptosis and the host cell cycle respectively. The 
effector IncA has been shown to localise to the inclusion membrane once secreted. 
Of the fifty putative Inc proteins identified, only twenty-two were experimentally 
shown to be secreted (Li et al., 2008). Inc proteins, characterised by a bi-lobed 
hydrophobic domain, are believed to play a central role in bacterial-host interactions 
(Bannantine et al., 2000). The first Inc to be characterised, IncA (Rockey et al., 1995), 
mediates homotypic fusion of multiple inclusions within the same infected cell 
(Suchland et al., 2000). IncA also displays homology to SNARE proteins, important 
regulators of membrane fusion. Finally, other Inc proteins have been reported to 
participate in the recruitment of various Rabs or SNAREs, which may regulate 
selective vesicular recruitment to the inclusion (Cortes et al., 2007, Delevoye et al., 
2008, Rzomp et al., 2006). Whilst the identification and functional characterisation of 
new chlamydial effectors will continue to reveal new insights into Chlamydia cellular 
biology, it is clear that the chlamydial T3SS is crucial at all stages of chlamydial 
development. Table 1.1 below provides a summary of secreted T3S-associated 
effector proteins. For clarity, a number of the identified Inc proteins have been 
omitted from the table. 
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Table 1.1 Overview of chlamydial T3S effector proteins.  
Legend: IncM, inclusion membrane; S/T, serine/threonine; GCIP, Grap2 cyclin D-
interacting protein; Ctr, C. trachomatis; Cpn, C. pneumoniae.  
Name Localisation Possible function Conservation 
 
IncA IncM Homotypic vesicle fusion 
(Hackstadt et al., 1999, 
Subtil et al., 2001) 
All Chlamydia 
spp.  
    
IncC IncM Unknown 
(Subtil et al., 2001) 
Ctr 
    
CT694 Bacteria and host 
cell cytosol 
Interacts with human 
AHNAK 
(Hower et al., 2009) 
Ctr-specific 
    
CT847 
 
 
 
CopN 
 
 
 
TarP 
 
 
 
CADD 
 
Host cell cytosol 
 
 
 
Surface of EB  
and IncM 
 
 
Surface of EB, host 
cell cytosol 
 
 
Host cell cytosol 
 
Interacts with human GCIP 
(Chellas-Gery et al., 2007) 
 
 
Sequesters tubulin 
(Archuleta et al., 2011) 
 
 
Invasion, actin recruitment 
(Jiwani et al., 2013, Lane et 
al., 2008) 
 
Modulation of host cell 
apoptosis 
(Stenner-Liewen et al., 
2002, Subtil et al., 2005) 
All Chlamydia 
spp. 
 
 
All Chlamydia 
spp. 
 
 
All Chlamydia 
spp. 
 
 
All Chlamydia 
spp. 
 
Cap1 
 
 
 
 
 
Pkn5 
 
 
 
Mip 
 
 
IncM 
 
 
 
 
 
Inclusion and host  
cell cytosol 
 
 
Surface of EB, RB  
and IncM 
 
Involved in early immune 
recognition  
(Subtil et al., 2005, Fling et 
al., 2001) 
 
 
S/T kinase activity 
(Verma and Maurelli, 2003) 
 
 
Induction of cytokine 
response 
(Bas et al., 2008) 
 
Ctr-specific 
 
 
 
 
 
Ctr, Cpn 
 
 
 
All Chlamydia 
spp. 
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1.3.5 Adhesins and host cell receptors 
 
An important prerequisite to successful Chlamydia infection is the capacity to 
efficiently attach and invade susceptible cells. At this stage, specificity is governed by 
interactions between chlamydial adhesins and receptors on the host cell surface. 
Heparan sulfate (HS)-containing glycosaminoglycan (GAG) structures on the surface 
of mammalian cells play an important role in host-pathogen interactions, and are 
recognised by a number of bacterial and viral adhesins. For chlamydiae, the 
mechanisms of attachment are less straightforward, although there is compelling 
evidence that GAGs play a role in attachment and subsequent infection (Chen et al., 
1996b, Wuppermann et al., 2001, Zhang and Stephens, 1992). The initial association 
of the chlamydial EB with the host has been shown to involve a reversible heparin-
sensitive electrostatic interaction. Indeed, the addition of exogenous HS or heparin 
inhibits infection (Zhang and Stephens, 1992). An added complexity, however, has 
been the reported display of HS-like GAGs or a functionally analogous compound on 
the surface of chlamydial EBs that may be used as adhesins. Indeed, pre-coating C. 
trachomatis and C. pneumoniae EBs with heparan-sulfate specific monoclonal 
antibody also prevents infection (Rasmussen-Lathrop et al., 2000). A popular attempt 
to elucidate the role of host GAGs in attachment has focused on mutant CHO cell 
line deficient in HS synthesis. While some have reported a reduction in attachment to 
these cell lines (Yabushita et al., 2002, Taraktchoglou et al., 2001, Wuppermann et 
al., 2001), more recent studies have indicated that host HS is not necessary for 
attachment (Stephens et al., 2006). Given the inconsistencies surrounding the role of 
host GAGs, two models have emerged.  One proposes that host GAGs serve as 
receptors for chlamydial GAG-binding adhesins such as MOMP or OmcB. Tryptic 
 
 
 
33 
cleavage of specific variable domains of MOMP was shown to significantly reduce 
attachment for C. trachomatis serovar B (Su et al., 1988, Su et al., 1990), whilst 
MOMP-specific antibody neutralises C. trachomatis infectivity (Su and Caldwell, 
1991). An alternative model is that the GAGs are Chlamydia-associated, referred to 
as HS-like GAGs, and function as adhesins to facilitate attachment and infection 
(Zhang and Stephens, 1992, Stephens et al., 2000, Rasmussen-Lathrop et al., 2000). 
Whilst conflicting, the data strongly indicate the use of GAGs to facilitate attachment, 
although the mechanisms of use appear to differ between different species and 
biovars.  
 
Infection of a mutant CHO cell line (D4.1-3) with C. trachomatis L2 strain revealed a 
second temperature-dependent binding step that follows the primary heparin-
sensitive association, but precedes infection (Carabeo and Hackstadt, 2001). EB 
attachment to wild type CHO cells at 4°C could be reversed by addition of heparin, 
but attachment at 37°C could not. In D4.1-3 cells, the addition of heparin at 37°C 
competitively inhibited EB attachment, indicating a loss of the heparin-resistant, 
temperature-dependent receptor. Taken together, chlamydial attachment is a two-
step process:  (i) reversible binding involving cell-surface GAGs and (ii) irreversible 
attachment to a cell-surface receptor.   
 
Critical to chlamydial survival, host cell attachment and entry has been the subject of 
intense investigation. However, efforts to identify a consensus adhesin or host cell 
receptor have been largely unsuccessful. Without appropriate genetic tools, it has 
been difficult to conclusively demonstrate chlamydial dependence for any of the 
candidate adhesins. With regards to the host cell receptor, even less is known. Some 
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bacterial adhesins, such as OmcB and polymorphic membrane proteins Pmp6, 
Pmp20 and Pmp21, have been implicated in host receptor binding. For OmcB, the 
GAG-dependent and independent binding demonstrated for C. trachomatis serovars 
L1 and E suggests it is involved in both primary and secondary binding (Fadel and 
Eley, 2008). Pre-treating human cells with recombinant Pmp6, Pmp20, or Pmp21 
protein reduces infectivity of C. pneumoniae, whilst antibodies specific to Pmp21 can 
neutralise infection (Molleken et al., 2010). Deletion analysis of the tetrapeptide 
repeat motifs, the presence of which is a hallmark for Pmp proteins, revealed 
involvement in mediating adhesion (Molleken et al., 2010). A more complex finding in 
the field has been determining the role of Protein Disulfide Isomerase (PDI). A CHO 
cell line defective in PDI N-terminal processing (CHO-6) exhibited resistance to 
attachment, and thus infectivity, for multiple chlamydial species.  By complementing 
CHO cells with full-length PDI, attachment and infectivity was restored (Conant and 
Stephens, 2007). Rather than functioning as an actual receptor, is it suspected that 
PDI structurally associates with another host receptor to initiate attachment 
(Abromaitis and Stephens, 2009). Another important feature of host PDI is its 
enzymatic activity, which is required for bacterial entry but not attachment. Taken 
together, investigators propose two independent functions for host PDI essential for 
attachment or entry of a number of chlamydial species.     
 
Susceptibility of Chlamydia infection to pre-treatment of host cells with trypsin 
provided an early indication of host involvement in attachment and subsequent 
infection. Indeed a number of host proteins have been shown to influence attachment 
including mannose 6-phosphate (M6P)/Insulin Growth Factor receptor 2 (IGF2) 
(Puolakkainen et al., 2005), platelet-derived growth factor receptor-b (PDGFR") 
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(Elwell et al., 2008) and epithelial membrane protein 2 (EMP2) (Shimazaki et al., 
2009). A number of approaches including genetic silencing (EMP2, PDGFR"), 
competitive inhibition (M6P/IGF2)), or the use of neutralizing antibodies (PDGFR", 
EMP2) have been used to demonstrate the involvement of these receptors in the 
attachment and entry of various chlamydial species.  
 
To date, a general mechanism to account for chlamydial attachment remains elusive. 
The main difficulty is the apparent preferential use of ligands and receptors, which 
varies according to the chlamydial species and cell type. Furthermore, as an obligate 
intracellular pathogen, it is likely that chlamydiae have evolved multiple mechanisms 
to ensure uptake and survival within the host. A summary of the research dedicated 
to the search of host and chlamydial receptors that mediated attachment can be 
found in Tables 1.2 and 1.3. 
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Table 1.2- Overview of chlamydial adhesins 
Legend: VD, variable domain; mAB; monoclonal antibody; HS; heparan sulfate; HP; 
heparin, rOmcB; recombinant OmcB; CHO; Chinese hamster ovary cells; GAG; 
glycosaminoglycans; CFTR; Cystic fibrosis transmembrane conductance regulator; 
Ctr, C. trachomatis; Cpn; C. pneumoniae; GPIC; C. caviae.  
 
Adhesin Supporting evidence Species/serovars 
   
MOMP 1. Trypsin-mediated cleavage of VD II and IV 
prevented attachment (Su et al., 1988) 
 
2.  mAB specific to VDs II and IV of MOMP 
inhibited electrostatic interactions (Su et al., 
1990, Su and Caldwell, 1991) 
 
3. Glycan cleaved from MOMP binds to HeLa 
cells and inhibited inclusion formation 
(Swanson and Kuo, 1994) 
 
4. MOMP expressed as a fusion with E. coli 
maltose binding protein (MBP) competed with 
EBs for HeLa cells binding and had reduced 
binding to HS synthesis-deficient CHO cells. 
(Su et al., 1996) 
B 
 
 
B 
 
 
 
Ctr 
 
 
 
Ctr 
 
OmcB 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Heparan 
sulfate-like 
GAGs 
 
1. An OmcB synthetic 20-mer peptide specifically 
bound HP. Surface localisation was 
demonstrated using a mAB specific to this 
peptide.  (Stephens et al., 2001) 
 
2. Infection carried out in the presence of rOmcB 
from LGV1, but not E, prevented EB 
attachment. In addition, only LGV1 rOmcB 
attachment was abrogated in the presence 
HP. (Fadel and Eley, 2008) 
 
3. Expression of Cpn OmcB in yeast cells was 
sufficient for adherence to epithelial cells. 
Binding of yeast cells was abrogated by the 
addition of HP. Cpn EB attachment was 
prevented by the addition of recombinant 
OmcB or anti-OmcB mAB. (Molleken et al., 
2010) 
 
1. Isolation of HS-like GAG from EBs recovered 
from GAG-deficient CHO cells. Later attempts 
to purify HS-like GAG from LGV or serovar E 
cultured in GAG-deficient CHO cells were 
non-productive. (Zhang and Stephens, 1992, 
Taraktchoglou et al., 2001) 
 
LGV 
 
 
 
 
LGV1, E 
 
 
 
 
 
Cpn, L1, E, GPIC 
 
 
 
 
 
 
 
Ctr 
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 2. Desulphation of EBs by sodium chlorate did 
not reduce infectivity. (Fadel and Eley, 2004) 
 
3. HP- or HS-coated microspheres displayed 
binding properties similar to those of 
chlamydiae and could be endocytosed by 
HeLa cells. (Stephens et al., 2000) 
 
LGV, E 
 
 
Ctr 
 
 
 
 
LPS 
 
 
 
Pmps 
 
 
 
4. Cpn strains and Ctr serovar E infectivity was 
inhibited by HP derivatives or heparinase. 
(Yan et al., 2006)  
 
1. Direct interaction between CFTR and LPS 
demonstrated by immune-colocalisation and 
co-immunoprecipitation. (Ajonuma et al., 
2010)  
 
1. Yeast cells expressing Pmp6, Pmp20 or 
Pmp21 adhered to epithelial cells. Treatment 
of host cells with recombinant Pmps or mAB 
against Pmp21 prevented Cpn infection. mAB 
against PmpD of Ctr inhibited infection. 
(Molleken et al., 2010)  
 
Cpn, Ctr 
 
 
 
Ctr 
 
 
 
Ctr, Cpn 
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Table 1.3- Overview of chlamydial receptors 
Legend: HS; Heparan Sulfate; HP; Heparin, CHO; Chinese Hamster Ovary cells; 
CFTR; Cystic fibrosis transmembrane conductance regulator; M6Pr; Mannose-6-
phosphate receptor Ctr, C. trachomatis; Cpn; C. pneumoniae; Cps; C. psittaci. 
 
PDI 1. The CHO-6 cell line is mutant for PDI and 
resistant to attachment of Ctr, Cpn and Cps. 
This cell line can accommodate infection 
following complementation with FL PDI. 
(Conant and Stephens, 2007) 
  
CHO-6 
 
 2. siRNA-mediated downregulation of PDI of PDI 
prevents Cps and Ctr infection. Expression of 
plasma membrane anchored PDI (PDI-gpi) 
indicated a lack of direct attachment. 
(Abromaitis and Stephens, 2009) 
 
HeLa 
 
 
 
 
 
Heparan 
sulfate 
1. Treatment of LGV or trachoma biovar EBs 
with heparitinase prevented attachment. 
(Chen and Stephens, 1994) 
 
HeLa, L929 
 2. A sulphated decasaccharide is able to rescue 
infectivity of LGV and trachoma infections. 
(Chen et al., 1996b)  
 
 
 
 
HeLa, L929 
Receptor Supporting evidence Cell types 
   
PDGFRb 
 
 
 
 
CFTR 
 
 
 
 
 
M6P 
1. Inhibition of PDGFR" by RNA interference or 
by PDGFR" neutralizing antibodies 
significantly reduces Ctr serovar L2 binding. 
(Elwell et al., 2008) 
 
1. Cellular uptake of Ctr was impaired following 
pre-treatment of cells with neutralizing mAB or 
infection in CFTR mutant mice. (Ajonuma et 
al., 2010) 
 
 
1. Mannose binding protein interacts with the 
mannose moities on MOMP to prevent Ctr 
interaction with host cells. (Swanson et al., 
1998) 
 
2. Addition of M6PR or M6P analogue prevents 
attachment of Cpn but not Ctr. (Puolakkainen 
et al., 2005) 
 
HeLa, S2 
 
 
 
 
Epithelial cells 
(HeLa, Capan,  
Calu-3), CFTR -/- 
mice 
 
 
HeLa 
 
 
 
HMEC-1 
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 3. Attachment of LGV EBs inhibited by 
pretreatment with HP or heparitinase. (Chen 
and Stephens, 1997, Taraktchoglou et al., 
2001) 
 
HeLa, L929 
 4. Attachment of Trachoma biovar EBs only 
partially disrupted by pretreatment with HP or 
heparitinase. (Chen and Stephens, 1997, 
Davis and Wyrick, 1997) 
 
CHO 
 5. HP or HS pretreatment did not affect Ctr 
serovar E attachment whereas these GAGs 
dramatically reduced Ctr L2. (Davis and 
Wyrick, 1997) 
 
HeLa, McCoy 
 6. HP and HS inhibited the attachment of Cpn to 
human epithelial cells. HS-deficient CHO cells 
were less susceptible to Cpn infection than 
WT CHO cells. (Wuppermann et al., 2001) 
 
CHO, HEp-2 
 7. Heparinase pretreatment prevented Ctr 
serovar L2 infection. The mutant cell line 
CHO-677, was less sensitive to L2. (Yabushita 
et al., 2002) 
 
HeLa, CHO 
 8. Desulfation of host cells by sodium chlorate 
inhibited Ctr serovar L2 but serovar E 
infection. (Fadel and Eley, 2004) 
 
McCoy, HeLA 
 9. HS-deficient CHO-18.4 cells and parental 
cells, CHO-22, were equally sensitive to 
infection by Ctr serovars L2 and D. (Stephens 
et al., 2006) 
 
CHO 
 
 
 
 
 
 
 
 10. Yeast cells expressing OmcB from Cpn were 
unable to bind heparinase-treated or GAG-
deficient CHO cells.  (Moelleken and 
Hegemann, 2008) 
CHO 
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1.4 Invasive bacteria: Exploitation of host actin dynamics  
 
1.4.1 Actin remodelling: A focus on cell signalling  
 
Actin remodelling is a dynamic biochemical process whereby signals from external 
stimuli are transduced through Rho family GTPases  (Rac, Rho, Cdc42), actin-
binding proteins, and lipids to influence actin dynamics. Historically, the family of Rho 
GTPases is found to associate primarily with the actin cytoskeleton, acting as master 
regulators of actin remodelling (Disanza et al., 2005, Hall, 1998). Briefly, Rac controls 
the formation of lamellipodia and membrane ruffling, Rho controls the formation of 
stress fibres, and Cdc42 regulates the formation of filopodia. Cycling between an 
active GTP-bound state and an inactive GDP-bound state, Rho GTPases are 
commonly referred to as molecular switches. Intrinsic phosphatase activity 
hydrolyzes GTP to GDP, a process accelerated by interaction with GTPase 
activating proteins (GAPs). Interaction with guanine-nucleotide exchange factors 
(GEFs) facilitates exchanges of GDP for GTP, whereas another class of regulatory 
proteins, termed guanine dissociation inhibitors (GDIs), prevent activation by 
inhibiting guanine nucleotide dissociation (Bos et al., 2007).   
 
Rho GTPases target a number of downstream effectors, such as kinases, formins 
and WASp family proteins including N-WASp (Neural Wiskott-Aldrich Syndrome 
Protein), WASp and WAVE1/2 (WASP family verprolin-homologous protein-1/2). 
WASp and WAVE play a crucial role in orchestrating the actin remodelling process. 
Under resting conditions, N-WASp is maintained in an inactive, autoinhibited state 
via interaction of the GBD (GTPase binding domain) and the C domain of the VCA 
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(Verprolin, Central hydrophobic, Acidic) module. In response to external stimuli, 
autoinhibition is relieved through binding of GTP-bound Cdc42 to the GBD domain 
and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2 or (PIP2)) binding to the 
basic (B) region. In resting conditions, the related protein WAVE is maintained in an 
inhibited conformation through interaction with Sra, Nap, Hspc300, and Abi1. But 
unlike WASp, WAVE does not posses a GBD domain. Instead, interaction with the 
activator Rac is through a number of adaptors. Once active, WASp and WAVE can 
bind to the actin-nucleator Arp2/3 through their respective VCA domains (Bompard 
and Caron, 2004, Stradal and Scita, 2006). The Arp2/3 complex associates with the 
formation of branched actin. Despite being dedicated to the bundling and contraction 
of filamentous actin (F-actin), RhoA can also participate in actin polymerisation by 
regulating the formin family of proteins, which polymerise linear F-actin. Interestingly, 
both branched and linear actin structures are observed during adhesion and/or 
invasion of intracellular bacteria, indicating an exploitation of endogenous signalling 
components that profit the pathogen. 
 
1.4.2 Invasive strategies  
 
Actin is a central component of the cytoskeleton and an important component of 
receptor-mediated endocytosis and phagocytosis. Invasion of non-phagocytic cells 
by subverting host actin machinery is an important prerequisite in the pathogenic 
process. Intracellular bacteria are characterised by their entry mechanism into two 
groups: “triggering” and “zippering” bacteria (Cossart and Sansonetti, 2004). 
Following attachment, triggering bacteria secrete dedicated effectors that allow for 
direct activation of cytoskeletal components. The cells respond with actin re-
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arrangements that facilitate entry. In contrast, zippering bacteria directly engage and 
cluster host cell surface receptors, leading to moderate cytoskeletal alterations 
accompanied by less dramatic cell surface alterations (Figure 1.5). Despite 
differences in the mode of invasion, both involve endogenous Rho GTPases, N-
WASp and/or WAVE2 and the Arp2/3 complex. 
 
The zipper mechanism is best characterised for invasion of Listeria monocytogenes 
and Yersinia pseudotuberculosis (Ireton and Cossart, 1998, Cossart and Lecuit, 
1998, Isberg and Tran Van Nhieu, 1994). Both exploit cell-surface adhesion proteins 
as receptors for entry into mammalian cells. The receptor clustering that ensues 
induces highly localised signalling events that modify the host actin machinery. The 
culmination is the formation of membrane extensions designed for bacterial uptake. 
The Yersinia outer membrane protein, invasin, binds to heterodimeric "1-integrin 
receptors normally implicated in adherence of cells to extracellular matrix. 
Oligomerisation of invasin induces integrin clustering and subsequent activation of 
Rac1 signalling, which indirectly modulates phosphatidylinositol metabolism to 
induce actin rearrangements. It is thought that Arf6, a GTPase involved in protein 
trafficking, regulates the actin dynamics involved in phagocytic cup closure (Wong 
and Isberg, 2003, Reis and Horn, 2010).  In Listeria, several surface proteins have 
been shown to facilitate invasion of non-phagocytic cells. The best-characterised 
protein is internalin (InlA), which binds and effectively clusters cellular adhesion 
glycoprotein E-cadherin. The cytoplasmic domain of E-cadherin transiently 
associates with the actin cytoskeleton through recruitment of #- and "-catenins to 
promote entry. Actin polymerisation is Rac-dependent and mediated by Arp2/3 
(Cossart and Sansonetti, 2004). Entry also requires myosin VIIa and vezatin, which 
are thought to influence dynamics of the phagoctyic cup (Sousa et al., 2004). The 
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second invasion protein of Listeria, Internalin B (InlB), interacts with host HGF 
(Hepatocyte Growth Factor)-receptor Met. Upon binding, the tyrosine kinase Met 
dimerises and autophosphorylates, leading to the recruitment and phosphorylation of 
adaptor proteins Cbl, Gab1, and Shc (Cossart and Sansonetti, 2004). The 
subsequent activation of phosphoinositide 3-kinase (PI3K) promotes actin 
polymerisation through stimulation of the Arp2/3 complex in a Rac1-dependent 
fashion (Cossart and Sansonetti, 2004). The molecular adaptor proteins also 
influence Met ubiquitination and subsequent endocytosis of the receptor via a 
clathrin-dependent mechanisms. 
 
An analogous strategy to localised activation of host cell receptors during 
bacterial attachment is the insertion of bacterially encoded signalling proteins, 
otherwise referred to as the trigger mechanism. A number of Gram-negative bacteria, 
such as Salmonella, Shigella, Chlamydia, and more recently, Enteropathogenic E. 
coli. (EPEC), have been shown to use this strategy to invade non-phagocytic cells 
(Bulgin et al., 2009, Cossart and Sansonetti, 2004, Clifton et al., 2004). For these 
pathogens, insertion of virulence factors into the host cell cytosol is by virtue of a 
T3SS.  
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Salmonella has long served as model organism for understanding bacterial invasion 
(Ohl and Miller, 2001). Following attachment, a number of effectors are translocated 
into the target cell to induce invasion. In certain cases the translocated proteins are 
able to subvert the functions of specific host cell proteins by mimicking their activity. 
Two of these effectors, SopE and SopE2, are bona fide GEFs for Cdc42 and Rac1 
and mimic host cell GEFs to catalyze activation of these GTPases and enable 
formation of cell surface structures required for invasion (Hardt et al., 1998, Fu and 
Galan, 1999, Stender et al., 2000). SipC and SipA influence actin dynamics directly 
to promote actin filament bundling or prevent disassembly of formed actin structures, 
respectively (Zhou et al., 1999, Hayward and Koronakis, 1999). Immediately 
following entry, the host cell re-adopts its normal architecture, highlighting the 
transient activation of the Rho GTPases and actin. Indeed, Salmonella translocates 
another effector, SptP, which is a GAP for Cdc42 and Rac1 (Stebbins and Galan, 
2000, Fu and Galan, 1999). Like Salmonella, Shigella translocates a number of 
virulence factors. IpaC is homologous to Salmonella SipC, and nucleates actin 
filament formation beneath invading bacteria (Osiecki et al., 2001). Indirect induction 
of actin polymerisation via Rac1 and WAVE2 follows translocation of VirA, which also 
destabilises microtubules (Yoshida et al., 2002). The extension of filopodia 
necessary for engulfment is promoted by the phosphatidylinositol phosphatase IpgD, 
which is homologous to SopB from Salmonella (Galan, 2009, Pizarro-Cerda and 
Cossart, 2004). IpaA mediates actin depolymerisation associated with Shigella 
internalisation (Bourdet-Sicard et al., 1999).  
 
 
 
 
 
 
46 
EPEC strains are generally considered to be extracellular pathogens. The 
attachment site is characterised by the T3S-mediated nucleation of actin-rich 
pedestal, as opposed to the membrane ruffle common to Shigella and Salmonella. 
The most extensively studied EPEC effector, Tir, is translocated into the plasma 
membrane where it functions as a receptor for the bacterial outer membrane protein 
intimin (Goosney et al., 2000). Clustering of Tir by intimin triggers formation of actin-
rich pedestal structures to which EPEC intimately associate (Campellone et al., 
2004). A crucial stage that follows clustering of membrane-associated Tir is 
phosphorylation of a tyrosine reside (Y474) within the C-terminus by Src (Sarcoma) 
and Abl (Abelson) tyrosine kinases (Phillips et al., 2004, Swimm et al., 2004, Kenny, 
1999). Phosphorylation of Y474 is required for binding of the host adaptor protein 
Nck (Campellone and Leong, 2005), which in turn binds N-WASp. Activation of N-
WASp subsequently leads to the recruitment and activation of the actin-nucleating 
Arp2/3 complex (Gruenheid et al., 2001, Campellone and Leong, 2003). A number of 
other EPEC effectors shown to manipulate host actin machinery include Map and 
EspM, which direct formation of transient filopodia and actin stress fibres, 
respectively (Arbeloa et al., 2008, Kenny et al., 2002, Alto et al., 2006). Finally, a 
recent and significant finding in the field has been the identification and functional 
characterisation of Esp-T, an effector that can promote EPEC invasion via the trigger 
mechanism. Esp-T activates the mammalian Rho GTPases Rac and Cdc42, leading 
to the formation of membrane ruffles and lamellipodia (Bulgin et al., 2009).  
 
Despite outward differences in disease pathology, most pathogenic bacteria rely on 
remodelling of host actin machinery to promote efficient adherence, colonisation, or 
eventual engulfment. Productive infection is, therefore, dependent on complex host-
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pathogen crosstalk that ultimately leads to a subversion of cellular functions. From 
the perspective of invasive bacteria, one of most the important pathogenic 
mechanisms is the ability to invade host cells efficiently. Through direct engagement 
of host cell surface receptors or direct translocation of bacterial proteins, intracellular 
bacteria have evolved effective strategies to influence plasma membrane 
architecture and promote engulfment. Overall, bacterial invasion is a dynamic 
process that can be subdivided into three successive steps: contact and adherence, 
actin recruitment, and finally, engulfment and actin disassembly. Through 
remodelling of host actin machinery, intracellular bacteria have perfected a 
mechanism for promoting uptake into non-phagocytic cells.  
 
1.5 Chlamydia-host interactions during invasion 
 
1.5.1 Reorganisation of host actin machinery  
 
As an obligate intracellular pathogen, Chlamydia has evolved to efficiently invade 
phagocytic and non-phagocytic cells in a process that has been termed “parasite-
specified phagocytosis” (Byrne, 1978). Like other invasive bacteria, chlamydial entry 
into host cells is initiated by their binding and is rapidly followed by signalling events 
that modify the host actin cytoskeleton into phagocytosis-competent structures. With 
host cell entry crucial to the pathogenic process, this stage represents an appealing 
therapeutic target and has, therefore, been subject to intense investigations aiming to 
understand the molecular mechanisms involved.  
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Following stable attachment, chlamydial EBs manipulate the host actin machinery to 
form hypertrophic microvilli and pedestal-like structures directly underneath attached 
EBs (Carabeo et al., 2002). This recruitment is transient and eventually leads to 
uptake of the EB in a membrane-bound vesicle. Inhibiting the formation of these cell-
surface projections using cytochalasin D, an inhibitor of actin polymerisation, 
correlates with a significant reduction in invasion efficiency for C. trachomatis 
serovars L2 and D (Carabeo et al., 2002), C. caviae (Boleti et al., 1999), and C. 
pneumoniae (Coombes and Mahony, 2002). Consistent with observations in other 
invasive bacteria, chlamydial entry involves an active remodelling process that 
results in the formation of phagocytosis-competent machinery.  
 
1.5.2 TarP-dependent pathways  
 
Chlamydial entry into host cells was known to be associated with an increased 
number of tyrosine phosphorylated proteins that were assumed to be of host origin. 
Immunoblotting with the antiphosphotyrosine antibody 4G10 was used to identify 
tyrosine-phosphorylated proteins in response to C. trachomatis infection. Focusing 
on high molecular mass proteins, only one phosphoprotein was found to increase in 
prominence in an MOI (multiplicity of infection)-dependent fashion following C. 
trachomatis infection. The phosphoprotein, isolated by immunopreciptation with 
4G10, was identified as the chlamydial protein CT456.  The protein was found to 
associate with EB uptake and be translocated by a TTSS. Once in the cytosol, 
CT456 is rapidly tyrosine phosphorylated within an N-terminal tyrosine-rich tandem 
repeat domain through the actions of Src and Abl family tyrosine kinases (Clifton et 
al., 2004). CT456 is spatially and temporally associated with actin at the site of EB 
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invasion, leading to the protein being named TarP (Translocated Actin Recruiting 
Protein).  TarP orthologs have been subsequently identified in all chlamydial species 
and have been implicated in actin remodelling and invasion. 
 
Studies using live cell imaging showed TarP tyrosine phosphorylation to precede 
actin recruitment, suggesting that TarP could play a key role in signal transduction 
initiation related to localised actin recruitment (Clifton et al., 2004). Indeed, a model 
for induction of a Rac-dependent signalling cascade to recruit actin via Arp2/3 
activation has been recently described for C. trachomatis (Lane et al., 2008). Pre-
treating cells with clostridial toxin B (inhibitor of Rac, Cdc42 and Rho GTPases), 
significantly reduced HeLa cell invasion by C. trachomatis, C. caviae and C. 
pneumoniae (Carabeo et al., 2004). Furthermore, Rac was empirically shown to be 
transiently activated and recruited to the site within 5 minutes of C. trachomatis and 
C. caviae entry. The use of a Rac N17 dominant negative mutant inhibited bacterial 
entry (Carabeo et al., 2004, Subtil et al., 2004). Interestingly, while C. trachomatis 
and C. caviae do not require Rho for entry, they differ on their requirement for Cdc42, 
which has only been implicated in C. caviae entry (Subtil et al., 2004, Carabeo et al., 
2004). Unlike Salmonella and Shigella, which use multiple members of the Rho 
GTPase family for invasion, C. trachomatis appears to exclusively rely on Rac for 
actin recruitment. Overall, C. trachomatis TarP functions to recruit GEFs, such as 
Sos-1 and Vav-2, which ultimately activate Rac signalling in a phosphotyrosine-
dependent manner (Lane et al., 2008). TarP translocation, tyrosine phosphorylation 
and association with pedestal-like structures are reminiscent of pedestal formation 
induced by the Tir effector of EPEC and Enterohemorrhagic E. coli (EHEC). Indeed, 
despite no significant homology between them, Tir and TarP share a similar tyrosine 
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phosphorylation motif that is recognised by Src kinase family and SH2 domain-
containing adapter proteins (Lane et al., 2008).  
 
Interestingly, all chlamydial species other than C. trachomatis contain TarP orthologs 
that lack the N-terminal tyrosine-rich tandem repeats, but still retain the ability to 
recruit and remodel actin. Furthermore, Jewett et al. demonstrated that TarP 
phosphorylation is not required for C. trachomatis invasion (Jewett et al., 2008). The 
addition of the Src and Abl family kinase inhibitor, PP2, prevented TarP 
phosphorylation in culture, but had no measurable effect on entry. In an alternative, 
tyrosine-independent model for invasion, Jewett et al. propose a role for TarP as a 
bacterial nucleator of actin (Jewett et al., 2006). The mechanism involves the direct 
actin nucleating activity of C-terminal WH2-like actin binding domains (ABD). The 
actin binding !-helix is a conserved feature for all TarP orthologs investigated, 
although chlamydial strains bear variable numbers of ABDs. However, the exact role 
of TarP actin nucleation remains unclear. The use of neutralizing antibodies indicated 
a requirement of the actin binding function of TarP for chlamydial pathogenesis 
(Jewett et al., 2010). Conversely, the actin nucleating function does not fully explain 
the numerous reports demonstrating chlamydial requirement for host cell signalling 
(Table 1.4).  
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Table 1.4- Summary of host cell signalling factors required during chlamydial 
invasion.  
 
Species N-terminal 
phosphodomain? 
Actin 
recruitment? 
Required host 
signalling factors 
 
 
C. trachomatis 
 
Yes 
 
Yes 
 
Rac, Arp2/3, WAVE2    
Abi-1 (Carabeo et al., 
2007, Carabeo et al., 
2004) 
 
 
 
C. caviae No Yes Cdc42, Rac, PI3K  
(Subtil et al., 2004) 
 
 
C. pneumoniae No Yes MEK, PI3K, Rho 
GTPases* (Coombes 
and Mahony, 2002) 
 
 
C. muridarum No Yes  Unknown  
     
__________________________________________________________________ 
 
*- The role or activation of specific Rho GTPases has not been investigated in C. 
pneumoniae-infected cells.  
__________________________________________________________________ 
 
In addition, a recent publication by Jiwani et al. supported a TarP-ABD/Arp2/3 
complex cooperation scenario (Jiwani et al., 2012).  In this report, Jiwani et al. 
demonstrated cooperation in vitro of the ABD domain with the Arp2/3 complex. Thus, 
it is apparent that the invasion process is not solely dependent on the nucleating 
activity of TarP (Figure 1.6). Overall, TarP can be added to a growing list of bacterial 
proteins shown to have actin nucleating activity, such as Salmonella SipC (Hayward 
and Koronakis, 1999) Vibrio parahaemolyticus VopL (Liverman et al., 2007) and 
Vibrio cholerae VopF (Tam et al., 2007). Although mechanisms of actin nucleation 
differ, all but SipC share a common feature of possessing one or more WH2-like 
ABD’s that facilitate productive infection.  
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1.5.3 TarP-independent pathways  
 
Intracellular bacteria employ a variety of mechanisms to efficiently invade the host 
cell and create a safe environment for replication. For chlamydiae, TarP may not be 
the only protein secreted at the entry step. Indeed, chlamydiae possess a number of 
proteins that bear type III secretion signals, some of which could also play a role in 
promoting invasion. Recently, a novel T3S invasion-associated chlamydial protein 
was identified. The protein, termed CT694, belongs to the membrane-localised family 
of Type III effectors (Hower et al., 2009, Bullock et al., 2012). A C-terminal binding 
domain promotes interaction with endogenous AHNAK (Hower et al., 2009, Bullock 
et al., 2012), a large protein involved in cytoskeleton maintenance and cell signalling. 
Based on the implications of interaction with AHNAK, the current model proposes 
that CT694 may play a role in host cell invasion through modulation of stress fibres 
(Bullock et al., 2012).  
 
Type III secretion, however, is not a prerequisite for all invasion models. Cholesterol- 
and sphingolipid-rich lipid rafts and caveolae have been suggested to act as 
platforms that facilitate entry of invasive bacteria (Lafont and van der Goot, 2005, 
Duncan et al., 2002, Manes et al., 2003, Zaas et al., 2005). In addition, several 
bacterial pathogens utilise clathrin-mediated endocytosis as a means of entry 
(reviewed in: Lafont and van der Goot, 2005). For Chlamydia, it has been suggested 
that some species invade the host through a lipid raft-mediated pathway (Jutras et al., 
2003, Stuart et al., 2003, Norkin et al., 2001). However, for C. trachomatis, the 
reported results are inconsistent (reviewed in: Dautry-Varsat et al., 2005), and the  
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idea of lipid raft and caveolae-mediated invasion of Chlamydia has been questioned 
(Gabel et al., 2004, Hybiske and Stephens, 2007). Similarly, studies have provided 
evidence both in support of clathrin-mediated endocytosis during chlamydial invasion 
and against it. A recent study reported that C. pneumoniae attachment and entry was 
dependent on host raft lipids, and is a clathrin-independent process (Korhonen et al., 
2012). Whilst the formation of clathrin-coated pits does not seem to be required for 
chlamydial entry, the clathrin protein itself does appear to have an important role for 
C. trachomatis serovar L2 invasion (Hybiske and Stephens, 2007). The involvement 
of microdomains suggests that adherence and entry of Chlamydia could be mediated 
by host cell surface receptors concentrated in the area. Indeed, PDGFR" has been 
proposed to function as a receptor for C. trachomatis (Elwell et al., 2008). Activation 
of PDGFR" culminates in the activation of Rac signalling, which ultimately associates 
with actin-remodelling events. Binding and activation of a host cell surface receptor 
has also been implicated in the tyrosine phosphorylation of ezrin; a host protein that 
associates with actin, specifically in microvilli. C. trachomatis-specific activation of 
ezrin following epithelial cell infection appears to be a species-specific mechanism of 
invasion (Swanson et al., 2007).  
 
Taken together, the findings underline that chlamydiae use a number of pathways to 
manipulate cellular functions for invasion. Chlamydiae exhibit distinct host infection 
tropisms and clinical expression of disease that are frequently correlated to 
differences in invading strategies between species. A consistent feature of 
chlamydial invasion, however, is the activation of host signalling molecules and a 
requirement for actin remodelling. Conserved in all chlamydial species and secreted 
almost immediately upon host cell contact, TarP has been implicated in signalling to 
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the actin cytoskeleton remodelling machinery. Indeed, TarP recruits host signalling 
molecules and it functions in actin recruitment, which together makes TarP an 
excellent pan-chlamydial invasin candidate (Clifton et al., 2005, Carabeo et al., 2007, 
Lane et al., 2008). Ultimately, however, the role of TarP in chlamydial invasion 
cannot be directly established due to the absence of tractable genetic systems. 
Advancing understanding of TarP and its role in invasion has, therefore, been reliant 
on a combination of imaging, cell biology, and biochemical approaches. 
 
1.6 Characterising TarP-mediated actin remodelling  
 
1.6.1 Potential role for a higher-ordered configuration  
 
A characteristic feature of bacterial invasion is the capacity to define a location at the 
plasma membrane to which signalling components are recruited. At these sites, 
clustering and/or oligomerisation is becoming more appreciated as a control to 
modulate signalling capacity. In Listeria, for instance, the engagement of the host cell 
Met receptor by InIB effectively clusters the receptor and, ultimately, activates a 
variety of signalling molecules to promote localised actin recruitment (Bierne and 
Cossart, 2002). Similarly, clustering of EPEC and EHEC Tir at the plasma membrane 
induces actin recruitment directly underneath the attached bacteria (Campellone et 
al., 2004, Kenny et al., 1997). For Chlamydia, the configuration of TarP immediately 
following translocation is not known. Observations by microscopy indicate that 
signalling induction to host actin machinery occurs directly underneath the invading 
EB, with noticeable restriction in lateral mobility of the signalling complex (Lane et al., 
2008). Phosphorylated, and thus translocated TarP, co-sediments with purified EBs 
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at early stages of infection (Carabeo, unpubl. obs.). Evidence, therefore, points to 
possible aggregation of TarP directly beneath the invading EB, with limited lateral 
diffusion of the TarP molecules along the plasma membrane. Finally, TarP has the 
capacity to adopt an oligomeric state through a conserved proline rich domain (PRD). 
Oligomerisation has been implicated in the actin nucleation mediated by chlamydial 
TarP (Jewett et al., 2010).  Overall, EPEC/EHEC and Chlamydia appear to define 
sites for actin recruitment through mechanisms that, in principal, are similar to the 
clustering and activation of host cell receptors mediated by Listeria (Carabeo, 2011).  
 
1.6.2 Current strategies  
 
The continuing elucidation of chlamydial TarP is revealing the extent to which it can 
directly modulate the host actin cytoskeleton. So far, domain analysis of TarP has 
identified distinct and conserved features such as the tyrosine repeat domain (Lane 
et al., 2008, Jewett et al., 2006) and the ABD respectively. Given the apparent 
requirement for clustering and/or oligomerisation of TarP, unique in vitro or in vivo 
approaches have been used to functionally characterise these domains in relation to 
actin remodelling. For instance, Jewett et al. describe an in vitro pyrene-actin 
fluorescence assay to investigate ABD-mediated actin nucleation in the presence or 
absence of the PRD (Jewett et al., 2010). For C. trachomatis L2, a species with only 
one copy of the ABD, an oligomerisation-dependent mechanism of nucleation has 
been proposed by Jewett et al. (Jewett et al., 2010). Conversely, TarP orthologues 
harbouring multiple ABDs are able to nucleate actin independently of the PRD. Given 
the conserved nature of the PRD, the authors propose that this domain is likely to 
play an essential role in promoting actin nucleation in vivo.  
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To characterise the TarP phosphorylation sites, Lane et al. describe the use of a 
fusion protein containing an N-terminal extracellular domain of CD4 and a single 
phosphodomain unit, with wild type (CD4-1xR) or mutant sequences (Lane et al., 
2008). Incubation of mammalian cells expressing CD4-1xR with Protein G beads 
coated with anti-CD4 antibody was sufficient to induce aggregation. Because of 
potential cross-reactivity issues, monoclonal or polyclonal antibodies against 
endogenous proteins could not be used in conjunction with the beads. Thus, cells 
were co-transfected with either GFP-actin or GFP-Rac.  Aggregation of CD4-1xR or 
the mutant derivatives CD4-1xR (Y1F2) and CD4-1xR (F1Y2), in which tyrosines 
were mutated to phenylalanines, resulted in the recruitment of GFP-actin and GFP-
Rac. Conversely, the double mutant CD4-1xR (F1F2) failed to demonstrate 
recruitment. Using this system, the authors concluded that recruitment of actin and 
Rac1 required phosphorylation of at least one of the two tyrosine residues.  Overall, 
both strategies have provided compelling evidence to demonstrate functionality of 
both the ABD and the tyrosine repeat domain in relation to actin remodelling. 
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1.7 General aims  
 
Host cell signal transduction pathways are often targets of bacterial pathogens, 
specially during the process of invasion, where robust actin remodelling is usually 
required for bacterial uptake. We propose that the virulence factor TarP of Chlamydia 
can signal to host actin machinery in a tyrosine-independent fashion. 
 
The general aim of this thesis was to contribute towards the current knowledge of 
signalling pathways induced by the invasion-associated effector TarP that culminate 
in the remodelling of the host actin cytoskeleton during different stages of infection. 
 
Aim 1- To adapt the EPEC heterologous system for analysis of C. caviae and C. 
trachomatis TarP 
Aim 2- To identify a potential pan-chlamydial signalling pathway that mediates 
invasion with a focus on a protein (TarP) common to all chlamydial species.  
Aim 3- To implicate vinculin in invasion and characterise the molecular basis for this 
recruitment.   
Aim 4- To determine if Chlamydia modulates cell adhesion, and to identify the 
molecular strategies employed. 
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2.1 Bacterial strains 
 
EPEC#tir and EPEC#escN have been previously described (Berger et al., 2009, 
Garmendia et al., 2004). All EPEC strains were grown in Luria-Bertani (LB) broth 
supplemented with kanamycin (50 !g ml$1) or ampicillin (100 !g ml$1) in a shaking 
incubator at 37°C. C. trachomatis serovars L2 (LGV 434) and Chlamydia caviae 
(GPIC) were grown in HeLa cells and EBs purified by Renografin density gradient as 
described (Caldwell et al., 1981). GPIC was chosen as a model for chlamydial 
species harbouring a TarP ortholog that lacked the tyrosine-rich repeat domain. Past 
reports indicated that GPIC TarP recruited actin independently of tyrosine 
phosphorylation and that invasion required Rac and Cdc42 signalling. Fluorescent 
CMTPX-labelled EBs were prepared as described (Carabeo et al., 2002). The 
chemically competent Top10 Escherichia. coli strain from Invitrogen was used for 
plasmid propagation.  
 
2.2 DNA manipulation 
 
A summary of all plasmids created and primers used in this study is provided in 
Tables 2.1 and 2.2, below respectively. For all PCR reactions, forward and reverse 
primers were used at a final concentration of 200nM. Template ranged from 0.1-1 ng 
plasmid DNA and 100-300 ng genomic DNA. For PCR amplifications of DNA 
sequences intended for use in cloning, Pfx master mix (Invitrogen) was utilised. For 
diagnostic PCR, Taq PCR mastermix (Invitrogen) was utilised. All constructs 
generated were verified by DNA sequencing (GATC; Germany).  
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Table 2.1 – Plasmids generated in this study   
 
Plasmid ID Vector Backbone Insert Insert origin 
 
TirM 
 
 
TirM-PD 1xR 
 
pcDNA-DEST 40 
(Invitrogen)  
 
pcDNA-DEST 40 
 
TirM 
 
 
1 copy of the tyrosine 
repeat phosphodomain 
 
 
 
pKC87 plasmid 
 
 
C. trachomatis  
(Serovar L2) 
 
TirM-#VBS2,3 pcDNA-DEST 40  
 
VBS1 C. caviae 
TirM-#VBS1,2 pcDNA-DEST 40  
  
VBS3 C. caviae 
 
TirM-#VBS3 pcDNA-DEST 40  
 
VBS1/2 
 
C. caviae 
TirM-#VBS2 pcDNA-DEST 40  
 
VBS1/3 C. caviae 
TirM-#VBS1 pcDNA-DEST 40   
 
VBS2/3 C. caviae 
TirM-VBS1mut-2-3 
 
 
TirM-VBD 
pcDNA-DEST 40 
 
 
pcDNA-DEST 40 
Mutant VBD 
(VBS1 mutated) 
 
VBD 
C. caviae 
 
 
C. caviae 
    
TirM-LD 
 
pHom-1-LD 
pcDNA-DEST 40   
 
pHom-1 
LD 
 
LD 
C. caviae 
 
C. caviae 
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TirM-mutLD 
 
TirM-LD-VBD 
 
TirM-TarP1-639 
 
 
TirM-TarP1-714 
 
 
TirM-TarP FL* 
 
 
TirM-TarP FL 
 
TirM-Pax LD2 
 
pcDNA-DEST 40   
 
pcDNA-DEST 40 
 
pcDNA-DEST 40   
 
 
pcDNA-DEST 40   
 
 
pcDNA-DEST 40   
 
 
pcDNA-DEST 40   
 
pcDNA-DEST 40   
 
 
Mutant LD 
 
LD and VBD 
 
TarP-  
Amino acids 1-639 
 
TarP-  
Amino acids 1-714 
 
TarP Full-length 
No proline-rich domain 
 
TarP Full-length 
 
paxillin LD2 
 
C. caviae 
 
C. caviae 
 
C. caviae 
 
 
C. caviae 
 
 
C. caviae 
 
 
C. caviae 
 
pEGFP-N3-paxillin  
plasmid (Addgene) 
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Table 2.2 – Primers used for PCR amplification in this study 
 
Primer ID Primer Name Sequence (5’-3’) 
 
1 
 
TirM Fwd 
 
CACCATGGGCTTAGGAAATGATGAAAGGGAACGG 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
 
17 
18 
19 
20 
21 
TirM Rev 
PD 1xR Fwd 
PD 1xR Rev 
#VBS2,3 Fwd 
#VBS2,3 Rev 
#VBS1,2 Fwd 
#VBS1,2 Rev 
#VBS3 Fwd 
#VBS3 Rev 
#VBS2 Fwd 
#VBS2 Rev 
#VBS1 Fwd 
#VBS1 Rev 
VBS1mut-2-3 Fwd 
VBS1mut-2-3 Rev 
 
VBD Fwd 
VBD Rev 
LD Fwd 
LD Rev 
pHom LD Fwd 
AGTATTGGTACCCCTGTTCTGCCGGCTG 
GCAGATAGGTACCGTATGACTTCAGAAAGCTCAGAAACT 
GCGGATGGTACCTTAGTAGGAGGAGCCTCTTAGA 
CATATCAGGTACCGTATGTTGGATAGTGCAGATACA 
ATAGTGGATGGTACCTTAGGAGTGTCTTTGAGG 
GAGGGCAGGTACCGTATGACTAGCAGTTCTGCA 
GATGCGGATGGTACCTTAACAGGTTGCTGTCTC 
TCTACGACAAGCACTACGGTAAGC 
GTCAGGGGAAGGTCCAGG 
GAAAAAGGCGCAAGATTGCAA 
TCCTGAAGGAGACCCTCC 
GAGGGCAGGTACCGTATGACTAGCAGTTCTGCA 
GCTGCGGATGGTACCTTATCTTGCGCCTTTTTC 
GAGGGCAGGTACCGTATGACTAGCAGTTCTGCA 
TAATATTATTTTGGTACCTTACCCCGTCACAGAAG- 
AAGAGGTTTTTGAAGACATTGTTGTTGTATTTCTAGAAGATTC 
GAGGGCAGGTACCGTATGACTAGCAGTTCTGCA 
ATAGTGGATGGTACCTTAGGAGTGTCTTTGAGG 
GTAAATAGGTACCGTATGTCTTCTGAATCACGAGCC 
GTCGCTTGTGGTACCTTATTTATCTCCCCCTGTACC 
GTACGTGACTAGTTCTTCTGAATCACGAGCC 
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22 
23 
24 
25 
 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
 
pHom LD Rev 
LD-VBD Fwd 
LD-VBD Rev 
mutLD Fwd 
 
mutLD Rev 
TarP1-639 Fwd 
TarP1-639 Rev 
TarP1-714 Fwd 
TarP1-714 Rev 
TarP PRD Fwd 
TarP PRD Rev 
TarP FL Fwd 
TarP FL Rev 
Pax LD2 Fwd 
Pax LD2 Rev 
GCTTGCACTAGTAGGAGTCGTTCTTTCTGC 
GTAAATAGGTACCGTATGTCTTCTGAATCACGAGCC 
ATAGTGGATGGTACCTTAGGAGTGTCTTTGAGG 
AAAATAATAGGTACCGTATGAGTGCTGCAGGTGGTGA- 
GGGCGCAGAAGGAGCCGAGCATGCAGCACCACAGGCA 
GGCGCCGCGGGTACCTTAAGGAGTCGTTCTTTCTGC 
GCCCTCAGGTACCGTATGACTAGTCCTATT 
GCAGCTAGGTACCGTATGAAGCCTACAGTATTGTTA 
GCCCTCAGGTACCGTATGACTAGTCCTATT 
GTCGCTTGTGGTACCTTATTTATCTCCCCCTGTACC 
AATGTTACTGGAGGGACAACGACG 
TCCTTTCAAACCACCGACATCACC 
GCCCTCAGGTACCGTATGACTAGTCCTATT 
TCTTATGGTACCGGAGTGTCTTTGAGGTGG 
CCAGTAAAGGTACCGTATGAAGTCTGCAGAACCA  
TTGCGAGGGTACCTTACTCTGGGATGACATA  
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2.2.1 Generation of fragments used in EPEC-based system 
 
2.2.1.1 TirM 
 
The TirMC plasmid (pKC87) previously described Campellone et al. (Campellone et 
al., 2004) was generously provided by Professor John Leong (Tufts University). This 
plasmid comprises amino acids (aa) 1–66 (26 NH2-terminal cytoplasmic residues, a 
22-aa transmembrane domain, and 18 extracellular residues) of the Newcastle 
Disease Virus HN surface protein, C-terminal of which is a hemagglutinin (HA) 
epitope tag and, finally, 260–550-aa of Tir. A region (TirM) encoding the HN surface 
protein, HA tag and Tir region of interest (Thr260-Gln395) was amplified using primer 
pair (1-2), which introduced the “CACC” sequence and an artificial start codon at the 
5’ terminus and a KpnI restriction endonuclease site at the 3’ terminus. The “C” 
region of TirMC was excluded as it harbours tyrosine residues known to be involved 
in actin mobilisation.  
 
The Blunt-end TirM PCR products were ligated into the pENTR™⁄D-TOPO® entry 
vector (Invitrogen), which uses the homologous recombination of the CACC 
sequence to directionally insert the PCR product into the vector. The introduction of 
the KpnI site facilitated the formation of TirM fusion proteins, discussed in more detail 
below.   
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2.2.1.2 TarP-FL  
 
The region (Met1-Ser880) encompassing full-length C. caviae GPIC TarP (CCA00170) 
was amplified from pEGFP-C3-TarP (Clifton et al., 2005) using primer pair (33-34), 
which introduced a KpnI site and an artificial start codon at the 5’ and 3’ terminus.  
 
2.2.1.3 LD, Mutant LD (mutLD), VBD, Mutant VBD (VBS1mut-2-3), #VBS1, 
#VBS2,3,  #VBS1,2, LD-VBD, phosphodomain (PD 1xR) and paxillin LD2 
 
The LD (LEHLLPQL; Ser640-Pro740), mutLD (AEHAAPQA; Ser640-Pro740), VBD  
(VBS1-LLEAARNTTTMLSKTLSKV; Thr714-Ser880), VBS1mut-2-3 
(Mutant VBS1-LLESSRNTTTMSSKTSSSV; Thr714-Ser880), #VBS1 (Thr714-Arg832), 
#VBS2,3 (Leu837-Ser880), #VBS1,2 (Thr714-Thr784) and the LD-VBD (Ser640-Ser880) 
fragments were amplified from the C. caviae GPIC TarP clone (Clifton et al., 2005) 
using primer pairs 19-20, 25-26, 17-18, 15-16, 13-14, 5-6, 7-8 and 23-24, 
respectively. Paxillin LD2 (LDRLLLEL Lys125-Glu186) was amplified from pEGFP-N3-
paxillin plasmid DNA using primer pair 35-36. 1 copy of the tyrosine repeat 
phosphodomain (PD 1xR) from C. trachomatis serovar L2 (CT456) was generated by 
PCR amplification from a C. trachomatis TarP clone (Elwell et al., 2008) using primer 
pair 3-4.  For both paxillin LD2 and PD 1xR, primers introduced a KpnI site and an 
artificial start codon at the 5’ terminus and a stop codon followed by a KpnI site at the 
3’ terminus.  
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2.2.1.4 Generation of entry clones: TirM-TarP, its derivatives and paxillin LD2 
 
The PCR products for TarP-FL, LD, mutLD, VBD, VBS1mut-2-3, #VBS1, #VBS2,3, 
#VBS1,2, LD-VBD, PD 1xR and paxillin LD2 were purified using the QIAquick PCR 
Purification Kit (Qiagen) and then digested with KpnI (New England Biolabs) for 2 h 
at 37ºC prior to resolution on agarose gel and gel purification (QIAquick Gel 
Extraction Kit; Qiagen). These fragments were mixed with KpnI-linearised pENTR-
TirM and ligated at 16ºC overnight (O/N) with T4 ligase (New England Biolabs). The 
ligations were used to directly transform chemically competent Top10 E. coli 
(Invitrogen), which were plated on LB agar containing 50 µg/ml kanamycin. Resultant 
colonies were verified for the presence of an insert using diagnostic PCR.  Positive 
entry clones were grown O/N in selective LB broth. Plasmid preparation was 
performed using the QiaSpin MiniPrep Kit (Qiagen) followed by sequencing 
verification.  
 
Deletion of the TarP proline-rich domain (PRD; Ile355-Val399), VBS3 (Leu746-Ala764) or 
VBS2 (IIe806-IIe824) was facilitated by inverse PCR using primer pairs 31-32, 9-10 and 
11-12, respectively. The plasmids pENTR-TirM-TARP FL (TirM-TarP FL; 4.1 kb) or 
pENTR-TirM-VBD (TirM-VBD; 3.7 kb) were used as template for deletion of the PRD 
or VBS motifs, respectively. Deletion of the TarP PRD was to aid solubility during 
overexpression. Fractions of the PCR reactions were resolved on TAE agarose gels, 
verifying the presence of products of approximately 4100 bp or 3700 bp had been 
amplified. The DNA amplicons were purified and then digested with DpnI (New 
England Biolabs) for 2 h at 37ºC. Another PCR purification step followed, after which 
50 ng unligated purified product was made up to 13 µl with water and mixed with 5 µl 
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4x Quickstick Ligase Buffer (Bioline). 1 µl of polynucleotide kinase (PNK; New 
England Biolabs) was added to the sample, which was incubated at 37ºC for 30 min 
and then cooled to room temperature (RT). The plasmids were recircularised using 1 
µl of QuickStick Ligase (Bioline) treatment for 15 min at RT. The ligations reactions 
were used to directly transform chemically competent Top10 E. coli, which were 
plated on LB agar containing 50 µg/ml kanamycin. As a control, 50 ng unligated 
purified product was added to 18 µl of water with no Quickstick ligase buffer, PNK or 
Ligase added. Resultant colonies were verified for the presence of TarP using 
diagnostic PCR.  Positive clones were grown O/N in selective LB broth and plasmid 
prepped as above.  
 
GPIC TarP-No VBD (Met1-Thr714) and GPIC TarP-No LD (Met1-Thr639) fragments 
were amplified from #PRD template (TirM-TarP FL*) using primer pairs 29-30 and 
27-28, respectively. The DNA amplicons were digested with KpnI and ligated into 
linearised pENTR-TirM as described above.  
 
2.2.1.5 Generation of expression clones: TirM-TarP, its derivatives and paxillin 
LD2 
 
Resultant entry clones were mixed with a Gateway destination vector (pcDNA-
DEST40; Invitrogen) in what is referred to as an LR reaction, which is the 
recombination between the attL (entry clone) and attR (expression vector) sites. A 
fraction of the LR reaction was used to directly transform Top10 E. coli (Invitrogen), 
which were plated on LB agar containing 100 µg/ml ampicillin. Plasmid preparation 
and sequence verification of positive clones was performed as above. The resultant 
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expression clones enable transient transfection in mammalian cells with the N-
terminal HA-tag in TirM being the method of detection.  
 
2.2.2 Generation of pHom-1-LD 
 
The pHom-1 plasmid is part of the iDimerise inducible homodimer system (Clontech). 
The vector contains a DmrB dimerisation domain, but lacks a subcellular localisation 
domain. An HA tag is located between the SpeI and BamHI sites and is expressed at 
the C-terminus of fusion proteins. In cells expressing a DmrB-tagged fusion protein, 
the addition of B/B homodimeriser can induce self-association of the fusion protein 
by promoting interaction of the dimerisation domains. The LD fragment (Ser640-
Pro740) was amplified from TirM-TarP FL* template using primer pairs 21-22, which 
introduced an SpeI restriction site at the 5’ terminus and 3’ terminus. The PCR 
product was purified and then digested with SpeI (New England Biolabs) for 2 h at 
37ºC prior to resolution on agarose gel and gel purification. The fragments were 
mixed with SpeI-linearised pHom-1 and ligated at 16ºC O/N with T4 ligase. For the 
data shown in this report, the B/B homodimeriser was not added to cells expressing 
DmrB-LD-HA fusion proteins.  
 
2.3 Tissue Culture 
Vinculin-deficient (vcl-/-) and vinculin-expressing (vcl+/+) mouse embryonic fibroblasts 
(MEFs) were generously provided by Dr Wolfgang Ziegler (Hannover Medical 
School). HeLa, FAK-/-,  FAK+/+ and Cos7 cells were from ATCC. All cell types were 
maintained in a humidified 5% CO2 incubator at 37°C in Iscove’s Modified DMEM 
medium (IMDM; Invitrogen) supplemented with 10% fetal bovine serum (FBS) and L-
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glutamine (1:100). Transfections were carried out following manufacturers 
instructions using Fugene6 (Roche), Lipofectamine 2000 (Invitrogen) or 
Lipofectamine LTX and plus reagent (Invitrogen). Cells were grown in 24-well cell 
culture plates to 50% confluence. Cells were subcultured routinely by 1), removing 
media; 2), washing with PBS; 3), adding 2-3ml 0.25% Trypsin-EDTA until cells 
detached; 4), replenishing with growth medium and 5), diluting cells 1:3-1:10 in new 
tissue culture flask.  All cells used for experiments were between 3rd and 10th 
passage. Adhesive micropatterns (CYTOOchips) were purchased from CYTOO, SA 
(Grenoble, France). 
 
2.4 Transfections and infections 
 
2.4.1 EPEC 
 
Cos7, FAK-/-, FAK+/+, vcl -/- and vcl +/+ cells were grown in 24-well cell culture plates to 
80% confluence. The cells were transfected with 100 ng plasmid DNA of TirM or TirM 
fused to TarP regions of interest using Lipofectamine (Cos7) or Lipofectamine LTX 
and plus reagent (FAK-/-, FAK+/+, vcl -/- and vcl +/+) following the manufacturers 
instructions. Transfected cells were incubated at 37ºC in a humidified incubator for 
32 h prior to infection. Bacterial cultures were primed for infection by dilution of 1:100 
of overnight bacterial culture with prewarmed DMEM with low glucose (1,000 mg 
liter$1) (Sigma) and incubated as static cultures at 37°C in 5% CO2 for 3 h. For EPEC 
infection, cells were washed twice with phosphate-buffered saline (PBS) and then  
infected with primed bacterial culture, diluted 1:500, at 37°C in a humidified 
atmosphere containing 5% CO2. The infection was allowed to proceed for 4 h in the 
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presence of gentamicin (200 µg/ml; Gibco) after the first hour. For experiments 
investigating Arp2/3 requirement, the Arp2/3 Complex Inhibitor I (CK-666; Millipore) 
or the negative control CK-689 (Millipore) were added at 100 µM for the duration of 
infection. Transfection efficiency and expression levels were assessed by confocal 
microscopy. 
 
2.4.2 Chlamydia 
 
Cos7 cells were grown in 24-well cell culture plates to 80% confluence. The cells 
were transfected with 750 ng pEGFP-C1-talin1 (Addgene), pEGFP-N1-EB1 
(Addgene) or pEGFP-N3-paxillin (Addgene) plasmid DNA using Fugene6. 
Transfected cells were incubated at 37ºC in a humidified incubator for 18 h prior to 
infection. Cells were washed three times with ice-cold HBSS, infected with C. caviae 
at MOI of 50 for 1 h at 4°C to allow for attachment. Unattached EBs were removed 
by washing with ice-cold HBSS three times. Internalisation was synchronised by the 
addition of prewarmed IMDM media was added and the infection allowed to proceed 
at 37°C for 30 min. 
HaCaT cells were grown in 24-well cell culture plates to 80% confluence. The cells 
were washed three times with ice-cold HBSS, infected with C. caviae or C. 
trachomatis serovar L2 at MOI of 1 for 1 h at 4°C. Unattached EBs were removed by 
washing with ice-cold HBSS. Prewarmed IMDM media was added and the infection 
allowed to proceed at 37 °C for 24 h.p.i. (hour post-infection). At 8 h.p.i., infected 
cells were re-fed growth medium or growth medium plus 20 U penicillin G ml$1, a 
known inducer of chlamydial persistence. Mock-infected cells were subjected to the 
same procedure in the absence of chlamydiae. 
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2.4.3 Invasion assay 
 
Efficiency of C. caviae strain GPIC invasion was performed using a double staining 
and fixation protocol as described previously (Carabeo et al., 2002) with the following 
modifications. FAK-/-, FAK+/+, vcl-/- and vcl+/+ cells were infected C. caviae at MOI of 1 
and spun at 1500rpm for 3 min at RT to synchronise infection. MEFs are temperature 
sensitive and cannot be subjected to the 1 h. treatment at 4°C to synchronise 
infection. A low MOI (i.e. MOI 1) is also preferred to improve cell viability. Unattached 
EBs were removed by washing cells three times with RT IMDM media. Prewarmed 
IMDM media was added and the infection was allowed to proceed at 37 °C for the 
appropriate time p.i. Coverslips were washed three times in PBS and fixed with 4% 
paraformaldehyde for 15 min. Extracellular EBs were labelled with a C. trachomatis 
anti-LPS 1:750 (Abcam) primary and Alexa Fluor 488 conjugated secondary antibody 
(Invitrogen). Cells were permeabilised with 0.25% triton for 5 min and washed 3x with 
PBS before a secondary fixation step with 4% PFA for 15 min. Total EBs were 
labelled with an anti-Chlamydia antibody as the primary antibody at 1:750 dilution 
(Abcam) and Alexa Fluor 594-conjugated secondary antibody (Invitrogen).  
 
2.4.4 Standardizing cell shape and morphology 
 
Cos7 cells were cultured on micropatterned CYTOOchips using proprietary 
technology obtained from CYTOO, Inc. Crossbow-shaped micropatterns of medium 
surface area size (1,100 !m2) were used for all fixed-sample experiments. Cells were 
seeded at 30,000 cells/ml (120,000 cells/chip) within a 6-well culture plate in 
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complete IMDM and then washed and incubated according to the manufacturer’s 
instructions. After achieving full spreading (%2 hours post-seeding), cells were 
infected with C. caviae at MOI of 1 and incubated for 8 h 37°C. Mock-infected cells 
were subjected to the same procedure in the absence of chlamydiae. 20 single-cell 
images for both the infected and mock-infected CYTOO chipsTM were taken. 
Confocal microscopy settings were optimised for uninfected cells, and pre-set for 
subsequent imaging of infected cells. Images were taken with identical exposure 
times and on the same day to allow accurate comparison of fluorescence intensities. 
The Individual images of infected or uninfected cells were combined into a single 
maximum projection to construct a heat map. Heat map representation generated 
using ImageJ.  
 
2.5 Microscopy 
 
2.5.1 Confocal microscopy 
 
Cells grown on coverslips were fixed with 4% PFA at room temperature for 20 min 
and then rinsed at least 3 times with 1x PBS. If required, cells were permeabilised 
using 0.25% triton x-100/PBS for 5 min at RT. The permeabilisation buffer was 
removed and cells washed a further 3 times with 1x PBS. Monoclonal (mAB) or 
polyclonal (pAB) primary antibodies diluted in 1x PBS to their respective working 
concentrations (anti-HA.11 clone 16B12 mAB 1:500 (Covance), anti-FAK (phospho 
Y397) pAB 1:750 (Abcam), Anti-p-34Arc pAB 1:300 (Millipore), Anti-vinculin mAB 
1:500 (Abcam), Chlamydia trachomatis anti-LPS mAB 1:750 (Abcam), anti-
Chlamydia mAB 1:750 (Abcam), "-catenin (H-120; Santa Cruz Biotechnology) and 
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anti-"-catenin mAB (E-5; Santa Cruz Biotechnology)) were added to fixed cells and 
incubated 37°C for 1 h. Anti-rabbit or anti-mouse IgG secondary antibodies were 
conjugated to either Alexa Fluor 488 or 594 (Invitrogen). DAPI (1:1000) was used to 
stain for DNA. Actin was detected with phalloidin (1:250 dilution) conjugated to Alexa 
Fluor 488 dye (Invitrogen). Coverslips were mounted onto glass slides using mowiol. 
Sample visualisation was performed at RT on a laser scanning microscope (LSM 
510; Carl Zeiss) using an oil-immersion PlanApochromat 63x/1.40 NA differential 
interference contrast. Images were processed using NIH ImageJ freeware or Adode 
Photoshop CS. For the generation of heat maps of pixel intensity, images for each 
cell population were taken with identical exposure times and on the same day to 
allow accurate comparison of fluorescence intensities between images. Images were 
exported into ImageJ for analysis.  
 
2.5.2 Live Cell microscopy 
 
The pEGFP-C1-FAK plasmid previously described by Iwanicki et al. (Iwanicki et al., 
2008) was generously provided by Dr. J. Thomas Parson (University of Virginia). 
Cos7 cells were subcultured onto 25 mm glass coverslips in 6-well plates. The cells 
were transfected with the pEGFP-C1-FAK, Arp3-GFP (Carabeo et al., 2007) or the 
GFP vector alone using the Fugene6 transfection reagent following the 
manufacturers instructions. The coverslips were placed in a coverslip holder for 
microscopy and temperature was maintained at 37°C throughout the experiment 
using an objective heater (Bioptechs, Butler, PA). At 18 h post-transfection, cells 
were infected with CMTPX-labelled C. trachomatis serovar L2 EBs. Images were 
collected live for varying lengths of time with a Perkin Elmer UltraView Spinning Disc 
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Confocal system connected to a Nikon Eclipse TE2000-S microscope using a 60&, 
1.4 NA oil immersion objective.  
 
For investigating the focal adhesion dynamics of infected cells, Cos7 cells were 
subcultured onto CYTOOchips Motility adapted for 1D single cell migration. Cells 
were seeded at 30,000 cells/ml (120,000 cells/chip) within a 6-well culture plate in 
complete IMDM and then washed and incubated according to the manufacturer’s 
instructions. After achieving full spreading (%2 hours post-seeding), cells were 
transfected with the pEGFP-C1-FAK using the Fugene6 transfection reagent. At 22 h 
post-transfection, cells were infected with C. trachomatis serovar L2 at MOI of 1 and 
incubated for a further 20 h at 37°C.  Coverslips were placed in a coverslip holder for 
microscopy supplemented with optimem. A microscope mounted incubation chamber 
ensured that the temperature was maintained at 37°C throughout the experiment. 
Images were collected live for 1' h at 1 min intervals using a spinning-disc confocal 
microscopy head mounted on a Nikon TE2000-E microscope controlled by the Andor 
iQ software (Andor Technology). Images were assembled into a time lapse 
Quicktime movie using ImageJ.  
 
2.5.3 Electron Microscopy 
2.2.1.1 Electron microscopy for optimal EB ultrastructure- Ruthenium Red 
staining of EBs 
 
A stock solution of 1% w/v aqueous Ruthenium Red (TAAB) was prepared the day 
before use.  The solution was heated to 60°C for 5 min, cleared by centrifugation at 
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1,600 xg for 10 min and stored at 4°C (Gebbers and Otto, 1974).  The stock solution 
was diluted 1:10 into 50 µL aliquots of freshly defrosted density gradient enriched 
Chlamydia trachomatis L2 EBs on ice in SPG buffer for 30 min, followed by two 
washes with ice cold SPG buffer. 
 
2.2.1.2 High pressure freezing (HPF) and freeze substitution (FS) 
 
50 µL aliquots of EBs stained with Ruthenium Red were pelleted at 6,000 xg for 3 
min and stored on ice.  The SPG supernatant was removed and replaced with 1-
hexadecene immediately prior to freezing.  Flat Specimen Carriers (1.5 mm x 200 !m, 
16706898 LEICA) were coated with freshly prepared 1% Lecitime (Lecigran Lecithin 
granules) in chloroform to aid specimen removal.  The specimen carriers were filled 
with as much sample as possible, the remaining space being filled with 1-
hexadecene cryo-filler prior to HPF using a LEICA EM PACT2.  The frozen cryo-filler 
was cracked under liquid nitrogen with sharp forceps, and the specimen carriers then 
transferred to freeze substitution mixture (1% osmium tetroxide / 0.1% uranyl acetate 
in acetone) in a LEICA EM AFS2 at -90°C with the sample on the upper 
surface.  The FS programme was as follows:  38 h at -90°C, 13 h with a ramp of 
5°C.hour-1 to -25°C, 12 hours at -25°C, 5 hours with a ramp of 5°C.hour-1 to 0°C 
followed by 15 min with a ramp of 88°C.hour-1 to 22°C.  This was followed by transfer 
to pure acetone and rinsing 3x over 15 min to remove the free substitution 
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mixture.  The specimen carriers were then transferred through a graded series of 
resin diluted in acetone, and the samples removed from the carriers prior to 
embedding in TAAB 812 polymerised at 60°C.  Ultrathin sections of 90-100 nm were 
cut on using a DiATOME ultra 35° diamond knife and collected on 200 mesh 
hexagonal copper grids (Gilder grids) using a LEICA Ultracut UCT microtome, 
counterstained with 2% aqueous uranyl acetate (30 min) and Reynolds lead citrate (3 
min) prior to standard imaging on a Philips FEG CM200 (200 kV) electron 
microscope. 
 
2.2.1.3 Immuno-electron microscopy 
 
Cells for transmission electron microscopy (TEM) were grown on 12mm coverslips or 
in a tissue culture flask to 90% confluency and infected with EBs at an MOI of 300. 
After allowing for attachment, cells were rinsed with cold HBSS 3 times to remove 
unattached EBs and shifted to 37°C for 10 min. Media was removed, samples were 
rinsed with 1x PBS, and fixed with 4% formalin in 0.1 M phosphate buffer / 0.15 M  
 
sucrose for 30 min.  The cells were pelleted / embedded in low gelling point agarose 
prior to freeze substitution with alcohols and embedding in Lowicryl HM20 (Agar 
Scientific), by progressive lowering of temperature using a Leica AFS.  Ultrathin 
sections were immuno-labelled with primary antibodies (anti-FAK (phospho Y397) 
1:200 (Abcam). 15 nm colloidal gold anti-rabbit IgG was diluted 1:20. Blocking 
included 0.1% Tween®20, 0.15 M glycine, 1% fatty acid free BSA (BBI), 1% non-
immune goat serum (Invitrogen), and 1% fish gelatin.  Counterstaining with heavy 
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metals was with 2% aqueous uranyl acetate.  Specimens were examined with FEI 
Tecnai T12 microscope (120 kv), or a Philips CM200 (200 kv), microscope. 
 
2.6 Western blot analysis 
 
HeLa cells were grown in 6-well cell culture plates to 80% confluence. Cells were 
washed 3 times with ice-cold HBSS and were either mock- or C. Caviae-infected 
infected at MOI of 300 for 1 h at 4°C. Unattached EBs were removed by washing 
with ice-cold HBSS. Prewarmed IMDM media was added and the infection allowed to 
proceed at 37 °C for specified time, Whole cells were washed with ice cold HBSS 
and lysed for 30 min at 4°C with RIPA buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 
0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40) supplemented with protease 
inhibitors (cOmplete ULTRA Tablets, EDTA-free; Roche) and phosphatase inhibitors 
(PhosSTOP phospatase inhibitor cocktail; Roche). The cells were resuspended by 
pipetting up and down in approximately 0.5 mL of ice-cold lysis buffer per well. 
Lysates were cleared by centrifugation at 13,000& g for 10 min at 4°C and protein 
concentrations were determined by BCA assay (Thermo Scientific) using 
manufacturers instructions.  Cell lysates were stored in 5x Laemmli sample buffer (60 
mM Tris-Cl pH 6.8, 2% SDS, 10% glycerol, 5% "-mercaptoethanol, 0.01% 
bromophenol blue) at -20°C. Samples were boiled for 5-10 minutes at 100°C prior to 
resolution by Tris-Glycine-SDS polyacrylamide gel electrophoresis (SDS-PAGE). 
Polyacrylamide gels were then equilibrated in ice cold transfer buffer (25mM Tris, 
192mM glycine, 20% MeOH, pH=8.3). Whatman 0.2 µm nitrocellulose (NC) 
membranes were equilibrated in transfer buffer at 4°C for at least 10 min. Proteins 
were transferred to NC membranes via the Mini Trans-Blot Electrophoretic Wet 
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Transfer Cell (Bio-Rad) at 80V for 80 min. Transfer efficiency was verified by staining 
with Ponceau solution (Invitrogen). Membranes were washed of Ponceau with TBS + 
0.1% Tween-20, and blocked in the same solution containing 5% BSA or 3% milk 
O/N at 4°C. After blocking, the membranes were probed in solution blocking 
containing primary antibody O/N at 4°C. Anti-FAK (phospho Y397; Abcam), anti-FAK 
(Cell Signaling Technology), anti-Tarp (Saka et al., 2011) or anti-"-tubulin 
(Horseradish peroxidase (HRP)-conjugated; Abcam) pABs were applied at dilutions 
of 1:1000 (Anti-FAK (phospho Y397) and Anti-FAK), 1:200 or 1:5000 respectively. 
Blots were washed fours times 5 min each time with blocking solution. When the 
primary antibody was not conjugated to HRP, a secondary anti-mouse or anti-rabbit 
HRP-conjugated antibody (Cell Signaling Technology) was applied at dilution of 
1:1000 in blocking buffer.  Blots were washed as before.  Chemiluminescent 
detection was performed Imobilon HRP-substrate chemiluminescent detection kit 
(Millipore), and images captured using the FUJI-3000 LAS imager at -30°C.  
 
2.7 Immunodetection 
 
Oligopeptide pulldown was as previously described (Lane et al., 2008) with the 
following modifications. Custom-synthesised oligopeptides with sequences 
EGAEGLEHLLPQLRSHLDDAFDQQGN (WT LD domain) and 
EGAEGAEHAAPQARSHLDDAFDQQGN (Mutant LD domain) purchased from 
Sigma-Genosys were designed to include an N-terminal biotin residue. Pulldown of 
biotinylated oligopeptides was performed using streptavidin-coupled Dynabeads 
(Invitrogen). 
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2.8 Bioinformatics 
 
All figures involving the alignments of nucleic acid sequence were generated using 
ClustalW.  Parameters for alignments shown are indicated within the figure legends 
describing the alignment. Helical wheel representations were generated using 
PROTEAN from DNASTAR inc.  
 
2.9 Homology modelling  
 
2.9.1 Binding of C. trachomatis L2 LD and C. caviae GPIC LD domains to the 
FAT domain of FAK 
 
Sequence alignment between the L2 LD, GPIC LD and LD2 paxillin domains was 
performed using the program T-Coffee (Notredame et al., 2000). The sequence 
alignment and the structure of the LD2 paxillin domain were used as input for the 
comparative homology-modelling program MODELLER (Sali and Blundell, 1993). 
The resulting L2 LD and GPIC LD models were superposed to the structure of the 
LD2 paxillin domain bound to the FAT domain of FAK with the graphical program 
PYMOL 1.4. Validation of the geometry of the models was performed with 
MOLPROBITY (Chen et al., 2010) and the surface electrostatic potential 
representation was generated with PYMOL 1.4. 
 
 
 
 
 
 
 
81 
2.9.2 Binding of the C. caviae GPIC VBS motifs to the Vh1 domain of vinculin 
 
Sequence based models of GPIC VBS1, VBS2 or VBS3 were generated and aligned 
to the solved structure of IpaA VBS1 in complex with Vh1 using PYMOL 1.4. Surface 
electrostatic potential representation was generated with PYMOL 1.4. 
 
2.10 Statistical analysis  
 
All statistical analyses were run in Mstat software. Unless stated otherwise, statistical 
differences were tested using one-way analysis of variance (ANOVA) and Tukey's 
post-hoc test. The Spearman rank order correlation test was used to determine the 
strength of association between the recruitment kinetics of phospho-active FAK, 
GFP-FAK, or both by C. caviae GPIC. Data presented either as mean and standard 
deviation (SD) or as median and range (10%-90%). Box and Whisker Plots represent 
lower and upper quartile values (box) with median and mean (+). Whiskers extend 
from each end of the box to the 10th and 90th percentiles. Where stated, the 
significance level, α was set to 0.05  or 0.01. All p-values ( α were considered 
statistically significant. 
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Chapter 3- Adapting the EPEC heterologous system for analysis of C. caviae 
and C. trachomatis TarP 
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3.1 Introduction 
 
3.1.1 Rationale for application of an alternative approach to characterise TarP  
 
Chlamydial TarP signalling to host actin machinery does not appear to be restricted 
to either the actin binding domain or the tyrosine repeat domain. Indeed, the current 
discrepancy in the field is the apparent independence on the tyrosine phosphorylated 
domain of TarP (Jewett et al., 2008), but the critical requirement for signalling 
molecules such as Rac, Cdc42, and the Arp2/3 complex (Carabeo et al., 2007). To 
date, the means by which Chlamydia subvert host cell signalling in a 
phosphodomain-independent manner is unclear. Interestingly, domain analysis of 
TarP has identified additional conserved features that may function as signalling 
domains (see chapters 4 and 5). Thus, like other bacterial effectors, TarP appears to 
exhibit a modular architecture comprised of domains that confer subversive functions 
within the host cell. To date, functionality of TarP domains has been addressed using 
either a highly specialised or a biochemically restricted strategy. Subsequently, there 
is a need for an alternative approach to extensively define a role for these molecular 
determinants in chlamydial infection.  
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3.2 The EPEC heterologous system 
 
The binding of the surface adhesin intimin to the extracellular domain of Tir 
triggers actin recruitment.  Like the cell based assay used to characterise the 
tyrosine phosphorylation motifs of TarP, Campellone et al. described a system that 
involved expressing a fusion protein in mammalian cells (Campellone et al., 2004). In 
this case, a viral membrane-targeting sequence replaced the NH2 terminus of Tir, 
promoting efficient surface expression of the COOH-terminal fragment of Tir. This 
fragment, termed TirMC, contains the intimin-binding extracellular loop (TirM) and the 
cytoplasmic domain (TirC) that harbours the tyrosine (Y474) critical for actin pedestal 
formation (Figure 3.1). Attachment of intimin-expressing tir-deficient (#tir) EPEC was 
sufficient to cluster this fusion protein and subsequently trigger localised actin 
pedestal formation. The #tir EPEC strain was used to exclude any unwanted 
signalling effects of translocated Tir. Endogenous proteins, such as Nck, N-WASp, 
Arp2/3 complex and !-actinin, localised to actin pedestals induced by clustering of 
TirMC (Campellone et al., 2004). Thus, a benefit of this system is that it artificially 
replicates the localised recruitment of signalling complexes observed at sites of 
EPEC/EHEC attachment under normal infection.  
 
In this chapter, I describe the steps taken to modify the EPEC heterologous system 
to enable functional characterisation of potential signalling determinants identified in 
TarP. Application of this genetically tractable system is an alternative strategy to 
artificially replicate the membrane-localised higher-ordered configuration adopted by 
TarP in vivo.  
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3.3 Results 
 
3.3.1 Adapting an EPEC-based system to artificially cluster chlamydial TarP  
  
To determine more precisely the localisation and configuration of TarP during 
invasion, immunoelectron microscopy was performed. At 30 min p.i., TarP was found 
to concentrate directly beneath invading EBs (Figure 3.2A), an observation 
consistent with previous findings by immunofluorescence (Clifton et al., 2005). This 
initial arrangement of TarP presumably ensures an optimal activation of downstream 
elements as has been reported for other signalling molecules of attached bacteria 
(Carabeo, 2011). To investigate TarP functionality in cells, the previously reported 
EPEC TirMC system was used to replicate the membrane-localised higher-ordered 
configuration adopted by TarP (Figure 3.2B). To achieve membrane-localisation, C. 
caviae GPIC TarP was fused with TirM, a Tir fragment containing an NH2-terminal 
plasma membrane targeting sequence derived from Newcastle Disease virus 
hemagglutinin-neuraminidase (HN) protein (Campellone et al., 2004). This HN 
segment, followed by an HA- epitope tag, directs surface expression of a fragment of 
Tir containing the intimin-binding extracellular loop and full length TarP (TirM-TarP 
FL). In Cos7 cells expressing TirM-TarP FL, intimin-expressing bacteria were 
predicted to attach and subsequently cluster membrane-targeted TarP. 
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3.3.2 Removal of TarP Proline-Rich Domain (PRD) improves membrane 
targeting  
 
Microscopic examination of transfected cells using fluorescently labelled anti-HA 
antibodies indicated that TirM-TarP FL generally aggregated in the cytosol. 
Furthermore, cells expressing TirM-TarP FL do not possess the capacity to support 
the attachment of a tir-deficient strain (#tir EPEC; Figure 3.3A). Conversely, Tir 
fragments harbouring the COOH-terminal cytoplasmic domain (TirMC) localised to 
the periphery of transfected cells and supported attachment of the #tir EPEC strain 
(Figure 3.3A). Thus, evidence points towards an inefficient targeting of TirM-TarP FL 
to the plasma membrane, possibly due to the prominence for full-length TarP to 
aggregate. Indeed, the cytoplasmic aggregation that results from ectopic expression 
of TarP FL has previously been reported and is thought to involve the proline rich 
domain (PRD). Conserved in all TarP orthologs, the PRD has been shown to 
promote TarP oligomerisation in vitro, having important implications for TarP-
mediated actin (Jewett et al., 2010). In an effort to reduce cytoplasmic aggregation, 
the PRD of C. caviae TarP was removed by inverse PCR (TirM-TarP FL*) (Figure 
3.3B). In addition to cytoplasmic staining, TirM-TarP FL* was found to localise to the 
periphery of transfected cells akin to TirMC (Figure 3.3C). To determine if Tir was 
present in a functional form at the cell surface, cells transfected with TirM-TarP FL* 
were assayed for the ability to bind the intimin-expressing #tir EPEC strain. For 
comparison, cells transfected with the TarP derivative harbouring the PRD (TirM 
TarP FL) were also examined. Transfected cells were identified using anti-HA 
antibody, and bacterial attachment quantified. Approximately 30% of cells expressing  
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TirM TarP FL and 80% of cells expressing TirM-TarP FL* bound at least 20 intimin-
expressing bacteria (#tir EPEC). Only 2.5% of mock-transfected cells demonstrated 
this level of binding (Figure 3.3D). Overall, only TirM-TarP FL* is able to support the 
binding of a tir-deficient strain to a significant degree. Any further investigations of 
full-length TarP using the EPEC-based system will, therefore, involve the TarP 
derivative lacking the PRD.  
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Figure 3.3- Intimin-expressing bacteria attach efficiently to cell expressing a TarP derivative 
lacking the proline rich domain. A) Cos7 cells transfected with plasmids encoding full length TarP 
(TirM-TarP FL) or TirMC (red) were stained with a mAb to the HA epitope to identify transfected cells, 
with DAPI (blue) used to visualise tir-deficient EPEC (#tir) by confocal microscopy. Note the 
aggregation of TarP is accompanied by the lack of EPEC attachment. In contrast, EPEC attachment is 
clear for TirMC-expressing cells. B) Schematic of TarP proteins indicating the locations of the actin 
binding domain (red box), the proline rich domain (PRD; green box), TirM (purple), the HA-tag (red) 
and the membrane targeting sequence (MTS; cyan). ) indicates amino acids deleted in mutant TarP 
proteins, and the numbers indicate amino acid positions encoded within the C. caviae TarP gene. * 
denotes TarP derivative deleted for the PRD. C) Cos7 cells transfected with TarP #PRD (TirM-TarP 
FL*) exhibit EPEC attachment and reduced cytoplasmic aggregation of TarP. D) Mock-transfected 
cells, or cells expressing TarP FL or TarP FL* were infected with #tir EPEC. The cell binding index, 
defined here as the percentage of cells with at least 20 bacteria bound, was measured microscopically 
and represented as the mean of three independent experiments. Scale bars: 10 !m. 
 
 
 
 
3.3.3 Bacterial infection conditions 
 
3.3.3.1 Length of infection 
 
To determine the functionality of surface-localised TarP, TirM-TarP FL* expressing 
cells were infected with EPEC and examined for localised actin recruitment using 
phalloidin. Cells transfected with TirMC were also investigated in parallel.  As the 
fusion of TarP with TirM replaced the majority of TirC, including the phosphotyrosines 
required for Tir-induced actin recruitment, any co-localisation of EPEC with actin was 
assumed to be a consequence of TarP-mediated signalling. In addition, clustering 
was induced using #tir EPEC to exclude any unwanted signalling effects of 
translocated Tir. At 2 h.p.i., TirMC localised to sites of EPEC adherence and actin 
pedestals formed beneath the bound bacteria (Figure 3.4). In contrast, #tir EPEC 
adhered to TirM-TarP FL* transfected cells failed to recruit actin (Figure 3.4). Unlike 
TirMC, TirM-TarP FL* was not enriched underneath adhered bacteria, suggesting 
that the absence of actin recruitment was due to inefficient clustering of membrane- 
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localised TirM-TarP FL*. To address this issue, the infection length was prolonged to 
4 hours. At this timepoint, both TirM-TarP FL* and actin were demonstrated to 
localise beneath the bound bacteria. Overall, these results indicate that TirM-TarP 
FL* is functional and signals to host actin remodelling machinery in a manner 
dependent on clustering. 
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3.3.3.2 Multiplicity of infection (MOI) 
 
In the study by Campellone et al., HEp-2 cells expressing TirMC were infected at an 
approximate MOI of 10 (Campellone et al., 2004), significantly less than the MOI 
used to infect TirM-TarP FL* transfected cells (Figure 3.4). A low MOI is preferred as 
it facilitates accurate judgement of localisation events beneath individual EPEC 
particles. To reduce the MOI, the EPEC innoculum was diluted 1:500, significantly 
greater than the generic 1:100 dilution used previously. In addition, gentamicin was 
added at bactericidal levels (200ug/ml) at 1 h.p.i. to prevent the bacterial overgrowth 
that can ultimately lead to host cell death and/or increases in MOI. The number of 
EPEC attached per cell was quantified microscopically at 4 h.p.i. For comparison, 
cells infected using the 1:100 infection approach were also analysed. Infecting cells 
with EPEC innoculum diluted 1:100 or 1:500 resulted in MOIs of approximately 380 
and 45 respectively (Figure 3.5). Although higher than the reported MOI used by 
Campellone and colleagues (Campellone et al., 2004), the significantly larger surface 
area of the Cos7 cells in comparison to the HEp-2 cells means that the cells are not 
overloaded with EPEC. The levels of colocalisation of #tir EPEC with actin were 
quantified for both MOIs in cells transfected with TirM-TarP FL*. A lower MOI 
enables a more comprehensive insight into TarP signalling capacity. At high MOI, 
actin recruitment is difficult to assess given the lack of isolated EPEC particles 
(Figure 3.5B). Indeed, comparing the two data sets revealed that actin recruitment 
was significantly greater in cells infected at low MOI (p<0.01). Taken together, the 
data indicate that quantification of TarP signalling benefits from an optimised 
infection protocol that maintains a low MOI.  

 
 
 
95 
 
3.3.3.3 Bacterial strain 
 
Under the modified infection conditions, the signalling efficacy of ectopically 
expressed TarP could be quantitatively determined. The recruitment of actin to sites 
of #tir EPEC adherence was monitored in cells transfected with TirM-TarP FL* or a 
TirM-only negative control. For comparison, cells expressing 1 copy of the tyrosine 
repeat phosphodomain from C. trachomatis serovar L2 (TirM-PD 1xR), a motif 
previously shown to recruit actin when artificially clustered, were also examined. 
Actin recruitment was most commonly observed in EPEC-infected cells expressing 
TirM-FL-TarP* (Figure 3.6A). As expected, actin recruitment was also observed in 
cells expressing the phosphodomain. In addition, heat map analysis of the actin 
profiles demonstrated a clear difference between TirM- and TirM-TarP-FL*- or TirM-
PD 1xR-expressing cells in terms of actin intensity at sites of bacterial adherence 
Scoring individual EPEC particles for colocalisation with actin showed an increase of 
2-fold for TirM-TarP-FL* and TirM-PD 1xR relative to the TirM-only negative control 
(Figure 3.6B). Comparison of the different data sets revealed that actin recruitment 
levels mediated by TirM-PD 1xR or TirM-TarP FL* were significantly different in 
comparison to the negative control (p<0.005). Taken together, the data indicate that 
TarP itself is sufficient to recruit actin and does so at frequencies similar to that of the 
tyrosine repeat domain of C. trachomatis TarP. To discount EPEC effectors other 
than Tir contributing to actin assembly, TirM-TarP FL* expressing cells were infected 
with #escN EPEC, a strain defective in T3S due to the deletion of the ATPase 
component (escN). Similar to #tir infection, TirM-TarP FL* was enriched at sites of 
#escN EPEC adherence (Figure 3.6C). However, with a marked propensity to form 
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dense microcolonies, the MOI of the #escN EPEC strain was difficult to regulate. 
Furthermore, the unique ring-like localisation of actin around some of the #escN 
EPEC particles contrasts with the punctate actin recruitment observed at sites of #tir 
EPEC adherence. This ring-like fluorescence was similar to that reported for intimin 
staining profile of EPEC, suggesting an involvement of intimin signalling. Overall, the 
#escN strain was not seen as an appropriate control to assess actin recruitment 
mediated by TarP. 
 
 
 
 
 
 
 
 
 
 
Figure 3.6- TarP-mediated actin recruitment is qualitatively and quantitatively different to the 
TirM-only negative control. A) Cos7 cells expressing a TarP derivative deleted of the proline-rich 
domain (TarP FL*) or a single tyrosine repeat of the C. trachomatis phosphodomain (TirM-PD 1xR) 
were infected with #tir EPEC and monitored for actin recruitment. TarP, the phosphodomain derivative 
or the TirM-only negative control were visualised with an anti-HA antibody (red), actin with phalloidin 
(green) and #tir EPEC with DAPI (blue). White arrowheads indicate actin and TarP-FL* or PD 1xR 
colocalising with #tir EPEC. Heat map of the actin channel highlights the intensity of actin recruited to 
sites of bacterial adherence. B) The percentage of bound particles recruiting actin was quantified. 
Data compiled from three independent experiments and represented as Box and Whisker plot. Plot 
shows range (statistical outliers excluded), first and third quartiles, and overall median (horizontal line). 
Diamonds show means. A range of 500-830 particles was counted. Insets show a magnification of a 
selected area of the cell. The asterisk and bars indicate significance difference between TarP FL* or 
PD 1xR and the TirM-only negative control (ANOVA (p<0.005) and post hoc testing (Tukey-Kramer; 
!=0.01, q=4.55)). C) Actin recruitment was monitored in Cos7 cells expressing TarP FL* and infected 
with #escN, a mutant EPEC strain defective in type III secretion. Scale bars; 10µm. Heat map 
representation (red, high; violet, low) generated using imageJ.  
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3.3.4 C-terminal truncations indicate a role for an LD motif in actin recruitment  
 
The current model of signalling to the host actin remodelling machinery involves the 
tyrosine-rich repeat region, a domain limited to C. trachomatis. A search of the 
different TarP orthologues identified an LD-like motif at the C-terminal half of C. 
trachomatis and C. caviae TarP orthologues that resembled the mammalian 
signalling LD motif present in paxillin. Further sequence analyses of all available 
TarP sequences revealed a conserved motif L{D/E}xxLLP{L/I} located downstream of 
the previously identified actin-binding WH2-like domains (ABDs) (Figure 3.7A and 
B). 
 
To test if the LD domain contributes to the actin recruitment mediated by TarP, the 
signalling domain of Tir was replaced by truncated versions of GPIC TarP. For 
comparison, cells expressing TirM-TarP FL* were also examined. Actin recruitment 
was most commonly observed in #tir EPEC-infected cells expressing TirM-TarP1-714, 
a C-terminal truncation derivative that retained the LD motif (Figure 3.8A). 
Progressive deletion that removed the LD domain (TirM-TarP-1-639) led to the loss of 
actin recruitment. Scoring individual EPEC particles for colocalisation with actin 
showed an increase of 2-fold for TirM-TarP1-714 relative to the TirM-only negative 
control (Figure 3.8B; p<0.006). Overall, the data indicates a potential role for the LD 
motif in TarP-mediated actin recruitment. This highly conserved chlamydial motif, 
therefore, warranted functional analysis.  
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Figure 3.8- TarP deletion derivatives implicate the LD domain in actin recruitment. A) Cos7 cells 
were transfected with full length TarP (TarP FL*; deleted for the proline rich domain) or TarP deletion 
derivatives lacking the C-terminal 166 amino acids (TarP1-714), the LD domain (TarP1-639) or the TirM-
only negative control. TarP or the TirM-only negative control was visualised with an anti-HA antibody 
(purple), actin with phalloidin (green) and #tir EPEC with DAPI (false-coloured red). White arrowheads 
indicate actin and TarP-FL* or TarP1-714 colocalising with #tir EPEC, or lack thereof in the case of 
TarP1-639- or TirM-expressing cells. Scale bars: 10µm. B) The percentage of bound particles recruiting 
actin was quantified. Data compiled from three independent experiments and represented as Box and 
Whisker plot. Plot shows range (statistical outliers excluded), first and third quartiles, and overall 
median (horizontal line). Diamonds show means. A range of 500-807 particles was counted. Insets 
show a magnification of a selected area of the cell. The asterisk and bars indicate significance 
difference between specific groups (ANOVA (p<0.006) and post hoc testing (Tukey-Kramer; !=0.01, 
q=4.7)). NS; not significant. 
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3.4 Chapter Discussion 
 
Like Tir, TarP is a self-contained effector, the signalling capacity of which is 
modulated in a manner analogous to the localised activation of host cell receptors. 
Replicating the higher-ordered configuration of these effectors has, therefore, been a 
key strategy to addressing signalling capacity. Whilst a number of strategies have 
been used to overcome the inherent difficulty in mutagenising a putative invasion 
factor of an obligate intracellular bacterium, the goal of this project was to adapt and 
optimise a previously described EPEC-based system. The rationale behind this 
decision was based on the emerging modular architecture of TarP and the lack of a 
current system to address potential signalling roles of these molecular determinants 
in vivo. This chapter describes the optimisation of the experimental system with 
regards to cell type, bacterial strain, protein solubility, membrane targeting, and 
multiplicity of infection.  The optimised system led to the functional characterisation of 
various TarP deletion derivatives, and provided the first indication that the candidate 
LD motif may be involved in actin remodelling. 
 
Campellone et al. previously described a system to define the minimal requirements 
for EPEC-mediated actin recruitment (Campellone et al., 2004). To determine if this 
system was applicable for investigations into TarP-mediated actin recruitment, the 
signalling domain of TirMC was replaced by a full-length version of C. caviae GPIC 
TarP.  Initial experiments showed recruitment and aggregation at the plasma 
membrane to be markedly inefficient compared to the positive control, TirMC. Indeed, 
despite the presence of an N-terminal viral membrane-targeting sequence, GPIC 
TarP was found to aggregate in the cytosol akin to the observations reported by 
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Clifton et al (Clifton et al., 2005). Solubility and membrane targeting were improved 
when the PRD was deleted, an observation consistent with the proposed 
oligomerising role for this domain (Jewett et al., 2010). In addition to the nucleating 
function of TarP, the PRD may a play a role in the oligomerisation-dependent 
enhancement of signalling at the point of translocation.  This stems from the 
observed enhanced signalling of membrane-associated molecules including that of 
EHEC Tir, whose signalling depends on the translocated effector EspFu.  Through its 
multiple N-WASp binding domains, EspFu clusters and hyperactivate N-WASp 
molecules to promote pedestal formation (Padrick and Rosen, 2010). It is possible 
that the oligomerisation/clustering of TarP may have a similar effect on signalling to 
the actin cytoskeleton machinery.  Indeed, the downstream signalling component, the 
WAVE2 complex, also exhibits enhanced activation of the Arp2/3 complex when 
clustered (Soderling, 2009).  Whilst the TirM-TarP system may not be optimal for 
addressing the role of oligomerisation, it nonetheless allowed for the careful analysis 
of the function of the domain of interest; and to do so required that solubility and 
plasma membrane targeting take priority.  
 
An unexpected finding was the difference in the ease of quantification of actin 
recruitment in Cos7 cells infected with #escN or #tir strains of EPEC. We observed 
that #escN bacteria formed microcolonies on the cell surface. Whilst actin 
recruitment was consistently observed, enumeration of individual EPEC bacterium 
that recruited actin was difficult.  This was in contrast to the distinct, well-separated 
#tir EPEC bacteria.  
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By establishing an experimental system that yielded robust and quantifiable 
phenotypes, we were able to demonstrate functionality to TarP, and identify the LD 
motif as a candidate domain required for signalling to the actin cytoskeleton. This 
heterologous system should be invaluable in the investigation of the function of the 
LD motif. A recent report by Jiwani et al., described the LD motif, which Jewett et al. 
previously annotated as a defective G-actin binding domain, as an F-actin binding 
motif in vitro (Jiwani et al., 2013, Jewett et al., 2010). We hypothesise that the 
resemblance of the TarP LD motif to the paxillin LD motif indicate a function related 
to signalling, rather than direct actin-binding. 
 
Chapter conclusions 
 
• The EPEC (#tir) system is sufficient to induce the clustering of a C. caviae 
TarP derivative lacking the oligomerising proline rich domain.  
• C. caviae TarP itself is responsible for recruiting actin, and does so at 
frequencies similar to that of the tyrosine repeat domain of C. trachomatis 
o The TirM-only control demonstrated a significantly reduced capacity to 
recruit actin 
o The primary purpose of intimin is to facilitate binding of #tir EPEC 
• Chlamydial TarP contains a putative LD motif usually involved in mammalian 
focal adhesion kinase signalling 
• The LD motif appears to be key to the actin remodelling mediated by TarP, as 
progressive deletion that removed the LD domain led to the loss of actin 
recruitment. 
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Chapter 4- A prokaryotic LD domain functions in FAK-to-Actin signalling 
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4.1 Chapter Introduction  
 
The first reported signalling cascade characterised for TarP involved the C. 
trachomatis-specific phosphodomain at the N-terminus of the protein (Lane et al., 
2008).  Despite this finding, the means by which other chlamydial species invade 
non-phagocytic cells independent of the TarP phosphodomain remained unanswered, 
until the characterisation of the direct actin nucleating activity of TarP. Actin 
nucleation required the WH2-like actin binding domains (ABD) in the C-terminal half 
of TarP, which are conserved amongst Chlamydia species (Jewett et al., 2010). More 
recently, in vitro experiments revealed that TarP also binds F-actin, with the activity 
narrowed to two distinct domains termed Fab1 and Fab2 (Jiwani et al., 2013). 
However, the direct actin nucleation or F-actin binding by TarP does not fully account 
for the observed actin recruitment and bacterial uptake. Inactivation of critical 
signalling molecules like Rac, Cdc42, and the Arp2/3 complex also led to inhibition of 
invasion (Subtil et al., 2004, Carabeo et al., 2004, Carabeo et al., 2007), despite the 
presence of TarP and its actin-nucleating activity.  Furthermore, the antibody-
mediated neutralisation of the ABDs of TarP only decreased invasion efficiency by 
approximately two-fold (Jewett et al., 2010). These observations collectively point to 
the existence of an alternate means of actin remodelling that, in conjunction with 
other actin recruitment strategies to promote efficient invasion of non-phagocytic 
cells.  
 
The signalling protein FAK has been implicated in the invasion of epithelial cells by 
various chlamydial species. For example, Coombes et al. demonstrated the rapid 
phosphorylation of FAK in response to C. pneumoniae infection (Coombes and 
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Mahony, 2002). Further evidence of FAK involvement in Chlamydia infection was 
obtained from an RNA interference screen that identified FAK and its downstream 
signalling components as necessary for C. trachomatis L2 infection in vitro (Elwell et 
al., 2008, Gurumurthy et al., 2010). Despite being implicated in chlamydial infection, 
the specific role of FAK in Chlamydia invasion has not been thoroughly investigated. 
 
 FAK is a cytosolic protein tyrosine kinase (PTK) that functions to regulate cell shape, 
adhesion and motility (Mitra et al., 2005). FAK is most commonly found in focal 
adhesions, where it interacts with integrin-associated proteins, such as talin and 
paxillin, through a C-terminal focal adhesion targeting (FAT) domain. The net result is 
the full activation of FAK and downstream Rho-family GTPases to influence actin and 
microtubule structures (Schaller, 2010) (Figure 4.1). 
 
Binding of paxillin by FAK requires a direct interaction of the FAT domain of FAK and 
the LD motifs of paxillin, with the signature sequence L(D/E)xLLxxL (Brown et al., 
1998, Brown et al., 1996). This motif, of which paxillin has five, is predicted to form 
an amphiphatic !-helix, which forms a hydrophobic interface with the FAT domain of 
FAK (Hayashi et al., 2002).  Of the five LD motifs of paxillin, the second (LD2) and 
fourth (LD4) motifs were implicated in binding FAK (Thomas et al., 1999, Scheswohl 
et al., 2008).  
 
To date, LD motifs with FAK-related functions are only found in eukaryotes, and to 
our knowledge, have not been described for any bacterial Type III effectors. Here, we 
report the characterisation of the LD motif within the C-terminal half of the chlamydial 
effector TarP. This report presents evidence for the functionality of this prokaryotic 
LD motif in signalling to the actin cytoskeleton in a pathway that required FAK and 
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the Arp2/3 complex.  Co-precipitation and cell-based functional assays indicated that 
the leucine residues, which are critical for binding of FAK to paxillin (Scheswohl et al., 
2008, Wade and Vande Pol, 2006), were also important for TarP-LD-FAK interaction.  
Structural modelling of the LD domains belonging to two divergent chlamydial 
species, C. trachomatis and C. caviae, the latter being an animal pathogen, revealed 
the same hydrophobic interactions between the amphiphatic !-helices of TarP LD 
and the FAT domain of FAK.  Together, the data form the first evidence of a 
signalling competent prokaryotic LD domain. 
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4.2 RESULTS 
 
4.2.1 FAK localises to sites of chlamydial attachment and is phosphorylated 
early in infection 
 
The role of FAK in chlamydial invasion has not been thoroughly explored, despite its 
reported phospho-activation during C. pneumoniae infection (Coombes and Mahony, 
2002). To gain insight into the involvement of FAK in chlamydial invasion, the 
localisation of FAK during infection was initially investigated using live cell imaging. 
We observed its immediate and specific localisation to the Chlamydia entry sites in 
cells expressing EGFP-FAK (Figure 4.2).  Arp3-GFP showed a similar transient 
profile of recruitment. 
  
Using confocal microscopy and immuno-electron microscopy, the activation status of 
FAK localizing to chlamydial EBs was investigated. Recruitment of GFP-FAK and/or 
phospho-active FAK (pY397-FAK) to adhered C. caviae GPIC EBs were monitored 
at 0, 10, 30, and 60 min after synchronisation by shift to 37°C incubation, and cells 
were immediately fixed with freshly-prepared paraformaldehyde at the designated 
time points.  As shown in Figure 4.3A, GFP-FAK and pY397-FAK could be observed 
as early as 10 min p.i. This early localisation was confirmed by immuno-EM analysis 
using anti-FAK (phospho Y397) antibody and an anti-rabbit secondary antibody 
conjugated to 15 nm gold (Figure 4.3B). From confocal microscopy images of 
infected cell monolayers expressing GFP-FAK, immunostained for pY397-FAK, or 
both, we quantified the levels of colocalisation of EBs to either one or both markers 
for each time point to gain insight into the relationship between FAK recruitment and 
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phosphorylation.  The graph in Figure 4.3C clearly shows a similar kinetics of 
recruitments of GFP-FAK or pY397-FAK individually, with a peak at 10 min p.i. 
followed by a gradual decrease, indicating that FAK recruitment and its phospho-
activation are related events. These recruitment profiles were confirmed when the 
localisation incidence of both pY397-FAK and GFP-FAK to the same EB was 
quantified, suggestive of rapid FAK phosphorylation associated with its recruitment to 
the sites of invasion. Indeed, there was greater than 60% coincidence of GFP-FAK 
and pY397-FAK recruitment. The recruitment profiles were consistent with the data 
obtained from Western blots of total FAK and pY397-FAK. In the latter, an increase 
was observed at 10 min p.i. (Figure 4.3D) and decreasing by 30 min, while total FAK 
levels remained unchanged. Note that in contrast to the infected 10 min sample, the 
uninfected control displayed a low level of phosphorylation, which we interpreted as 
an infection-dependent induction of FAK phosphorylation at Tyr397.  
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Figure 4.3- Chlamydia attachment induces highly localised recruitment and phospho-activation 
of FAK. A) C. caviae (GPIC) EBs were visualised with DAPI (blue) were added to Cos7 cells and 
infected for 0, 10, 30, or 60 min as described in Methods. Cells were stained with an anti-FAK 
(phospho Y397; red) antibody.  At T=0, we only observed focal adhesion structures, which comprise 
FAK and phospho-active FAK (pY397-FAK).  White arrowheads indicate colocalisation of pY397-FAK 
and GFP-FAK with GPIC EBs, or lack thereof for T=0. Scale bars: 5 !m.  B) Post-embedding 
immunoelectron microscopy of phospho-active FAK. C. trachomatis serovar L2 (L2)-infected HeLa 
cells were fixed 30 post-infection and stained as described in Methods. Activated FAK concentrates 
directly beneath the invading EB. Scale bar: 100 nm C) In separate experiments, EB colocalisation 
with phospho-FAK (pY397-FAK), GFP-FAK, or both was enumerated and data expressed as the 
percentage of total EBs displaying colocalisation. The asterisk and bars indicate significance 
difference between pY397-FAK, GFP-FAK or both from T=0 to T=10 (one way ANOVA, Tukey’s post-
hoc test (q=4.7, !=0.01), pY397-FAK p<0.005; GFP-FAK p<0.004; Both p<0.03). Correlation of the 
recruitment kinetics was tested using the Spearmann’s test for correlation (one-tailed; p< 0.05). Data 
represented as means + SD of two independent experiments. D) HeLa cells were left uninfected, or 
infected with GPIC for 10-120 min. Solubilised lysates were probed with an anti-FAK (phospho Y397) 
or anti-FAK antibody to monitor FAK activation or total FAK, respectively. Exposure to GPIC induced 
FAK Y397 phosphorylation that peaked at 10 min post-infection before returning to basal levels. The 
lane labelled “Uninf 10’” refers to a parallel sample collected at the 10-min time point after mock-
infection. "-tubulin served as a loading control. 
 
 
 
 
4.2.2 Structural modelling of TarP LD interaction with FAK reveals similarities 
with paxillin-FAK interaction 
 
FAK association with signalling partners is conferred by its FAT domain binding to 
the LD motif (LDxxLLxL) via hydrophobic interactions. Prompted by the findings from 
bioinformatics analyses (Figure 4.4A), the TarP LD-like motifs of C. trachomatis and 
C. caviae were modelled structurally to determine their likelihood of interacting with 
FAK. The paxillin LD2 was used as a reference. The modelling experiments 
highlighted the conserved three-dimensional structure of the C. trachomatis serovar 
L2 LD and C. caviae GPIC LD domains and the conserved hydrophobic surface 
complementarity indicated by the white area (Figure 4.4B). Validation of the 
geometry of the modelled L2 LD and GPIC LD domains shows that all nine residues 
of the LD motif are in the allowed region of the Ramachandran plot (Figure 4.5), 
including the proline residue at position 6, the presence of which neither affected the 
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formation of the !-helical conformation of the domains, nor, importantly, the TarP-LD-
FAK hydrophobic interface. The modelling data indicated a likely interaction of TarP 
LD with FAK. The sequence conservation of the LD motif amongst all chlamydial 
species suggested that the modelled hydrophobic interactions between FAT and 
L2/GPIC LD motifs likely applies to the other TarP orthologues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4- Predicted structure of TarP-LD closely resembles paxillin LD2.  A) ClustalW 
sequence alignment of the putative LD domains from TarP orthologues with the representative paxillin 
LD2 motif. Identical amino acids within each alignment are in red. Similar residues are in blue. B) C. 
trachomatis serovar L2 LD (L2; cyan) and C. caviae LD (GPIC; magenta) domains were both 
modelled using the comparative homology modelling program MODELLER (Sali and Blundell, 1993). 
The paxillin LD2 motif (yellow) was used as a template for sequence alignment using T-Coffee 
(Notredame et al., 2000). Superposition between the modelled domains and the crystal structure of 
paxillin LD2 in complex with FAT domain (green) highlights the conserved amphiphatic !-helical 
structure and the conserved hydrophobic amino acid distribution at the protein-protein interface. 
Protein-protein interaction between the GPIC LD (magenta), L2 LD (cyan) and paxillin LD2 (yellow) 
domains and the FAT domain of FAK (1OW8) was modelled. Analysis of the electrostatic surface 
potential highlights the hydrophobicity of the helix-helix interaction. Surface colours: red, negative; 
white, hydrophobic; blue, positive Image was produced using PYMOL 1.4. 
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4.2.3 C. caviae TarP LD domain recruited phospho-activated FAK and actin 
 
Prompted by the findings from the structural modelling experiment, we investigated if 
TarP alone would be sufficient to recruit FAK. Because no robust system is currently 
available for genetic manipulation in the Chlamydiaceae, we utilised a heterologous 
system for the induction of host actin signalling pathways, described previously by 
Campellone et al. (Campellone et al., 2004). In brief, various deletion derivatives of 
TarP were fused with a truncated version of the intimin receptor (Tir) from EPEC 
(Figure 4.6A).  Wild type Tir inserts into a host cell membrane and provides an 
extracellular adhesion domain for bacterial attachment, as well as a cytoplasmic 
actin-signalling domain.  The truncated version of Tir used in this assay lacked any 
original signalling components, while maintaining the extracellular intimin binding 
domain, thus allowing a Δtir EPEC mutant to adhere to a host cell, but not cause 
actin-rearrangement.  By fusing this truncated Tir to various deletion derivatives of 
TarP, we could ascertain the ability of separate motifs to recruit actin-signalling 
molecules to the site of a bacterial adhesion.  In Figure 4.6B, recruitment of 
phospho-active FAK (pY397-FAK) was most commonly observed in EPEC-infected 
cells expressing TirM-TarP FL* or TirM-TarP1-714, a C-terminal truncation derivative 
that retained the LD motif. Only true phospho-FAK recruitment appeared bright and 
punctate and distinct from weak and diffused background fluorescence (see inset). 
Progressive deletion that removed the LD domain (TirM-TarP-1-639) led to the loss of 
pY397-FAK recruitment. Also, TirM fusion of the C-terminal 166 amino acid residues 
downstream of the LD motif was, by itself incapable of recruiting pY397-FAK, 
indicating that the loss of pY397-FAK recruitment in TirM-TarP-1-639 could be  
 
 
 
 
118 
attributed to the deletion of the LD motif and not the downstream terminal 166 amino 
acid residues. Scoring individual EPEC particles for colocalisation with phospho-FAK 
showed an increase of 2.7-fold for TarP-FL* and 2.45-fold for TarP1-714 relative to the 
TirM-only negative control (Figure 4.6C; p<0.00001). Taken together, we concluded 
that TarP itself was sufficient to recruit pY397-FAK, with the putative LD motif 
possibly key to this interaction.  
 
Figure 4.6 
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To further implicate the TarP LD motif, we studied it in isolation, either in the wild 
type or mutant forms. We conducted a mutagenesis of the LD domain, in which the 
conserved leucine residues have been reported to be critical for paxillin LD2-FAK 
interaction (Wade and Vande Pol, 2006, Scheswohl et al., 2008). Cells expressing 
TirM-GPIC LD (Residues 640-740) or a mutant LD (mutLD) containing alanine 
substitutions for the leucine residues were monitored for pY397-FAK recruitment. 
Additionally, pY397-FAK was monitored in cells transfected with TirM-Pax LD2; a 
known FAK-interacting LD motif of the mammalian protein paxillin (Figure 4.7A). The 
incidences of recruitment were clearly greater for GPIC TarP-LD (2.2-fold) and 
paxillin LD2 (2.4-fold), in comparison to the negative control TirM lacking the LD motif  
(Figure 4.7B; p<0.00001). Also, there were no obvious qualitative differences in 
pY397-FAK recruitment intensity between GPIC TarP-LD and paxillin LD2. Mutation 
to the GPIC LD motif, in which leucine residues were changed to alanines, reduced 
pY397-FAK colocalisation incidence by approximately 2-fold relative to wild type LD. 
To confirm that FAK recruitment was LD specific and dependent on the leucine 
residues, biotinylated custom-synthesised oligopeptides were used. FAK was co-
precipitated from the lysates, and visualised by an !-FAK polyclonal antibody. The 
level of co-precipitation was abolished with the mutant oligopeptides (Figure 4.7C), 
confirming a previous report highlighting the importance of the conserved leucine 
residues of the LD domain (Wade and Vande Pol, 2006). In conjunction with results 
shown in Figure 4.6, we concluded that the LD motif of TarP was sufficient to recruit 
Y397-phosphorylated FAK, and equally importantly, at recruitment frequencies 
similar to that of the LD2 domain of paxillin.   
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The same set of TirM fusion constructs were evaluated for their ability to recruit actin 
using the same EPEC-based assay. The transfected cells were infected with EPEC, 
and the samples stained with fluorescent phalloidin to visualise recruited actin by 
confocal microscopy. Incidences of recruitment were determined, and data 
expressed as percentage of total EPEC associated with the cells (Figure 4.8A and 
B). It is evident from the confocal images shown that actin recruitment in TirM-LD or 
Pax LD2-expressing cells was significantly more robust than in cells expressing the 
negative control construct TirM. The data is consistent with the findings that TarP-
mediated actin recruitment requires the LD domain (Figure 3.8A and B). Indeed, 
there was a greater than 75% coincidence of FAK and actin positivity, suggesting 
that the two events are functionality related (Figure 4.9). Quantifying the incidences 
of actin recruitment to adhered EPEC showed 2.3- and 2-fold increases for LD and 
Pax-LD2 respectively, relative to the negative control TirM (Figure 4.8C; (p<0.0003). 
In cells expressing TirM-mutLD, the percentage of actin-positive EPEC was reduced 
2.4-fold relative to LD. Based on these data, we concluded that the LD domain of 
TarP was functional and sufficient to mediate pY397-FAK and actin recruitment.  
 
Figure 4.7- The TarP LD domain is functional and able to recruit Y397-phosphorylated FAK. A) 
Cos7 cells transfected with the plasmid encoding TirM-LD, a mutant LD derivative (TirM-mutLD), the 
FAK-interacting LD2 domain of paxillin (TirM-Pax-LD2) or the control vector TirM were infected with 
#tir  EPEC to induce clustering of the proteins. Cells transfected with constructs were identified by 
staining for the HA-tag present in the fusion proteins. The white arrowheads indicate colocalisation of 
phospho-active FAK (pY397-FAK) with adhered #tir EPEC, or lack thereof in the case of mutLD- or 
TirM-expressing cells. Phospho-active FAK (green) was visualised with an anti-FAK (phospho Y397) 
antibody. Bacteria (blue) were visualised by DAPI. Note the punctate recruitment of phospho-active 
FAK to EPEC in cells expressing TirM-LD or TirM-Pax-LD2. Scale bars: 10 !m.  B) Adhered EPEC 
able to recruit phospho-FAK were enumerated and data represented as Box and Whisker plot. Data 
compiled from three independent experiments. Plot shows range (statistical outliers excluded), first 
and third quartiles, and overall median (horizontal line). Diamonds show means. A range of 650-1300 
particles was counted. Insets show a magnification of a selected area of the cell. The asterisk and 
bars indicate significance difference between specific groups (ANOVA (p<0.00001) and post hoc 
testing (Tukey-Kramer; !=0.01, q=4.59)). NS; not significant. C) Oligopeptide pulldown using HeLa 
cell lysates showed that FAK specifically recognises the TarP LD motif, whilst amino acid substitutions 
abrogated interaction. Lane 1, 10% input; lane 2, wild type LD, lane 3, Leu-to-Ala substitution mutant, 
lane 4, Streptavidin beads only.  
Figure 4.7
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Figure 4.8- The TarP LD domain mediates actin mobilisation. A) Cos7 cells transfected with the 
plasmid encoding TirM-LD, a mutant LD derivative (TirM-mutLD), the FAK-interacting LD2 domain of 
paxillin (TirM-Pax-LD2) or the control vector TirM were infected with #tir  EPEC to induce clustering of 
the proteins. Cells transfected with constructs were identified by staining for the HA-tag present in the 
fusion proteins. The white arrowheads indicate colocalisation of actin with adhered #tir EPEC, or lack 
thereof in the case of mutLD- or TirM-expressing cells. Actin (green) was visualised with phalloidin. 
Bacteria (blue) were visualised by DAPI. Scale bars: 10 !m. B) Adhered EPEC able to recruit actin 
were enumerated and data represented as Box and Whisker plot. Data compiled from three 
independent experiments. Plot shows range (statistical outliers excluded), first and third quartiles, and 
overall median (horizontal line). Diamonds show means. A range of 780-1100 particles was counted. 
Insets show a magnification of a selected area of the cell. The asterisk and bars indicate significance 
difference between specific groups (ANOVA (p<0.0003) and post hoc testing (Tukey-Kramer; !=0.01, 
q=4.82)). NS; not significant. 
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4.2.4 The recruitment of actin by the TarP LD domain requires FAK 
 
The functional relationship between the FAK and actin recruitment by the LD domain 
was investigated in mouse embryo fibroblasts (MEF) genetically ablated for the PTK2 
gene, which encodes for FAK. Demonstrations of FAK-dependent actin recruitment 
by TarP-LD would support a signalling function for this domain. Firstly, because 
FAK-/- cells were reported to exhibit abnormal actin dynamics, possibly through 
hyperactivation of the RhoA GTPase (Ren et al., 2000, Chen et al., 2002, Schober et 
al., 2007), they were infected with wild type EPEC and actin-rich pedestal formation 
was monitored. As shown in Figure 4.10, FAK-/- cells supported EPEC pedestal 
formation. 
 
 
 
 
 
127 
 
Next, FAK+/+ and FAK-/- MEFs were transfected with either TirM-only or TirM-LD 
expression constructs, and the recruitment of actin visualised with Alexa488-
phalloidin.  In addition, the recruitment of the actin-nucleating Arp2/3 complex was 
also monitored by indirect immunofluorescence confocal microscopy using a 
monoclonal antibody against p34Arc.  The incidences of recruitment of actin and 
p34Arc to adhered EPEC particles were quantified.  First, the recruitment of both actin 
and p34Arc were evident in the wild type cells. In contrast, EPEC adhered to TirM-LD-
expressing FAK-/- MEFs that lacked both actin and p34Arc, indicating that FAK was 
essential for the recruitment of both p34Arc and actin.  (Figure 4.11A). The levels of 
colocalisation of EPEC for either actin or p34Arc were quantified for both FAK+/+ and 
FAK-/- cells.  As shown in Figure 4.11B and C, the respective recruitments of actin 
and p34Arc by TirM-LD were largely FAK-dependent; increasing 2.5- and 2.3-fold, 
respectively in FAK+/+ cells (Actin and p34Arc: p<0.00001). We also observed p34Arc 
recruitment in Cos7 cells expressing TirM-LD, but not TirM, indicating that p34Arc 
recruitment was dependent on the presence of the LD domain (Figure 4.12).   
 
These findings raised the possibility that the FAK-dependent actin recruitment 
mediated by the TarP LD domain also required the Arp2/3 complex. To address this 
possibility, a cell-permeable inhibitor (CK-666) that specifically targets Arp2/3-
mediated actin filament nucleation was used. The inhibitor prevents Arp2/3 from 
shifting into an active conformation by targeting the pocket formed by the subdomain 
4 of Arp2 and subdomain 1 of Arp3, without affecting its recruitment to the complex 
(Nolen et al., 2009). As above, FAK+/+ cells were transfected with the TirM-LD 
expression constructs.  Recruitment of actin and Arp2/3 were visualised with 
Alexa488-phalloidin and anti-p34Arc, respectively. Just prior to infection, cells were 
 
 
 
128 
exposed to 100µM CK-666 or the inactive control, CK-689.  In cells treated with the 
CK-689, recruitment of both actin and p34Arc was evident. In contrast, EPEC, 
adhered to TirM-LD-expressing FAK+/+ MEFs exposed to CK-666 lacked actin, but 
not p34Arc, indicating that Arp2/3 activation was essential for LD-mediated actin 
recruitment.  (Figure 4.13A). The levels of colocalisation of EPEC for either actin or 
p34Arc were quantified for both CK-666- and CK-689-treated cells.  As shown in 
Figure 4.13B and C, recruitment of actin, but not p34 Arc, was significantly reduced in 
cells treated with inhibitor (Actin, p<0.005; p34Arc, p<0.3). Taken together, the data 
suggest that TarP-LD signalling to actin is dependent on the Arp2/3 complex 
adopting an active conformation.  More importantly, the data also indicate that TarP, 
via its LD motif, FAK, and the Arp2/3 complex constitute a functional signalling 
pathway to mediate actin recruitment. 
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4.2.5 FAK is required for C. caviae GPIC invasion 
 
The involvement of FAK in the signalling by the TarP LD domain to the Arp2/3 
complex and actin prompted an investigation into its role in C. caviae GPIC invasion. 
To avoid functional redundancy in signalling to the actin remodelling machinery, C. 
caviae GPIC was chosen because it lacked the N-terminal phosphodomain 
previously shown to promote Sos1- and Vav2-mediated actin recruitment (Lane et al., 
2008). Invasion of wild type and FAK-/- MEFs by C. caviae GPIC EBs was performed 
and quantified as previously described (Carabeo et al., 2002). Invasion was 
monitored at various time points, and data was expressed as invasion efficiency per 
cell. The invasion efficiencies of wild type and FAK-/- MEFs were similar at 10 min p.i. 
until the 30-min time point when efficiencies significantly differed (Figure 4.14; 
(p<0.00001). The similar, but low efficiencies of invasion for wild type and knockout 
cells at 10 min p.i. may be related to the method of synchronizing infection that 
involved centrifugation delaying the invasion-related manifestation of FAK deficiency 
(Synchronisation by centrifugation: Subtil et al., 2004). A highly localised recruitment, 
an invasion-related phosphoactivation as monitored by microscopy and Western 
blotting, and a statistically significant reduction of invasion efficiency in FAK-/- cells all 
point to an essential role of FAK in Chlamydia invasion.  
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4.3 DISCUSSION 
 
A number of bacterial pathogens rely on the FAK signalling pathway to invade host 
cells, and this is most commonly achieved by the engagement of integrin receptors 
during adhesion, leading to actin remodelling and engulfment of the pathogen. For 
instance, uptake of Yersinia through invasin-mediated engagement of "1-integrin and 
Streptococcus via fibronectin-binding integrins is dependent on FAK (Bruce-Staskal 
et al., 2002, Ozeri et al., 2001). More recently, FAK has also been shown to play a 
role in integrin #1"5-mediated invasion of Staphylococcus (Agerer et al., 2005). In 
each case, integrin clustering at sites of bacterial attachment leads to the formation 
of focal adhesion complexes and activation of integrin-mediated signalling. 
Furthermore, internalisation of these pathogens is accompanied by increased 
tyrosine phosphorylation of FAK, an indication of its activation (Shi and Casanova, 
2006). When phosphorylated, FAK presents docking sites for SH2-containing 
adapters and other signalling molecules, such as the p85 subunit of the 
phosphatidylinositol 3-kinase (PI3K) (Chen et al., 1996a), which has been implicated 
in Chlamydia pneumoniae invasion (Coombes and Mahony, 2002). For C. caviae, 
FAK activation was observed early in infection. This activation may act as the 
catalyst for downstream signalling and eventual actin remodelling. Thus, rather than 
interpreting the invasion assay data as indicating a role for FAK at later stages of 
invasion, we propose that the absence of early FAK phosphorylation has 
downstream consequences. To address whether phospho-activated FAK is required, 
the invasion efficiency of GPIC could be monitored at 30 min p.i. in FAK -/- cells 
transfected with the non-catalytic C-terminal domain of FAK (FRNK). In any case, 
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manipulation of focal adhesion kinase signalling represents a mechanism to induce 
the cytoskeletal rearrangements required to form invasion-related structures. 
 
The invasion process of the obligate intracellular pathogen Chlamydia also requires 
actin remodelling, but in a manner that involves the T3SS effector and virulence 
factor TarP. This protein stimulates intermolecular interactions with a number of host 
signalling proteins to bring about the actin cytoskeletal remodelling essential for 
chlamydial invasion. The mode by which TarP achieves this has been characterised 
only for the C. trachomatis-specific N-terminal tyrosine-rich repeat targeted by host 
cell kinases for phosphorylation, and the WH2-like actin binding domains conserved 
amongst all chlamydial species (Lane et al., 2008, Jewett et al., 2010).  The exact 
role of ABDs in invasion has not been fully defined in vivo, with the only functional 
data acquired through the neutralisation of the ABD domain function by antibodies 
introduced by either microinjection or protein “transfection” (Jewett et al., 2010). This 
led to a 2-fold reduction in invasion efficiency, and thus, raising the possibility of the 
actin nucleating function of TarP as the invasion mechanism used by all chlamydial 
species. However, this model does not fully explain the numerous reports of the 
chlamydial requirement for host cell signalling to promote invasion (Lane et al., 2008, 
Carabeo et al., 2007, Carabeo et al., 2004, Subtil et al., 2004). The current prevailing 
model is the potential cooperation between the actin nucleating and signalling 
functions of TarP. Although this model has yet to be investigated in detail, a recent 
publication by Jiwani et al. supported a TarP ABD/Arp2/3 complex cooperation 
scenario (Jiwani et al., 2012).  In this report, Jiwani et al. demonstrated cooperation 
in vitro of the ABD domain with the Arp2/3 complex, with the latter artificially 
activated by the addition of the VCA domain of N-WASP (Jiwani et al., 2012). Here, 
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we described the identification and functional characterisation of the LD signalling 
motif within TarP conserved amongst a number of chlamydial species. The 
dependence of actin recruitment on signalling to FAK and the Arp2/3 complex 
contrasts with the findings of Jiwani et al., which showed an F-actin binding activity of 
TarP via the Fab1 and Fab2 domains, the former overlapping with the LD domain.  It 
was clear both from the images and quantification of the level of actin recruitment 
that the LD domain did not efficiently recruit actin to the plasma membrane in FAK-/- 
cells.  If the TarP Fab1 domain had F-actin binding activity, actin should have been 
present.  An obvious explanation for this discrepancy was the difference in the 
experimental system used. Jiwani et al. primarily used purified TarP and derivatives 
to investigate in vitro the interaction of Fab1 (Jiwani et al., 2013). This report relied 
on ectopic expression in cells, and monitoring FAK and/or actin recruitment at the 
plasma membrane.  Whilst the TirM-LD or TirM-TarP1-714 fusion system may not 
accurately reflect the true configuration at the plasma membrane of the TarP 
molecules, it nonetheless demonstrated an ability to recruit FAK to a similar level as 
paxillin LD2.   
 
The loss of actin recruitment by the LD domain in FAK-/- MEFs suggested FAK 
involvement. We contend this to be a true failure in actin recruitment, rather than an 
artefact of abnormally high levels of RhoA activity in these cells that affect non-
specifically actin remodelling, because pedestal formation by wild type EPEC 
remained unaffected.  In conjunction with the lack of FAK and actin recruitment to 
TarP deleted of its LD domain and the LD domain with mutated dileucine motif, we 
conclude that there is true signalling occurring. The signalling pathway presented 
here consists of the TarP LD domain, FAK, the Arp2/3 complex, and actin.  This 
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hierarchy is supported by a number of observations.  First, TarP, specifically the LD 
domain, was implicated in experiments in which this motif was either deleted or 
mutated. Second, in the FAK-/- background, Arp3 and actin failed to be recruited.  
Third, in FAK+/+ cells, the inhibition of the Arp2/3 complex prevented actin recruitment.  
Collectively, the data indicate a recruitment hierarchy of host signalling components 
by a bacterial virulence factor. 
 
We also note that FAK-/- cells remained capable of supporting invasion of 
approximately 30% of the GPIC EBs, thus hinting at an alternate invasion-related 
signalling, which may or may not function via the actin-nucleating function of the 
TarP actin binding domains. An equally plausible model is an invasion mechanism 
that bypasses TarP altogether through the activation of signalling from a number of 
cell surface receptors (e.g. platelet-derived growth factor receptor, fibroblast growth 
factor receptor, etc.) already implicated in Chlamydia invasion (Elwell et al., 2008, 
Kim et al., 2011). While we do not know at this time if there exists a dominant 
pathway of chlamydial invasion, a model invoking multiple invasion strategies makes 
evolutionary sense for an obligate intracellular pathogen to ensure access to the 
protective intracellular niche. Regardless of the details of these invasion-related 
signalling cascades, these pathways must converge on actin. The inhibition of actin 
polymerisation by cytochalasin D and the titration of the Arp2/3 complex by 
overexpressed VCA domain of N-WASp, inhibited the efficiency of chlamydial 
invasion to much lower levels (~10% efficiency) compared to inhibition or depletion of 
upstream signalling components (Carabeo et al., 2002, Carabeo et al., 2007).  Thus, 
regardless of the invasion-related signalling strategy employed by Chlamydia, the 
host Arp2/3 complex remains a critical component in Chlamydia invasion.  
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All species of Chlamydia investigated so far are able to recruit actin, and for some, 
like C. trachomatis, C. pneumoniae, and C. caviae, also recruit and/or activate FAK.  
One of the long-standing questions in the Chlamydia pathogenesis field is the 
mechanism by which Chlamydia recruit actin. It has been established that actin 
recruitment requires the phosphatidylinositol 3-kinase (PI3K), Rac and/or Cdc42, and 
the Arp2/3 complex (Carabeo et al., 2004, Subtil et al., 2004, Coombes and Mahony, 
2002).  The highly conserved nature of the C-terminal half of TarP from all Chlamydia 
species sequenced to date made this region a perfect candidate to investigate.  And 
in this report, we provided evidence that fit with previously published reports - LD 
domain conservation in all Chlamydia species, and signalling to the Arp2/3 complex. 
Based on this fit with previous reports, and the data presented here, it is likely that 
Fab1 may instead function as an LD motif to recruit FAK to initiate signalling to the 
Arp2/3 complex and the actin cytoskeleton. However, it also remains possible that a 
pan-chlamydial mechanism of invasion may be TarP-independent.  That is, a 
ubiquitous host cell receptor, when bound by chlamydial EBs, triggers a signalling 
cascade that results in actin cytoskeletal remodelling. However, a common receptor 
used by all chlamydial species has yet to be identified, and those implicated in 
invasion of one species have yet to be tested for all chlamydial species. Here, we 
propose a TarP-based invasion mechanism that depends on the conserved TarP LD 
(Figure 4.15). Structural modelling was able to provide significant insight into the 
TarP LD-FAK interaction and overcome the difficulties in interrogating the nature of 
this interaction using conventional molecular biology approaches. 
 
Finally, in a broader context of microbial pathogenesis, the presence of a signalling 
competent LD domain in a bacterial virulence factor was an unexpected finding, but 
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given that an obligate intracellular pathogen like Chlamydia has co-evolved with 
eutherians it should not be surprising that the bacterium has adapted host strategies 
to ensure its survival. From multiple evidence of functionality, and the inability of the 
LD domain to recruit a different focal adhesion protein, namely vinculin (Chapter 5; 
Figure 5.15B and C), it is likely that the interaction observed was indeed a bona fide 
LD-TarP interaction similar to what is observed between FAK and paxillin.  Together, 
the data highlights two important findings - i) that the domain is not unique to 
eukaryotes, and ii) that this is a unique bacterial strategy to usurp FAK signalling of 
the host cell. Interestingly, structural mimicry as a pathogenic mechanism is not 
limited to the manipulation of FAK signalling. The next chapter will provide evidence 
and discuss the implications of Chlamydial mimicry of talin to subvert vinculin 
functions.  
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4.4 CHAPTER CONCLUSIONS 
 
- The paxillin LD motifs function as the binding site for the focal adhesion kinase 
(FAK). 
- An LD-like motif is conserved in all TarP orthologs investigated 
- Structural modelling of the TarP LD-FAK interaction revealed common features 
with that of paxillin LD-FAK binding including the formation of the hydrophobic 
interface. 
- FAK recruitment by C. caviae TarP requires the LD motif 
- TarP-LD alone is sufficient to recruit phospho-active FAK (pY397-FAK) leading to 
FAK- and Arp2/3–dependent actin recruitment. 
o Frequencies of pY397-FAK or actin recruitment by TarP-LD were similar to 
that of the FAK-interacting LD2 domain of paxillin 
- LD-mediated actin recruitment requires FAK and Arp2/3 
- TarP functional mimicry of the mammalian LD motif represents a pan-chlamydial 
invasion mechanism and a novel means of subverting mammalian FAK signalling 
by bacterial pathogens 
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Chapter 5- The Chlamydia effector TarP modulates vinculin activity 
during invasion 
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5.1 Chapter Introduction  
 
In mammalian cells, the actin-binding protein vinculin associates with the cytoplasmic 
face of focal adhesions to facilitate linkage of integrin adhesion molecules to the actin 
cytoskeleton. Like FAK, vinculin is a frequently used marker for focal adhesions, the 
most stable and mature type of cell-matrix adhesion. Upon cell adhesion, talin rapidly 
accumulates at focal contacts prior to the recruitment of vinculin that ultimately 
strengthens adhesions and promotes maturation. Talin comprises a head domain 
that can bind integrin directly and a larger tail domain that can bind least one actin 
filament. Recent genetic, biochemical, and structural data have shown that that talin 
is essential for the assembly of multiprotein complexes following integrin clustering.  
 
Structurally, vinculin is composed of three major domains: an N-terminal head (Vh), a 
flexible proline-rich hinge region, and a C-terminal tail domain (Vt). Intramolecular 
associations between the head and tail domains constrain vinculin to an inactive 
state. Upon integrin engagement, locally applied tensile force enhances vinculin 
recruitment by exposing Vinculin Binding Sites (VBS) buried in the talin tail domain. 
Talin initially associates with Vh domain 1 (Vh1) of inactive vinculin through 
hydrophobic surface interactions. Switching to an open, active conformation allow for 
complete binding of vinculin to talin and is crucial to allow for direct interaction with 
Arp2/3 to the neck and actin, PIP2, and paxillin to Vt.  Thus, the binding of vinculin to 
talin can facilitate a localised increase in the number actin filaments and the number 
of focal adhesion forming molecules recruited to focal adhesions (reviewed in: 
Ziegler et al., 2006)(Figure 5.1).  
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Not surprisingly, a number of bacterial pathogens have been shown to employ 
vinculin to facilitate entry into host cells. Focal adhesion proteins including talin and 
vinculin have been found to accumulate within Salmonella-induced membrane ruffles 
(Finlay et al., 1991). More recently, the Rickettsia cell surface antigen, sca4, and the 
Shigella flexneri effector protein, IpaA, have been shown to bind and activate vinculin 
(Park et al., 2011a, Tran Van Nhieu et al., 1997, Nhieu and Izard, 2007). Both sca4 
and IpaA permit connections to host F-actin by functioning as talin mimics to bind 
and activate vinculin (Park et al., 2011b, Hamiaux et al., 2006, Park et al., 2011a). In 
each case, the invasins harbour at least two VBS domains that can bypass the pre-
activation steps required for the binding of talin to vinculin. For Rickettsia and S. 
flexneri, this strategy effectively sequesters the essential F-actin binding protein that 
is vinculin to permit invasion, motility and cell-cell spread.  
 
To date, the question of whether vinculin plays a role in Chlamydia invasion remains 
largely unknown. The requirement for FAK, one of the major kinases implicated in 
focal adhesion signalling, suggests that other focal adhesion proteins may be 
involved. Indeed, RNA interference screens have identified a number of downstream 
components including Dock180, talin, and vinculin, as necessary for C. trachomatis 
L2 infection in vitro (Gurumurthy et al., 2010, Elwell et al., 2008). In this study, we 
show that vinculin can be recruited by Chlamydia in a FAK-independent fashion, and 
demonstrate that vinculin is required for chlamydial invasion.  Bioinformatic studies 
identified three putative VBSs located at the C-terminus of TarP, and there appears 
to be a variation in the numbers of VBSs found in the different chlamydial TarP 
orthologues. Evaluation using the EPEC-based system found C. caviae TarP to co-
localise with vinculin, binding through functional VBS motifs akin to the IpaA and 
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sca4 invasins. Recently, in vitro experiments revealed that TarP binds F-actin 
through two distinct domains termed Fab1 and Fab2, the latter overlapping with 
VBS3 of C. caviae TarP (Jiwani et al., 2013). Here, we show that in cultured cells, 
VBS-mediated actin recruitment requires vinculin, indicating that it functions in 
signalling, rather than direct binding to F-actin. To further support this signalling 
function, the VBS motifs were found to positively influence the actin-recruiting 
function of the FAK-interacting LD domain.  Overall, we propose that the importance 
of the conserved VBS motifs in chlamydial invasion rests on its function to signal to 
the actin recruitment machinery.   
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5.2 RESULTS 
 
5.2.1 Chlamydia requires vinculin for invasion 
 
The recruitment of FAK to sites of chlamydial attachment and its requirement for 
invasion points towards the induction of focal adhesion-like complexes. Indeed, GFP-
talin and GFP-paxillin were found to be strongly concentrated beneath invading 
bacteria and colocalising with actin. In addition, the microtubule end binding protein 1 
(EB1), reportedly involved in regulating focal adhesion stability, was also found to 
localise to invading EBs (Figure 5.2). 
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Like FAK, vinculin is a frequently used marker of focal adhesions and has been 
shown to be a target of a number of microbial pathogens as they take advantage of 
its ability to mobilise actin. Given the data presented here and elsewhere 
demonstrating the involvement of various focal adhesion components during 
chlamydial infection (Gurumurthy et al., 2010, Coombes and Mahony, 2002, Elwell et 
al., 2008), it seemed appropriate to interrogate vinculin. The potential requirement for 
vinculin was investigated in vcl-/- MEFs.  To avoid functional redundancy in signalling 
to the actin remodelling machinery, C. caviae GPIC was chosen because it lacked 
the N-terminal phosphodomain previously shown to promote Sos1- and Vav2-
mediated actin recruitment (Lane et al., 2008). Invasion of wild type (WT) and vcl-/- 
MEFs by C. caviae GPIC EBs was performed and quantified as previously described 
(Carabeo et al., 2002). Invasion was monitored at various time points, and data was 
expressed as invasion efficiency per cell. The invasion efficiencies of wild type and 
vcl-/- MEFs were significantly different as early as 5 min p.i., a difference that 
increased further at 15 min p.i. (Figure 5.3; (p<0.008)). Overall, the data highlights 
the importance of vinculin for the efficient invasion by C. caviae.   

 
 
 
151 
 
5.2.2 Chlamydia recruits vinculin to sites of infection 
 
Vinculin localisation to the sites of invasion was also evaluated. HeLa cells were 
infected with C. caviae GPIC and recruitment monitored at 0, 10 and 30 min after 
synchronisation by shift to 37°C incubation. Cells were immediately fixed with freshly 
prepared paraformaldehyde at the designated time points.  As shown in Figure 5.4A, 
vinculin was observed to be strongly concentrated around EBs as early as 10 min 
post-infection. From confocal microscopy images of infected cell monolayers, we 
quantified the levels of colocalisation of EBs to vinculin for an extended time point up 
to 120 min p.i. The graph in Figure 5.4B clearly shows recruitment at 10 min p.i., and 
that these levels remain elevated until at least 120 min p.i.  
 
FAK is one of the first cytoplasmic proteins recruited to clustered integrins, where its 
phosphorylation facilitates the expansion of the multiprotein cell adhesion complex, 
which includes vinculin. Because of the prominent role of FAK in the recruitment of 
vinculin to focal adhesions, its role in vinculin localisation at the sites of entry was 
investigated. Vinculin recruitment was monitored at 30 min post-infection in wild type 
and FAK-/- MEFs infected with C. caviae GPIC. In cells lacking FAK, vinculin was still 
found to localise with chlamydial EBs (Figure 5.5), indicating a FAK-independent 
recruitment of vinculin at sites of invasion.  
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Figure 5.4- Chlamydia recruits vinculin to sites of infection. C. caviae (GPIC) EBs were visualised 
with DAPI were added to Cos7 cells and the infection allowed to proceed for 0, 10, 30, 60, 90 or 120 
min as described in Methods. Cells were stained with an anti-vinculin antibody. Note the increase in 
the number of co-localisation events from 0 to 10 min and the continued colocalisation of EBs (false-
coloured green) and vinculin (red) up to 120 min post-infection. Scale bars: 5 !m. Insets show a 
magnification of a selected area of the cell. White arrowheads indicate vinculin colocalising with GPIC 
EBs, or lack thereof in the case of T=0. B) EB colocalisation with vinculin was enumerated and data 
expressed as the percentage of total EBs displaying colocalisation ± SD of two independent 
experiments. 
 
 
 
 
5.2.3 C. caviae TarP is sufficient to recruit vinculin  
 
The type III effector TarP is capable of interacting with a variety of host signalling 
molecules (Lane et al., 2008), and thus, potentially implicating it in vinculin 
recruitment. To test this hypothesis, the EPEC-based system was used to investigate 
TarP in isolation. Briefly, the TarP domain of interest was fused to the extracellular  
and transmembrane domains of Tir, and expressed in host cells where it is targeted  
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at the plasma membrane (Campellone et al., 2004). This enabled the functional 
characterisation of TarP derivatives in isolation. In Figure 5.6A, vinculin recruitment 
was most apparent in EPEC-infected cells expressing TirM-TarP FL*. Progressive 
deletion that removed the C-terminal 166 amino acid residues led to a demonstrable 
loss of vinculin recruitment, indicating that this region could be attributed to TarP co-
opting vinculin activities. As expected, actin recruitment was still observed in cells 
expressing TarP1-714, a TarP deletion derivative that has retained the LD domain. 
Scoring individual EPEC particles for colocalisation with vinculin showed an increase 
of 3.1- and 8.9-fold for TirM-TarP1-714 and TarP-FL*, respectively, relative to the TirM-
only negative control (Figure 5.6B; (p<0.00001). Taken together, we concluded that 
TarP itself was sufficient to recruit vinculin, requiring the C-terminal 166 amino acid 
residues. 
 
To further implicate this C-terminal domain of TarP in vinculin recruitment, we studied 
this 166 amino acid region (TarP714-880; Figure 5.7A) in isolation. Vinculin recruitment 
was clearly greater for TirM-TarP714-880 (9.5-fold) relative to the TirM-only control 
(Figure 5.7B and C; p<0.00001). Heat map analysis revealed notable differences in 
vinculin recruitment intensity between TirM and TirM-TarP714-880.    
Figure 5.6- TarP-mediated vinculin recruitment requires the C-terminal 166 amino acids A) Cos7 
cells transfected with plasmids encoding full length TarP (TirM-TarP FL*), progressive TarP deletion 
derivatives (TirM-TarP1-714 or TirM-TarP-1-639) or the TirM control were infected with Dtir  EPEC to 
induce clustering of the fusion protein. Transfected cells were identified by their ability to bind Dtir  
EPEC. The white arrowheads indicate colocalisation of vinculin (red) and actin (green) with Dtir EPEC 
(blue), or lack thereof in the case of TarP1-639-, Tarp1-714- or TirM-expressing cells. Vinculin was 
visualised with an anti-vinculin antibody and actin with phalloidin. Bacteria were visualised by DAPI 
staining. Scale bars: 10 !m. Refer to Figure 4.6A for schematic of TarP and its deletion derivatives B) 
Adhered EPEC able to recruit vinculin were enumerated for TirM, TirM-TarP-1-639, TirM-TarP1-714 and 
TirM-FL-TarP*, and data represented as Box and Whisker plot. Data compiled from three independent 
experiments. Plot shows range (statistical outliers excluded), first and third quartiles, and overall 
median (horizontal line). Diamonds show means. A range of 360-600 particles was counted. Insets 
show a magnification of a selected area of the cell. The asterisk and bars indicate significance 
difference between specific groups (ANOVA (p<0.00001) and post hoc testing (Tukey-Kramer; a=0.01, 
q=4.8)). NS; not significant. 
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Figure 5.7- The region encompassing the C-terminal 166 amino acids of TarP is functional and 
able to recruit vinculin. A) Schematic of full length C. caviae TarP deleted of the proline rich domain 
(TarP FL*) and the C-terminal 166 amino acids of TarP (TirM-TarP714-880) indicating the locations of 
the N-terminal membrane targeting sequence (yellow box), Ha-tag (brown box), TirM (amino acids 
260-395; orange box), actin binding domains (red box) and the LD domains (blue box). The numbers 
indicate amino acid positions encoded within the C. caviae TarP gene. * denotes TarP derivative 
deleted for the PRD. B) Cos7 cells transfected with plasmids encoding TirM-TarP714-880 or the TirM 
control were infected with #tir  EPEC to induce clustering of the fusion protein. Transfected cells were 
identified by their ability to bind #tir  EPEC. Heat map of the vinculin channel highlights the intensity of 
vinculin recruited to sites of bacterial adherence.  The white arrowheads indicate colocalisation of 
vinculin (red) with #tir EPEC (false-coloured green), or lack thereof in the case of TirM-expressing 
cells.  Vinculin was visualised with an anti-vinculin antibody. Bacteria were visualised by DAPI staining. 
Scale bars: 10 !m. Heat map representation (red, high; violet, low) generated using imageJ. C) 
Adhered EPEC able to recruit vinculin were enumerated for TirM or TirM-TarP714-880 and data 
represented as Box and Whisker plot. Data compiled from three independent experiments. Plot shows 
range (statistical outliers excluded), first and third quartiles, and overall median (horizontal line). 
Diamonds show means. A range of 310-680 particles was counted. Insets show a magnification of a 
selected area of the cell. The asterisk and bars indicate significance difference between specific 
groups ANOVA (p<0.00001) and post hoc testing (Tukey-Kramer; !=0.01, q=4.45)). NS; not 
significant. 
 
 
A hallmark of vinculin activation is its ability to bind to F-actin.  Cells expressing TirM-
TarP714-880 were monitored for actin recruitment to examine whether the vinculin 
recruitment was accompanied by actin. The transfected cells were infected with 
EPEC, and the samples stained with fluorescent phalloidin to visualise recruited actin 
by confocal microscopy. As shown in Figure 5.8A, actin recruitment in TirM-TarP714-
880-expressing cells was significantly more robust than in cells expressing the 
negative control construct TirM. In addition, the frequencies of actin recruitment were 
significantly greater (3.45-fold) relative to the TirM-only control (Figure 
5.8B;p<0.00001). Taken together, we concluded that the TirM-TarP714-880 is 
functional and primarily responsible for TarP-mediated vinculin and actin recruitment.  
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5.2.4 Identification of VBS motifs in the chlamydial effector TarP 
 
Some proteins that interact with vinculin, including the focal adhesion-associated 
talin require vinculin binding sites (VBS). To identify putative VBS motifs within TarP, 
a 19-residue consensus motif (LLxAAKAVADAxSKLLKAx) for vinculin recognition 
was generated by aligning the eleven VBSs of talin (Gingras et al., 2005), the three 
VBSs of IpaA (Park et al., 2011b) and the two VBSs of sca4 (Park et al., 2011a), and 
used to identify a potential VBS within the C-terminal portion of TarP. As shown in 
Figure 5.9A, C. caviae Tarp harbours three candidate VBSs with VBS1 being the 
most C-terminal. These motifs were predicted to form amphiphatic #-helical 
secondary structure, a conserved feature of all known VBSs. Further analysis of all 
available TarP sequences identified between 1 and 3 VBSs arranged in tandem 
within the C-terminal 166 amino acid region, which will now be referred to as the 
Vinculin Binding Domain (VBD; Figure 5.9B).   
 
Interestingly, helical wheel representation of the C. caviae TarP VBS motifs showed 
VBS1 to be most similar to the C-terminal VBS of IpaA (IpaA-VBS1), with 
comparable directions and magnitudes of the hydrophobic moments. Conversely, 
VBS2 or VBS3 had smaller magnitudes of the hydrophobic moments, which indicate 
lower amphiphilicity (Figure 5.10A, B and C). Izard et al. reported that there are at 
least two residues of the IpaA-VBS1 consensus, Tyr-2 and Ala-4, which contribute to 
very high-affinity interactions with the hydrophobic interface with vinculin (Izard et al., 
2006). For the TarP VBS motifs, it is clear that there is a perfect conservation of the 
alanine residue at position 5 and considerable variation at position 2. Indeed, the  
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histidine residue present in VBS3 is contrary to the conservation of a hydrophobic 
residue as this position for all known VBSs. For VBS1, a leucine residue at position 2 
is consistent with the consensus VBS sequence (Figure 5.10C). 
 
Finally, it is interesting to note that the VBS2 helix harbours a proline residue, which 
could possibly affect the formation or the stability of the amphiphatic #-helix to some 
degree. To gain further structural insight, the Tarp VBS motifs were modelled and 
aligned to the solved structure of IpaA VBS1 bound to the Vh1 domain (Figure 
5.11A) of vinculin. Notable features include the conserved three-dimensional 
structure of the TarP VBS motifs (Figure 5.11B) and the hydrophobic face crucial for 
interaction with Vh (left images in Figure 5.11C). Generally, polar residues appear to 
be conserved on the side of the amphiphatic a-helices exposed to the solvent (right 
images in Figure 5.11C). The first three amino acids of VBS2, including the proline 
at position 2, were not predicted to form !-helical structure, resulting in a motif that 
does not associate with the entirety of the hydrophobic groove. Overall, the structural 
modelling and cell based colocalisation experiments suggested that C. caviae TarP 
harbours three VBS motifs individually capable of directly manipulating vinculin.  
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Figure 5.11- Predicted structure of C. caviae TarP VBS1 closely resembles IpaA VBS1. A) 
Solved structure of the vinculin Vh1 hydrophobic groove shown to interact with IpaA VBS1 (Izard et al., 
2006) B) Shigella flexneri IpaA VBS1 (cyan), C. caviae GPIC VBS1 (yellow), GPIC VBS2 (orange) and 
GPIC VBS3 (purple) domains were modelled using PYMOL 1.4. The IpaA VBS1 motif was used as a 
template for sequence alignment using PYMOL 1.4. B) Superposition between the modelled domains 
and the crystal structure of IpaA VBS1 in complex with the Vh1 hydrophobic groove of vinculin (not 
shown) highlights the conserved amphiphatic !-helical structure. C) Protein-protein interaction 
between IpaA VBS1, GPIC VBS1, GPIC VBS2 or GPIC VBS3 motifs and the Vh1 hydrophobic groove 
of vinculin was modelled. Analysis of the electrostatic surface potential highlights the hydrophobicity of 
the helix-helix interaction. Surface colours: red, negative; white, hydrophobic; blue, positive. Note the 
apparent reduction in amphiphilic character of GPIC VBS2 and VBS3 in comparison to GPIC VBS1. 
Image was produced using PYMOL 1.4. 
 
 
5.2.5 Functional analysis of VBD derivatives reveals an important role for VBS1 
 
The S. flexneri effector IpaA possesses three functional VBSs in tandem 
arrangement, of which the highest affinity C-terminal motif has been proposed to 
function as the trigger for vinculin activation (Izard et al., 2006). Like the IpaA effector, 
C. caviae TarP harbours three VBS motifs. A number of VBD derivatives were 
constructed for use with the EPEC system (Figure 5.12A) to evaluate the various 
combinations of VBSs with regards to frequency or intensity of vinculin recruitment, 
with the latter represented as heat-map images. As shown in Figure 5.12 B and C, 
deletion of select VBS motifs amino-terminal to VBS1 (TirM-#VBS2, TirM-#VBS3 or 
TirM-#VBS2,3) had no influence on the quantitative or qualitative aspects of vinculin 
recruitment in comparison to the wild type VBD. Progressive deletions of the VBD 
that removed VBS1 (TirM-#VBS1) or VBS1 and VBS2 (TirM-#VBS1,2) led to a 
reduction of vinculin and actin staining intensity. Scoring individual EPEC particles for 
colocalisation with vinculin demonstrated that vinculin recruitment frequencies 
decreased 1.6 and 2.4-fold in cells expressing TirM-#VBS1 or TirM-#VBS1,2 
respectively, relative to wild type VBD (Figure 5.12 C; p<0.03). The data highlights  
the greater importance of VBS1 relative to either VBS2 or VBS3, in agreement with  
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predictions raised by the structural modelling analyses. Also, a VBD mutant 
derivative (VBS1mut-2-3) in which the conserved hydrophobic residues of VBS1 were 
substituted for hydrophilic serine, showed similar recruitment frequencies to #VBS1 
(Figure 5.12C). VBS1 appears to be the most effective as a signalling determinant, 
which may be facilitated by the preservation of structural features related to efficient 
vinculin binding. In the presence of VBS1, these VBS motifs could represent a 
strategy to amplify TarP signalling and promote rapid changes in the actin 
cytoskeleton. 
 
Figure 5.12 
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5.2.6 VBD-mediated actin recruitment is vinculin-dependent 
 
Prompted by the observation that the robustness of vinculin recruitment influenced 
the intensity of the actin aggregates, we next investigated the role of vinculin in 
mouse embryo fibroblasts (MEF) genetically ablated for the vinculin gene (vcl). When 
TirM-TarP-VBD was ectopically expressed in both vcl+/+ and vcl-/- cells, only the 
former supported actin recruitment (Figure 5.13A). Quantification of bacteria 
displaying strong F-actin aggregates at the adhesion sites revealed an approximately 
3-fold increase in the incidence of actin recruitment in wild type cells (Figure 5.13B; 
p<0.00001).  In addition, there was a greater than 73% coincidence of vinculin and 
actin positivity in Cos7 cells (Figure 5.8A), suggesting that the two events are 
functionality related.  
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5.2.7 Investigations of the LD and VBS motifs together highlight a potential 
modulatory trend 
 
In C. caviae-infected Cos7 cells, FAK and vinculin colocalised early in infection 
(Figure 5.14).  The colocalisation of FAK and vinculin at sites of entry could be 
influenced by the proximity of the LD and VBD domains in TarP. To investigate this 
possibility, TirM-LD-VBD fusion protein (Figure 5.15A) was expressed in cells, and 
its ability to recruit pY397-FAK or vinculin was monitored in parallel with TirM-LD and 
TirM-VBD (Figure 5.15B).  The presence of either the LD or the VBD domain had no 
effect on the recruitment of vinculin or pY397-FAK, respectively (Figure 5.15C). In 
contrast, the TirM LD-VBD clusters colocalised with more intense actin aggregates 
than either LD or VBD alone (Figure 5.16A). Scoring individual EPEC particles for 
colocalisation with actin showed an increase of 3.5-fold for LD-VBD relative to the 
TirM-only negative control (Figure 5.16B; (p<0.00001). Overall, the data indicated 
that the VBD and LD domains cooperate to enhance actin recruitment.   
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Figure 5.15- The LD-VBD protein is functional and able to recruit phospho-active FAK or vinculin. A) 
Schematic of full length TarP (TarP-FL) or its derivative, the LD-VBD, which represents a 
combination of the TarP LD domain and the TarP Vinculin Binding Domain (VBD). Indicated are 
the locations of the membrane targeting sequence (MTS; cyan box), Ha-tag (red box), TirM 
(amino acids 260-395; purple box), actin binding domains (red box), the LD domains (blue box), 
VBS3 (brown box), VBS2 (orange box) and VBS1 (yellow box). The numbers indicate amino 
acid positions encoded within the C. caviae TarP gene. B) Cos7 cells transfected with the 
plasmid encoding LD-VBD were infected with #tir  EPEC to induce clustering of the proteins. 
Transfected cells were identified by the capacity to facilitate bacteria attachment. The white 
arrowheads indicate colocalisation of phospho-active FAK (pY397-FAK) or vinculin with 
adhered #tir EPEC. pY397-FAK (green) and vinculin (red) were visualised with an anti-FAK 
(phospho Y397) or an anti-vinculin antibody, respectively. Bacteria (false-coloured green 
(vinculin) or red (pY397-FAK)) were visualised by DAPI. Scale bars: 10 !m. C) and D) Adhered 
EPEC able to recruit vinculin (C) or pY397-FAK (D) were enumerated and data represented as 
Box and Whisker plot. Data compiled from two independent experiments. Plot shows range 
(statistical outliers excluded), first and third quartiles, and overall median (horizontal line). 
Diamonds show means. Roughly 200 particles were counted for both conditions. The asterisk 
and bars indicate significance difference between specific groups (ANOVA: pY397-FAK: 
p<0.00001, Tukey-Kramer; !=0.01, q=4.59; vinculin: P<0.00001, Tukey-Kramer; !=0.01, q=4.7)). 
NS; not significant. For comparison, previously quantified data for the LD domain alone or the 
VBD domain alone with pY397-FAK or vinculin was included. 
 
 
 
 
 
 
 
 
Figure 5.16- The LD-VBD induces robust actin recruitment. A) Cos7 cells transfected with the 
plasmid encoding LD-VBD were infected with #tir  EPEC to induce clustering of the proteins. 
Transfected cells were identified by the capacity to facilitate bacteria attachment. Heat map of the 
actin channel highlights the intensity of actin recruited to sites of bacterial adherence. The white 
arrowheads indicate colocalisation of actin with adhered #tir EPEC. Actin (green) and bacteria (false-
coloured red) were visualised with phalloidin or DAPI, respectively. Scale bars: 10 !m. Heat map 
representation (red, high; violet, low) generated using imageJ.   B) Adhered EPEC able to recruit actin 
were enumerated and data represented as Box and Whisker plot. Data compiled from three 
independent experiments. Plot shows range (statistical outliers excluded), first and third quartiles, and 
overall median (horizontal line). Diamonds show means. A range of 300-680 particles were counted. 
Insets show a magnification of a selected area of the cell. The asterisk and bars indicate significance 
difference between specific groups (ANOVA p<0.00001) and post hoc testing (Tukey-Kramer; !=0.01, 
q=4.59). For comparison, previously quantified data for the LD domain alone or the VBD domain alone 
actin was included. 
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5.3 Chapter Discussion 
 
Vinculin is exploited by a number of microbial pathogens as a means of facilitating 
productive infection.  Shigella flexneri, Rickettsia, Enteropathogenic E. coli (EPEC) 
have all been reported to subvert vinculin functions directly through type III-secreted 
effectors (S. flexneri and EPEC (Freeman et al., 2000, Park et al., 2011b)) or cell 
surface antigens (Rickettsia (Park et al., 2011a)). In each case, vinculin recruitment 
is regarded as a mechanism to induce localised actin remodelling. Here, we show 
that vinculin is a cellular target for invasion-associated effector TarP and is required 
for chlamydial entry. Our results reveal that chlamydiae have engineered vinculin 
binding sites that share a remarkable level of homology with the VBSs of talin. It is 
now clear that Chlamydia employ a number of strategies to hijack actin 
polymerisation, with evidence pointing towards mimicry as the prevailing theme.  
 
 An important component of focal adhesion structures, vinculin functions to anchor 
the actin cytoskeleton to the plasma membrane via the "1 cytoplasmic domain of 
integrins. Binding of the tail domain (Vt) to F-actin requires that vinculin adopts an 
activated “open conformation.” Recently, the VBSs of talin have been reported to be 
triggers that activate vinculin by binding to its head domain (Vh1) and displacing 
interactions with Vt (Bois et al., 2006). The Sca4 and Ipa invasins of S. flexneri and 
Rikettsia, repesectively, have been previously shown to colocalise with vinculin. 
Interestingly, biochemical work demonstrated that this occurs through mimicry of the 
talin-vinculin interaction and, thus, represents a direct mechanism to manipulate 
vinculin function. The binding of the sca4 or IpaA VBSs to the Vh1 domain can 
displace the intramolecular interactions with the Vt domain to facilitate vinculin 
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activation and, ultimately, actin recruitment (Park et al., 2011a, Park et al., 2011b, 
Hamiaux et al., 2006). Importantly, this scenario bypasses the “pre-activation” steps 
described for talin-mediated vinculin activation (Fillingham et al., 2005, Grashoff et al., 
2010, del Rio et al., 2009), allowing these effectors to efficiently sequester this F-
actin binding protein for pathogenic purposes. Interestingly, the recruitment of 
vinculin observed during Chlamydia infection was due to a C-terminal VBD within 
TarP. Chlamydia TarP orthologs harbour variable numbers of VBS motifs that 
together comprise the VBD. Like IpaA, the VBD of C. caviae TarP possesses three 
VBS motifs and functions to recruit actin in a vinculin-dependent fashion. The high 
local concentration of these VBS motifs would ensure a tight association with vinculin. 
Indeed, the structural modelling experiments suggested that all three VBS motifs of C. 
caviae could associate with vinculin within the hydrophobic groove of Vh1, albeit with 
potentially different affinities. Indeed, such may be the case for S. flexneri. Izard et al. 
proposed that IpaA alters vinculin function through its high-affinity interaction 
between its VBS1 and the vinculin Vh domain (Izard et al., 2006). It was suggested 
that this interaction bypasses the force generation requirement (del Rio et al., 2009) 
to bind and activate vinculin.  
 
Interestingly, TarP harbours three VBSs with variations in amino acid residues in the 
hydrophobic face of the amphiphatic !-helices that likely manifest as differences in 
the strength of interaction with vinculin. The three VBSs of IpaA appear to have 
different roles in Shigella entry, which has been traced to differences in affinity for 
vinculin (reviewed in (Carayol and Tran Van Nhieu, 2013). The most carboxy-
terminal VBS1 promotes vinculin activation by functioning as a supermimic of talin. 
Coincidentally, the most C-terminal VBS of TarP (VBS1), which most closely 
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resembled the IpaA VBS1, demonstrated the highest level of vinculin recruitment. 
When deleted for VBS1, the remaining VBS2 and VSB3 domains were less able to 
recruit vinculin. Thus, it appears that the configuration of TarP VBSs reflect that 
found in IpaA.  It would be of interest to investigate in greater detail the functions of 
TarP VBS2 and VBS3, which may include stabilisation and maturation of the protein 
complex to maintain vinculin activation and actin binding. 
 
The dependence of actin recruitment on signalling to vinculin contrasts with the 
findings of Jiwani et al., which showed an F-actin binding activity of TarP via the 
newly discovered Fab1 and Fab2 domains, the latter overlapping with GPIC VBS3 
(Jiwani et al., 2013). It was clear both from the images and quantification of the level 
of actin recruitment that the VBD did not efficiently recruit actin to the plasma 
membrane in vcl-/- cells.  If the TarP VBD had F-actin binding activity, actin should 
have been present. We have already shown that Fab1, which overlaps with the LD 
domain, recruits actin in a manner dependent on FAK, rather than having F-actin 
binding ability. We recall the argument used to address this discrepancy, which is 
that the Jiwani report relied on ectopic expression in cells rather than the use of 
purified TarP or its derivatives to investigate interactions in vitro. 
 
From a mechanistic point of view, it remains unclear how vinculin mediates 
Chlamydia invasion. In a study investigating neurite outgrowth, vinculin was 
proposed to play a role in the stabilisation of these cellular extensions, rather than 
their formation (Varnum-Finney and Reichardt, 1994). Because of its recruitment to 
actin pedestals of EPEC or the Shigella-induced actin-rich foci, vinculin has also 
been proposed to participate in the stabilisation of these cellular extensions (Tran 
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Van Nhieu et al., 1997). For EPEC, a VBS motif present in Tir may facilitate the 
formation of the talin/vinculin rich region at the site of intimate contact with the 
bacterium. In this case, the recruitment of vinculin and talin has been proposed to 
confer an evolutionary advantage in enabling EPEC to be held on the surface of 
infected cells, although this has not been investigated further (Freeman et al., 2000). 
For Shigella, IpaA-mediated vinculin activation has been linked to the formation of a 
pseudo-focal adhesion structures that can organise the actin network to enable 
anchoring of the bacterial body in the entry focus (Tran Van Nhieu et al., 1997). Our 
observations that FAK, vinculin, talin, paxillin and EB1 were recruited to the sites of 
Chlamydia invasion imply the formation of pseudo-focal adhesion structures that can 
organise the actin network to enable bacterial entry. 
 
In this study, we provide another mechanism for TarP signalling to actin, which is 
through subversion of vinculin signalling. The tandem VBS repeats of C. caviae are 
somewhat comparable to those seen in talin, which possesses 11 VBS motifs that 
have been proposed to assist in binding multiple vinculin molecules and amplifying 
outside-in integrin signalling (Izard and Vonrhein, 2004). Thus, it is conceivable that 
the three VBS motifs of C. caviae TarP serve to amplify the response (Figure 5.17). 
  
Indeed, it is now known that the vinculin Vt domain is able to bundle F-actin through 
formation of a Vt dimer. Studies point to the existence of an actin-dependent 
conformational change in Vt that is important for actin-induced Vt dimer formation 
and enables F-actin cross-linking. It is conceivable, therefore, that the binding of 
several vinculin molecules would promote actin cross-linking  that could ultimately 
stabilise the focal adhesion-like complexes seen at sites of chlamydial entry (Shen et 
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al., 2011). We also recognise that vinculin, like talin, is an actin binding protein. For 
Shigella, one of the difficulties in establishing the hierarchy of events leading to the 
formation of cytoskeletal structures is that actin polymerisation itself can influence the 
distribution of actin binding proteins. Here we refer to assays involving TarP1-714, a 
TarP deletion derivative that retains the LD domain. Clustering of TarP1-714 was able 
to induce actin mobilisation, but not a level of vinculin recruitment that was 
comparable to the VBD or indeed the VBD derivatives. If vinculin recruitment was 
being positively influenced by actin polymerisation, then a more demonstrable level 
of vinculin should have been present at sites of TarP1-714 clustering.  Here, we 
propose that vinculin recruitment is due to direct interaction with the TarP VBD. We 
show that this vinculin recruitment is required to facilitate actin mobilisation. With the 
LD, VBD and ABDs, the invasion-associated effector TarP possesses an impressive 
array of functional molecular determinants to manipulate actin. For the VBD, its 
importance rests on its actin recruitment ability and possible modulatory functions, as 
highlighted using the LD-VBD construct. With both the LD and VBD, Chlamydia is 
unique in that it has evolved mechanisms to directly target two central components of 
focal adhesion signalling, which are FAK and vinculin respectively. Whilst the 
implications of this have now been discussed with regards to actin recruitment during 
invasion, the next chapter will address potential post-invasion roles.   

 
 
 
181 
 
Chapter Conclusions  
 
- The talin VBS motifs function as the binding site for the vinculin 
- VBS motifs are found in a number of pathogenic bacteria including S. flexneri and 
Rickettsia 
- Varying numbers of VBS motifs conserved in all TarP orthologs investigated 
- C. caviae has 3 VBS motifs that together comprise the VBD 
- Structural modelling of the TarP-VBS1, 2 or 3 interaction with Vh1 revealed 
common features with that of IpaA-VBS1-Vh1 binding including the formation of 
the hydrophobic interface 
- Vinculin recruitment by C. caviae TarP requires the VBD domain 
- TarP-VBD alone is sufficient to recruit vinculin and actin 
- Vinculin is required for VBD-mediated actin recruitment  
- The requirement for both FAK and vinculin in chlamydial invasion suggests that 
Chlamydia nucleate focal adhesion-like complexes  
o Paxillin, talin, and EB1 localise to sites of C. caviae attachment 
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Chapter 6- Chlamydia modulates host cell focal adhesions 
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6.1 Chapter Introduction 
 
Both the epithelial monolayer and the mucosal surface serve as an intrinsic barrier 
against microbial pathogens. The integrity of the epithelial monolayer is sustained by 
various intercellular junctions including adherens junctions (AJ) and tight junctions 
(TJ) (reviewed in (Niessen, 2007)). Both junctional complexes associate with the 
actin cytoskeleton, the remodelling of which leads to the formation and maturation of 
these cell-cell contacts. AJs maintain the cell-cell contacts and consist of the 
transmembrane protein E-cadherin, and intracellular components, p120-catenin, "-
catenin and !-catenin. In contrast, the tight junctions regulate the paracellular 
permeability. Finally, two major cell-matrix adhesion in the form of hemidesmosomes 
and focal adhesions (FAs) also play an important role maintaining the integrity and 
tensile strength of epithelial sheets. 
 
Interestingly, invasive tumour cells exhibit a disruption of cell-cell contacts and an 
enrichment of cell-matrix adhesion en route to becoming migratory (Serrels et al., 
2011).  At the centre of this process, known as the epithelial–mesenchymal transition 
EMT, is E-cadherin (Serrels et al., 2011). Src family kinases (SFKs), particularly the 
ubiquitous Src, Yes and Fyn family members, co-localise with E-cadherin at the sites 
of cell–cell adhesion to regulate intercellular contact dynamics. A common 
observation during epithelial cancer progression is elevated Src activity, which 
results in the activation of integrin and FAK signalling (Avizienyte et al., 2002, Serrels 
et al., 2011). Disruption of the FAK/Src signalling axis deregulates E-cadherin in a 
manner dependent on FAK phosphorylation and leads to the suppression of cell-cell 
adhesion (Avizienyte et al., 2002). In turn, vinculin is redistributed to Src-induced 
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integrin–adhesion complexes, leading to further disorganisation at intercellular 
contacts (Avizienyte et al., 2002).  
 
Bacterial infection of mucosal epithelial cells triggers the antimicrobial defence 
strategy of cell exfoliation and apoptosis induction (reviewed in: Kim et al., 2010). The 
expulsion of damaged host cells and colonised pathogens, otherwise known as 
exfoliation, requires the degradation of cell adhesion factors. Bergin et al. 
demonstrated that mouse proximal tubular (MPT) cells, when deprived of cell-matrix 
and cell-cell adhesion, die by apoptosis (Bergin et al., 2000). Indeed the cell-matrix 
adhesion is a well-known survival signal (Stupack and Cheresh, 2002, Reddig and 
Juliano, 2005). In epithelial cells, "1-integrins are primarily responsible for cell-matrix 
attachment. As such, a number of integrin signal transducers, the most notable of 
which is FAK, have been implicated in controlling adhesion-dependent cell survival 
(Schaller, 2001). In addition, cell-cell adhesion has also been reported to inhibit 
apoptosis through cadherin-dependent activation of PI3K (Dejana, 2004, Pece et al., 
1999).  
  
An exciting emerging development is that cell-cell junctions can also function as 
signalling structures that communicate cell position and limit growth and apoptosis. 
Thus, adhesion junctions appear to mediate ‘stabilisation’ signals that maintain cells 
in a resting state (Dejana, 2004). Interestingly, a number of bacterial pathogens 
including EPEC and Salmonella have been shown to disrupt cell-cell junctions and 
epithelial polarity through the actions of dedicated type III-secreted effectors. These 
include Map (Alto et al., 2006), EspF (Alto et al., 2007), EspM (Arbeloa et al., 2008) 
and NleA (Kim et al., 2007) of EPEC and SopB, SopE, SopE2, and SipA of 
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Salmonella (Boyle et al., 2006). It is conceivable that this benefits the pathogen by 
limiting the exogenous cues that can influence the state of the infected cell. 
Dismantling of cell-cell junctions, however, can have adverse effects such as an 
increase in apoptosis and uncontrolled cell proliferation. Unsurprisingly, a strategy 
employed by bacteria to circumvent exfoliation and apoptosis associated with loss of 
cell-cell adherence is to reinforce cell-matrix adherence. The best-characterised 
example lies with Shigella, which is able to circumvent exfoliation and colonise the 
epithelium efficiently. It does so by delivering the OspE effector by type-III secretion. 
This protein reinforces host cell adherence to the basement membrane by interacting 
with integrin-linked kinase (ILK), a serine/threonine kinase FA component. A 
consequence of the OspE-ILK interaction is an increase in surface levels of "1-
integrin, which in turn promotes FA assembly. In addition, the OspE-ILK complex 
stabilises the FAs by reducing FAK (Y397) and paxillin phosphorylation, which has 
been shown to induce FA disassembly (Kim et al., 2009).   Interestingly, some EPEC 
and EHEC strains as well as Citrobacter rodentium possess the effector EspO, which 
shares strong homology with OspE (reviewed in (Vossenkamper et al., 2011). As 
such, it is conceivable that these pathogens also exercise a capacity to reinforce 
adherence of the infected epithelium to secure an infectious foothold. Indeed, the 
EspZ effector of EPEC and EHEC has been shown to reduce cell death and 
detachment in vitro (Shames et al., 2010). EspZ binds the transmembrane 
glycoprotein CD98 and enhances its effect on "1-integrin signalling and cell survival 
via activation of FAK. Finally, through interaction with human carcino-embryonic 
antigen-related cell adhesion molecules (CEACAM), bacterial pathogens such as 
Neisseria gonorrhoeae, Neisseria meningitidis, Moraxella catarrhalis, and 
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Haemophilus influenzae, can activate "1-integrin signalling and inhibit epithelial cell 
detachment (reviewed in: Kim et al., 2010). 
 
The entire intracellular growth cycle of Chlamydia takes !48–72 h and occurs within 
a membrane-bound inclusion. With the RBs structurally fragile and non-infectious, it 
is essential that the structural integrity of the infected epithelial cells is sustained 
during growth to facilitate chlamydial evasion from host defences.  A number of 
studies have focused on the chlamydial capacity to inhibit apoptotic pathways. Anti-
apoptotic activity is thought to be conveyed by a Chlamydia-secreted protein called 
CPAF (chlamydial protease/proteasome-like activity factor), which contributes to the 
degradation of the proapoptotic BH3-only proteins (Pirbhai et al., 2006). Recruitment 
of certain BH3 proteins, such as BAD, away from their functional site at the 
mitochondria has also been observed and is mediated by the activation of the PI3K 
pathway (Verbeke et al., 2006). In addition to this, Chlamydia activates the mitogen-
activated protein kinase (MAPK) pathways, which leads to the upregulation of a 
major anti-apoptotic protein in the form of Mlc-1 (Rajalingam et al., 2008). Finally, the 
C. trachomatis TarP interaction with SHC1 via the tyrosine-rich tandem repeats was 
found to induce host cell survival, which may be facilitated by the regulation of 
apoptosis and growth-related genes (Mehlitz et al., 2010).  
 
Whilst there is still much more to be understood, it is becoming increasingly evident 
that Chlamydia exercises the capacity to influence cellular integrity. For instance, C. 
trachomatis infection disrupts epithelial cell-cell adhesion by inducing the breakdown 
of N-cadherin/β-catenin complexes (Prozialeck et al., 2002). In addition, the host 
adherens junction molecule, nectin-1, was found to be downregulated in infected 
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cells (Sun et al., 2008). Thus, chlamydiae appear to modulate adhesion-associated 
signalling molecules from the early stages of invasion through to the later stages of 
intracellular growth.  
 
Here, the main objective was to gain further insight into chlamydial modulation of 
cellular adhesion. We show that C. trachomatis and C. caviae could induce the 
formation of focal adhesions. Initial molecular investigations point to TarP being 
involved in this process, as exhibited by its overexpression leading to a similar 
increase in focal adhesion numbers. Furthermore, overexpressed TarP LD domain 
localised to these structures. Finally, infection led to a dramatic decrease in the 
peripheral localisation of "-catenin, suggesting that chlamydial modulation of cellular 
adherence is not limited to focal adhesions.   
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6.2 Results 
 
6.2.1 Chlamydia induce the formation of focal adhesions 
 
Epithelial cell exfoliation is an intrinsic host defence mechanism against bacterial 
infection in which damaged host cells and colonising pathogens are quickly expelled 
from the epithelial lining. A shared bacterial strategy to circumvent this host cell 
detachment is the reinforcement of epithelial adhesions to the ECM.  To determine if 
chlamydial targeting of focal adhesion components extends beyond invasion, Cos7 
cells were plated on fibronectin (FN)-micropatterned coverslips (CYTOO chips) that 
maintained a uniform shape and adhesion profile. The uniform cell shape permitted a 
quantitative and spatial analysis of focal adhesion enrichment during infection.  Cells 
were infected with C. caviae GPIC and the phospho-active FAK (pY397-FAK) profile 
examined 8 h after synchronisation by shift to 37°C incubation. Confocal microscopy 
settings were optimised for uninfected cells, and pre-set for subsequent imaging of 
infected cells. The Individual images of infected or uninfected cells were combined 
into a single maximum projection to construct a heat map. As shown in Figure 6.1, 
uninfected cells typically exhibited a small number of focal adhesions (FAs) of low 
pY397-FAK intensity that localised to small patches at the cell periphery. In contrast, 
infected cells exhibited a demonstrable augmentation in numbers of pY397-FAK-rich 
focal adhesions condensed around the periphery and centre of the cell.  Furthermore, 
there appears to be a dramatic induction of pY397-FAK activity, as demonstrated by 
the global increase in pY397-FAK signal intensity.  
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Figure 6.2 shows representative immunofluorescent images of GPIC-infected Cos7 
cells plated on CYTOO chips that were examined 8 h post-infection (h.p.i.) for both 
pY397-FAK and actin. Despite being plated on FN, which is known to support 
migration, we found that infected cells showed signs of increased adherence. This 
included a marked increase in actin stress fibres (visualised by phalloidin staining) 
and associated focal adhesions (FA; identified by pY397-FAK staining) compared to 
uninfected cells. The appearance of stress fibres signifies a shift in the balance to 
adhesion, rather than migration.  
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The next step was to determine whether these alterations in focal adhesion profile 
also occur in a more relevant cell type that mimics the architectural organisation 
encountered by Chlamydia in vivo. HaCaT cells are immortalised undifferentiated 
epithelial (keratinocyte) cells and have been described in the context of Chlamydia 
infection. Indeed, the use of HaCaT keratinocytes were central to the model 
proposed by Joubert et al. to better understand C. trachomatis LGV pathogenesis 
(Joubert and Sturm, 2011). Here, HaCaT cells were infected with C. trachomatis L2 
or C. caviae GPIC. In parallel experiments, cells were treated with penicillin, a known 
inducer of chlamydial persistence. The phenomenon of ‘persistence’ is a scenario 
where Chlamydia arrests its developmental cycle resulting in aberrant RBs (Skilton et 
al., 2009, Wyrick, 2010).  This is thought to be a mechanism that allows Chlamydia to 
bide its time until conditions optimal for EB differentiation returns.  Here, penicillin 
was added to C. trachomatis- infected cells at 8 h.p.i. to simulate persistent growth. 
The infection was allowed to proceed for an additional 16 hrs after which cells were 
fixed in 4% PFA. In this case, the distribution of an alternative focal adhesion marker, 
vinculin, was monitored, as the anti-FAK (phospho Y397) antibody was not suitable 
for this cell type. Infection of HaCaT cells with C. trachomatis or C. caviae GPIC 
resulted in a peripheral accumulation of vinculin (Figure 6.3). In addition, aberrant 
Chlamydia could maintain this altered adhesion profile (Figure 6.4).  
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Finally, to gain preliminary insight into the stability of focal adhesion structures during 
infection, cells transfected with GFP-FAK and infected with L2 were monitored by live 
cell imaging for 1'h at 20h p.i. As shown in Figure 6.5, focal adhesion structures 
exhibited a stabilised nature. If the infected cell retained its migratory capacity, a 
dynamic focal adhesion profile should have been observed. Indeed, cells were plated 
on adhesive tracks that promote cellular motility. A limitation to this assay, however, 
was that an uninfected control was not done in parallel. Based on these data, we 
concluded that Chlamydia possesses mechanisms to induce focal adhesions 
biogenesis, conferring an adhesive, rather than a migratory phenotype to the infected 
cell.   
 
 
 
 
 
 
196 
 
6.2.2 Chlamydial TarP may be involved in focal adhesion biogenesis 
 
For a number of bacterial pathogens, circumvention of host cell detachment through 
modulation of cellular adherence is facilitated by the action of type III-secreted (TTS) 
effectors, such as OspE of Shigella and EspO of EPEC. One candidate TTS 
chlamydial protein that may be involved is TarP. This virulence protein is present 
during early post-invasion stages, where it continues to contribute towards productive 
infection (Wang et al., 2009, Clifton et al., 2004). Moreover, this report has shown 
TarP can directly interact with focal adhesion-associated proteins during invasion. 
Here, time course experiments performed in HeLa cells revealed a band unique to 
Chlamydia-infected cells, raising the possibility of a cleavage event (Figure 6.6).  
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Figure 6.6- Presence of a unique cleavage product following Chlamydia infection. HeLa cells 
were infected with L2 or mock-infected and subjected to SDS!PAGE and immunoblotting. The 
immunoblot was probed with an !-TarP antibody. Lane 1, MW maker; lane 2, 2 h post-infection (h.p.i.) 
soluble; lane 3, 2 h.p.i. insoluble; lane 4, 8 h.p.i. soluble; lane 5, 8 h.p.i. insoluble; lane 6, 12 h.p.i. 
soluble; lane 7, 12 h.p.i. insoluble; lane 8, 24 h.p.i. soluble; lane 9, 24 h.p.i. insoluble; lane 10, mock 
infected; lane 11, mock infected; lane 12, EB; lane 13, EB. The arrowhead indicates the unique 
cleavage product.  
 
 
Prompted by the findings from western blot analysis, we investigated whether focal 
adhesion (FA) biogenesis could involve chlamydial TarP or its functional derivatives. 
Focal adhesion numbers were monitored in transfected cells; an assay similar to the 
one used to characterise the FA-forming function of OspE (Kim et al., 2009). In this 
assay, Cos7 cells were plated on glass coverslips. To remain consistent with the 
CYTOO chip assay, focal adhesions were identified using an anti-FAK (Y397) 
antibody.  As shown in Figure 6.7A, TarP, the LD motif and a TarP deletion 
derivative lacking the VBD (TirM-TarP1-714) localised to adhesion structures 
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comprising phospho-active FAK (pY397-FAK). In cells transfected with TarP FL*, 
TirM-TarP1-714 or TirM-LD, the number of pY397-FAK-positive focal adhesions were 
augmented approximately 1.67, 2.28- and 2.15-fold in comparison to TirM-
expressing cells or untransfected cells (Figure 5.17; p<0.003). In addition, 
transfecting cells with a TarP deletion derivative lacking the LD domain (TarP1-639) 
reduced FA numbers to control levels (Figure 6.7B). 
 
 
 
 
 
 
 
 
 
 
Figure 6.7- Cells expressing TarP or LD-harbouring derivatives exhibit increased numbers of 
focal adhesions. Cos7 cells transfected with plasmids encoding full length TarP (TirM-TarP FL*), 
progressive TarP deletion derivatives (TirM-TarP1-714 or TirM-TarP-1-639), the Vinculin Binding Domain 
(TirM-VBD), the LD domain (TirM-LD) or the TirM control were monitored for phospho-active FAK 
(pY397-FAK; green) and actin (purple). Untransfected cells (Utr) were monitored in parallel. Cells 
transfected with constructs were identified by staining for the HA-tag present in the fusion proteins.  
The white arrowheads indicate colocalisation of pY397-FAK and actin with TarP or TarP derivative. 
FAK Y397 was visualised with an anti-FAK (Y397) antibody, actin with phalloidin and the HA-tag with 
and anti-HA antibody. Scale bars: 10 !m. B) Focal adhesions numbers per cell were enumerated and 
data represented as Box and Whisker plot. Data compiled from 1 experiment. Plot shows range 
(statistical outliers excluded), first and third quartiles, and overall median (horizontal line). Diamonds 
show means. A minimum of 10 cells was counted for each condition. The asterisk and bars indicate 
significance difference between specific groups (one way ANOVA (p<0.003) and post hoc testing 
(Tukey-Kramer; !=0.01, q=4.23)). 
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Finally, overexpression of the GPIC LD motif lacking a membrane localisation 
domain (pHom-1-LD) localised to actin-rich adhesion structures (Figure 6.8). 
Importantly, LD overexpression and subsequent enhancement of stress fibres 
replicates the findings of the CYTOO assay. However, initial efforts to transfect cells 
plated on CYTOO chips with TirM-LD proved unsuccessful because cell division, 
which disrupts the uniform shape and adhesion profile, occurred too quickly for the 
TarP derivatives to be expressed at sufficient levels to induce a cell architecture 
phenotype. All together, the data presented here suggests a role for TarP in focal 
adhesion formation. 
 
 
 
 
Figure 6.8- The LD domain localises to focal adhesion-like structures. Cos7 cells were 
transfected with a plasmid encoding the C. caviae TarP LD domain (pHom-1-LD) and monitored for 
actin (green). Transfected cells were identified by staining for the HA-tag (red) present in the fusion 
protein. Actin was visualised with phalloidin and the HA-tag with and anti-HA antibody. Note the 
distribution of the LD domain at the tips of actin stress fibres, the typical location of focal adhesions. 
Image shown is representative of 1 experiment.  
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6.2.3 Chlamydial modulation of host adherens junctions 
 
The data presented so far indicate that Chlamydia augment focal adhesions numbers 
in a process that involves tyrosine phosphorylation of FAK. Interestingly, elevated 
activation of this tyrosine kinase in epithelial cells has been linked to a switch in 
adhesion type predominance from cell-cell  (Cadherin-based) to cell-matrix (integrin-
based) adhesions, leading to a destabilisation of cell-cell contacts. The deregulation 
of E-cadherin, a key component of adherens junctions (AJ), has been proposed to 
facilitate the disruption of cell-cell adhesion. For pathogenic bacteria, this may serve 
as a defence strategy to isolate the infected cell from intercellular signalling linked to 
exfoliation and apoptosis induction. To determine if Chlamydia target intercellular 
junctions, the staining profile of "-catenin, an essential component of cadherin-based 
AJ, was monitored in HaCaT cells infected with C. trachomatis L2. HaCaT were the 
preferred cell type for this assay due to their efficient nature to link together through 
intercellular junctions in tissue culture.  As shown in Figure 6.9, it is clear that 
chlamydial infection leads to a loss of the "-catenin distribution at cell contacts and 
minimal accumulation around the inclusions. All together, the data suggests that 
Chlamydia-induced biogenesis of focal adhesions is accompanied by a modulation of 
adherens junctions.  
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6.3 Chapter Discussion 
 
The host epithelium deploys a number of intrinsic defence mechanisms to combat 
microbial infection. Nevertheless, many bacterial pathogens have evolved a 
remarkable array of countermeasures to circumvent these defence systems and use 
the epithelium as a replicative foothold. For invasive bacteria, the past decade has 
seen significant advances in understanding the adherent and invasive strategies 
used to initiate infection. However, we have relatively limited understanding in 
bacterial mechanisms to overcome epithelial barrier functions, especially those that 
prevent cell death, exfoliation and cell turnover. In this report, we provide evidence to 
suggest that Chlamydia possess mechanisms to counteract epithelial exfoliation 
through the induction of focal adhesion (FA) biogenesis and modulation of adherens 
junctions. Initial molecular investigations suggest that FA formation may involve TarP, 
implying a post-invasion role for this virulence factor.  
 
The maintenance of cell adhesion is becoming more appreciated as a widespread 
strategy for bacterial infection of the epithelium. A well-known example involves 
Shigella, which delivers the type III effector OspE to directly target integrin-like kinase 
(ILK) and reinforce epithelial adhesion. The OspE-ILK interaction increases levels of 
"1-integrin on the epithelial cell surface, stabilizing FA complexes (Kim et al., 2009). 
In addition to FAs, a number of pathogens also target the intercellular adhesion 
network as a means of reducing epithelial barrier functions. Most pathogenic 
strategies involve regulating Rho GTPases and/or myosin light-chain kinase MLCK-
mediated signalling (Kim et al., 2010), which deregulates actomyosin through its 
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actions on myosin II regulatory light chain (MLC) (Shen et al., 2010). Thus, junction 
architecture is modified through signalling that affects cytoskeletal organisation.  
 
A study by Prozialeck et al. found that human cervical epithelial cells lose cell-cell 
contacts, but remain adhered to the growing surface (Prozialeck et al., 2002). This 
was proposed to be due to the marked loss of both N-cadherin and "-catenin 
labelling from the junctional complexes as a result of C. trachomatis infection. 
Another adhesion protein targeted by Chlamydia is Nectin-1, which regulates cell–
cell adhesion and cell polarisation in a Cdc42- and Rac-dependent manner (Sun et 
al., 2008). To date, the precise mechanisms for how Chlamydia modulate cellular 
adherence are not well understood. In this report, we demonstrate that numbers of 
vinculin and phospho-active FAK-rich adhesions are augmented in response to 
infection. We argue that FA biogenesis is a true consequence of chlamydial infection. 
Indeed, preliminary investigations used a monolayer that was normalised to a 
homogenous adhesion profile. This involved using specialised adhesive (CYTOO) 
coverslips. Cell shape uniformity permitted conclusive identification of phenotypic 
differences. Furthermore, alterations to the adhesion profile were also observed in a 
more natural epithelial (HaCaT) host. Chlamydial subversion of cellular integrity, 
therefore, appears to involve hijacking of both intercellular and FA networks.  
 
FAs are sites of tight adherence, providing a structural link between the actin 
cytoskeleton and the extracellular matrix. During invasion, Chlamydia manipulates 
FA signalling to facilitate localised actin recruitment. Central to this process is TarP, 
which can directly interact with FA components through the LD or VBD. Interestingly, 
TarP does not appear to be restricted to invasion. Wang et al. monitored TarP 
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expression using an immunofluorescence assay and noted that TarP was still 
detectable at 8 hours post-infection (Wang et al., 2009).  In addition, tyrosine 
phosphorylation of C. trachomatis TarP remained detectable for at least 24 hours 
(Clifton et al., 2004). Finally, Mehlitz et al. demonstrated with investigations involving 
SHC1 that TarP still possesses a functional capacity post-invasion (Mehlitz et al., 
2010). In this report, we provide preliminary evidence to suggest TarP involvement in 
a post-invasion event, specifically FA formation, which may be facilitated by the LD 
domain. This is supported by the following data. Firstly, cells transfected with TarP, 
TarP1-714 or TarP-LD had an increased number of pY397-FAK-rich focal adhesions. 
Secondly, a TarP deletion derivative lacking the LD domain failed to influence the 
adhesion profile. Thirdly, only TarP-FL*, TarP1-714 or TarP-LD localised to these 
adhesion structures. We note that the difference in adhesion numbers following 
overexpression of TarP, whilst statistically significant, is not as dramatic as that seen 
following Chlamydia infection. Kim et al. had a similar finding, where GFP-OspE was 
only found to increase FA numbers 1.8-fold whilst infected cells exhibited a more 
dramatic phenotype (Kim et al., 2009). For these effectors, it is possible that 
artificially high levels may have some negative effects, such as sequestering of focal 
adhesion components, resulting in global FA disassembly. To rationalise this 
argument from a TarP perspective, we refer to paxillin and its ability to promote FA 
disassembly and turnover by switching its binding partner from FAK to GIT1. This is 
driven by phosphorylation of serine 273 within the FAK-interacting LD4 of paxillin, 
which decreases the helical propensity and, subsequently, FAK binding affinity. It is 
conceivable that the sequestering of FAK via overexpression of TarP LD would also 
have a similar effect on FA dynamics. Interestingly, transfection of Cos7 cells with 
pHom-1-LD phenocopied the enhancement of actin-rich adhesion-like structures 
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observed following GPIC infection. A major difference between pHom-1-LD and the 
TirM-LD construct used to quantify FA numbers is the absence of a membrane 
localisation domain, which ensured a more efficient production of cytosol-localised 
recombinant proteins for a shorter period of time, than TirM-LD.  
 
 In the context of chlamydial infection, however, it remains unclear at this point as to 
whether additional bacterial factors are required to maintain FA numbers, or if TarP is 
sufficient. TarP expression was found to decrease during the mid-stages of infection, 
during which time the inclusions are enriched with RBs. If TarP is the only protein 
required to maintain increased FA numbers, then it would have to be stable, 
processed for increased solubility and localisation to the focal adhesions. We have 
provided evidence that TarP could be detected up to 24 h p.i., while there is some 
evidence to suggest that TarP is proteolytically processed. Because the TarP 
antibody we have is not compatible with immunofluorescence experiments, we were 
unable to localise it to the focal adhesion in infected cells. In addition, the cleavage 
products will need to be characterised to determine if one (or more) of the products 
contain the LD domain. 
 
 It is clear from the preliminary data provided in this study that Chlamydia infection is 
accompanied by an augmentation in pY397-FAK-rich FAs and associated actin-
based stress fibres. Interestingly, Belland et al. noted that infection with MoPn or C. 
trachomatis serovar D strains at high MOI resulted in disassembly of stress fibres 
and pronounced cellular detachment (Belland et al., 2001). Thus, the upregulation of 
stress fibre assembly is likely to provide a mechanism by which to circumvent cell 
detachment. Finally, there appears to be a redistribution of vinculin to peripheral 
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adhesion structures, indicative of intercellular contact disruption as vinculin is found 
at both peripheral adhesions and intercellular junctions (Geiger et al., 1980, Geiger et 
al., 1981).  
  
Supporting evidence for intercellular disruption during Chlamydia infection came from 
monitoring the "-catenin profile. "-catenin associates with the cytoplasmic tail of E-
cadherin, and this complex recruits !-catenin, which mediates anchorage to the actin 
cytoskeleton either by binding directly to F-actin or indirectly via interaction with F-
actin binding proteins. In addition, "-catenin has a second function as a 
transcriptional co-activator of the Wnt signalling pathway in the regulation of gene 
expression (Kuphal and Behrens, 2006). In this study, we observed a marked 
reduction in peripheral staining of "-catenin following C. trachomatis infection.  In 
contrast, we did not observe a sequestering of "-catenin to C. trachomatis inclusion 
bodies as reported by Prozialeck et al. in human cervical epithelial cells or Kessler et 
al. in human fallopian tubes (Prozialeck et al., 2002, Kessler et al., 2012). Indeed, 
both studies described using the same anti-"-catenin antibody. In contrast, we 
assayed two anti-"-catenin antibodies different from the one described and found no 
colocalisation with the chlamydial inclusion. Surprisingly, Chlamydia pneumoniae 
upregulates the expression of AJ proteins VE-cadherin, N-cadherin and "-catenin 
facilitating its transmission in human brain microvascular endothelial cells (MacIntyre 
et al., 2002). However, "-catenin localisation was not investigated.  
 
There is an inverse relationship between the signalling processes in focal adhesions 
and intercellular junctions.  Enhanced FA signalling via Src and FAK typically leads 
to the disassembly of intercellular junctions and E-cadherin/"-catenin signalling 
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(Serrels et al., 2011, Avizienyte et al., 2002). The tyrosine-rich tandem repeats of C. 
trachomatis TarP are known to induce a localised elevation in Src activity. (Jewett et 
al., 2008) It is possible that this population of active Src can then enhance FAK 
signalling. For all other chlamydial species that harbour a TarP orthologue lacking 
the phosphodomain, elevations in Src activity may be a downstream consequence of 
FAK recruitment and activation. Therefore, rather than the sequestration model 
proposed by Prozialeck et al. (Prozialeck et al., 2002), we favour intercellular junction 
disassembly as a consequence of enhanced focal adhesion signalling (Figure 6.10). 
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Kumar et al. and, very recently, Heymann et al., noted that C. trachomatis infection 
perturbed migration of HeLa cells (Kumar and Valdivia, 2008, Heymann et al., 2013). 
In the latter investigation, the authors focused on the failure of infected cells to 
reorient the Golgi apparatus (GA) or MTOC, proposing that this disrupts the polarity 
required for migration. Indeed, the onset of migration is accompanied by the 
acquisition of spatial asymmetry manifested in a polarised morphology, i.e., a clear 
distinction between cell front and rear. This morphological polarisation is 
characterised by the formation of a leading edge at the front of the cell (lamellipod) 
(Pouthas et al., 2008). Adhesion receptors on this protrusive organelle bind to 
ligands on the underlying substratum, followed by cell body translocation. During this 
process, the MTOC and Golgi complex are reoriented to the leading edge (Nabi, 
1999). This contributes to polarised migration by 1), facilitating microtubule growth 
into the lamellipod; and 2), mediating microtubule-based delivery of Golgi-derived 
vesicles to the leading edge, which provides proteins needed for forward protrusion 
(Pouthas et al., 2008, Etienne-Manneville and Hall, 2002). Like many other 
intracellular pathogens, C. trachomatis requires host cell lipids, such as sphingolipids 
(Hackstadt et al., 1995) and cholesterol (Carabeo et al., 2003), produced in the 
endoplasmic reticulum (ER) and GA. Interestingly, Chlamydia infection induces Golgi 
fragmentation as a mechanism for lipid acquisition. Chlamydia infection induces the 
proteolytic cleavage of golgin-84, which results in the fragmentation of the GA into 
functional ministacks that surround the inclusion (Heuer et al., 2009). When 
investigating what implications this Chlamydia-induced disruption to Golgi integrity 
might have on the host cell, Heymann et al. noted that the infected cells had reduced 
migratory capacity (Heymann et al., 2013). Interestingly, silencing of golgin-84 only 
partially reduced cell motility, whereas stabilisation of the GA through Rab 
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knockdown only partially rescued migration. The authors propose that additional 
factors affect motility of infected cells. In this report, we propose that a Chlamydia-
induced upregulation of cellular adherence could also contribute towards preventing 
cellular migration. It is interesting to note that despite being seeded on a migration-
favouring fibronectin (FN)-coated substratum, infected Cos7 cells still exhibited an 
adhesion profile typical of a stationary cell. FN is an extracellular matrix (ECM) 
component involved in a number of processes including cell adhesion and migration. 
Transmembrane integrin receptors are induced to cluster by matrix proteins such as 
FN, which promotes the recruitment of focal adhesion-associated proteins. These 
initial steps in integrin-mediated signalling can activate Rac GTPase, which ultimately 
regulates cell adhesion and motility (Huttenlocher and Horwitz, 2011). Dynamic 
assembly and disassembly of focal adhesions plays a central role in cell migration. 
Thus, it is possible that Chlamydia has evolved a strategy to stabilise FAs. Indeed, 
using a live cell imaging approach, we found that the focal adhesion structures 
remained stable in infected cells, despite the use of migration-promoting coverslips. 
Such a pathogenic strategy has been previously reported for Shigella. The 
investigators propose that adhesion stabilisation was facilitated by OspE-mediated 
downregulation of FAK phosphorylation, which can accompany FA disassembly (Kim 
et al., 2009). Recent studies have shown FA disassembly to be a highly complex 
process with evidence accumulating to suggest that microtubles (MT) are at the 
centre of this process (Ezratty et al., 2005). Exposure of cells to nocodazole, which 
disrupts polymerised MTs, stabilises FA structures by preventing their disassembly. 
Removal of the drug initiates disassembly of FAs in a synchronous manner (Ezratty 
et al., 2005). The FAK phosphorylation states could be monitored during nocodazole 
addition and washout to correlate their roles in FA stabilisation and disassembly in 
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infected cells. Here, we observed a clear involvement of pY397-FAK during the early 
post-invasion stages of infection, which could reflect FA biogenesis. From here, it is 
important to establish the FAK activation profile from a protein perspective. It may be 
that FAK activation levels are high during early infection stages, but then decrease at 
the later stages when the established adhesions would presumably require 
stabilisation. The nocodazole-washout assay could be used to further strengthen our 
argument of a role for pY397-FAK in FA biogenesis rather than global disassembly.     
 
Chlamydial infection can cause disease in many organ systems, including the 
genital tract. In women, the upper genital tract (endocervix) is covered with a 
columnar epithelium whilst the lower genital tract (ectocervix) is lined by stratified 
squamous epithelia. The organisation of the epithelial mucosa is essential for its 
barrier function.  That Chlamydia can manipulate the adherence, motility, and 
intercellular junction of the infected cell could have significant pathologic 
consequences, especially in persistent infections. For instance, an infected cell with 
disrupted cell-cell junctions may not be able to coordinate its differentiation and 
stratification program with the surrounding cells. This may lead to abnormalities in 
the epithelium at a particular point, resulting in a non-optimal barrier against infection. 
Interestingly, Rank et al. recently proposed that polymorphonuclear leukocytes 
(PMNs) act to ‘push’ C. caviae-infected cells off the epithelium by disconnecting 
epithelial adherence to the basal lamina (Rank et al., 2008). The end result is the 
release of an intact, infected epithelial cell and subsequent breach in the barrier. 
Overall, this could result in susceptibility to secondary infections not necessarily with 
Chlamydia, but other STIs that are linked (Human papillomavirus (Smith et al., 2002, 
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Safaeian et al., 2010)) or concurrent (Neisseria gonorrhoeae, Candida albicans 
(Ridgway and Oriel, 1977)) with Chlamydia infection.  
 
Chapter Conclusions 
 
- Cells infected with C. caviae or C. trachomatis exhibit an altered adhesion profile 
- Ectopic expression of chlamydial TarP, TarP1-714 or TarP-LD leads to an increase 
in focal adhesions numbers 
- C. trachomatis infection induces a dramatic reduction in peripheral localisation of 
"-catenin  
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A major focus of microbiological research has been to gain insight into the 
complexities underlying the interplay between bacterium and host that facilitate 
disease progression. One of the most remarkable and sophisticated adaptations 
found in bacterial pathogens that have coevolved with their eukaryotic host is the 
type III secretion system (T3SS). Through the delivery of effector proteins, this 
bacterial organelle permits an intricate biochemical cross talk that subverts host cell 
functions to benefit microbial survival and replication. Found in many gram-negative 
bacteria, the T3SS is an essential virulence factor, highlighting the central 
importance of the effectors proteins for disease progression.  
 
The type III-secreted (T3S) effector protein family is evolutionarily diverse, resulting 
from their central roles in pathogenesis and host adaptation, which exposes them to 
very strong selective pressures. Typically, individual bacterial effectors have a 
modular architecture, which is composed of domains and/or motifs that confer a 
subversive function. One strategy to usurp host cell activities is through mimicry. In 
some instances, mimicry can be detected at the level of primary amino acid 
sequence (Galan, 2009). As such, the proteins can be regarded as direct 
homologues of host proteins. For instance, both YopH and the carboxy-terminal half 
of SptP from Yersina and Salmonella, respectively, possess sequence and structural 
(the fold) similarities to eukaryotic tyrosine phosphatases (Stebbins and Galan, 2000, 
Stuckey et al., 1994). For the most part, however, T3S effectors mimic activities of 
cellular proteins without recognizable amino acid sequence similarity. For example, 
SopE and SptP Salmonella effectors function as a guanine nucleotide exchange 
factor (GEF) or GTPase activating protein (GAP), respectively, without any 
indications from amino acid sequence (Galan, 2009). Activity was inferred by 
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determining the crystal structures of the effector/target protein complexes, which 
found some structural components to mimic the chemical groups and interactions 
from host proteins. The examples discussed here represent two different pathways in 
the evolution of mimicry. Effectors such as YopH and SptP are thought to originate 
from some event of horizontal gene transfer, perhaps from a eukaryote, as tyrosine 
phosphatases are absent from most bacteria. In contrast, effectors that display 
molecular surfaces to mimic host protein surfaces are more likely examples of 
convergent evolution (Stebbins and Galan, 2001). Overall, mimicry represents very 
appropriate strategy, as it facilitates reversible modulation without apparent harm to 
the host.  
 
An important target for intracellular bacteria is the host actin cytoskeleton, 
exploitation of which facilitates entry in non-phagocytic cells. A number of bacterial 
pathogens orchestrate the formation of phagocytosis-competent machinery through 
the actions of bacterial mimics, such as SipA and SipC of Salmonella or IpaA of 
Shigella (Zhou et al., 1999, Hayward and Koronakis, 1999, Tran Van Nhieu et al., 
1997). In this study, we focused on another emerging invasion-associated bacterial 
mimic in the form of chlamydial TarP. This T3S effector is translocated at the time of 
initial contact of EBs with the host cell and has been implicated both here and 
elsewhere in the actin remodelling essential for chlamydial invasion. In the past 
decade, the modularity of this effector has become evident, which has coincided with 
efforts to characterise TarP-mediated actin mobilisation. C. trachomatis TarP, for 
instance, possesses a functionally distinct N-terminal tyrosine-rich repeat domain 
and well-known pan-chlamydial features including the proline rich domain and C-
terminal Wasp homology 2 (WH2) actin binding domain. The role of the tyrosine-rich 
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repeat domain, however, is not clear as inhibition of C. trachomatis Tarp tyrosine 
phosphorylation had no effect on entry (Clifton et al., 2005). It is possible that TarP 
tyrosine phosphorylation plays a more significant role post invasion, a scenario we 
will return to later in this discussion. Nonetheless, studies investigating the tyrosine 
repeat domain highlighted a key feature of invasion, which is chlamydial dependence 
on signalling components including Rac and/or Cdc42 and Arp2/3 (Carabeo et al., 
2004, Subtil et al., 2004). As such, the invasion process appears to have additional 
requirements beyond the actin nucleating activity in TarP.  
 
For most T3S effectors, the functional domains typically localise to the central and C-
terminal portions, suggesting distinct selection pressures act on the N-terminal and 
C-terminal domains (Dean, 2011). In spite of this, the C-terminal half is highly 
conserved among TarP orthologues. This modularity was exploited in this study to 
identify a conserved molecular determinant in TarP that could address the emerging 
discrepancy, which was the involvement of a phosphotyrosine-independent signalling 
pathway during invasion. Here, bioinformatic analyses of TarP revealed two highly 
conserved features: an LD motif and Vinculin Binding Domain (VBD). Through the 
LD motif, Chlamydia can directly subvert FAK signalling, representing a novel 
pathogenic strategy for pathogenic bacteria. Remarkably, a functional VBD has been 
described for a number of T3S effectors (Park et al., 2011b, Park et al., 2011a). 
Activity at these molecular surfaces appears to rely on mimicry, although solving the 
crystallographic structures of effector–host protein complexes is required to confirm 
this prediction. This approach would be particularly beneficial for the chlamydial VBD 
and, indeed, has already been applied to demonstrate IpaA or Sca4-directed mimicry 
of talin in activating vinculin (Park et al., 2011b, Park et al., 2011a). 
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From an invasion perspective, the subversion of FAK activities represents an efficient 
tactic to induce localised alterations to the actin architecture.  Amongst its many 
functions, it is the capacity for FAK to regulate actin organisation that has drawn 
attention to its potential involvement in bacterial invasion. FAK does this by triggering 
the downstream activation of Rac through adaptor and activating proteins (Cary et al., 
1998, Klemke et al., 1998). Once activated, Rac can induce actin polymerisation 
through the Arp2/3 complex. For Chlamydia, therefore, the subversion of FAK 
represents an attractive strategy for inducing actin recruitment in a signalling-
dependent, but phosphotryosine-independent fashion. Remarkably, chlamydiae also 
have the means of subverting another key focal adhesion component in the form of 
vinculin. As such, it is difficult not to draw parallels between the integrin clustering 
that induces focal adhesion formation and the signalling emanating from clustered 
and/or oligomerised TarP. Evidence presented here suggests that Chlamydia induce 
a focal adhesion-like structure, although the significance of this in relation to invasion 
is not clear. The involvement of vinculin suggests the formation of a stabilised 
platform, as it is involved in the anchoring of actin to intergrin receptors at focal 
adhesions. In conjunction with an anchoring role, studies in Shigella have also 
highlighted the importance of vinculins capping activity. Ramarao et al. propose that 
the IpaA-mediated vinculin-dependent capping of actin filaments could inhibit growth 
of protrusions at the site of invasion, preventing the repulsion of the bacterium 
(Ramarao et al., 2007). At the later stages of infection, the capping activity of the 
IpaA-vinculin complex has been proposed to combine with signalling emanating from 
the amino two-third moiety of IpaA to induce actin depolymerisation. Srikanth et al. 
propose that IpaA may be subjected to caspase 3 cleavage allowing its amino- and 
carboxy-terminal domains to perform distinct functions (Srikanth et al., 2010). While it 
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is not clear whether vinculin performs a similar function during Chlamydia infection, it 
is evident that actin disassembly is crucial for invasion. Indeed, chlamydial invasion 
was inhibited upon treatment with the actin stabilising drug, jasplakinolide. (R. 
Carabeo, unpubl. obs.) Furthermore, the actin reorganisation induced by Chlamydia 
is transient (Carabeo et al., 2002), suggesting that chlamydiae may also secrete 
effectors to regulate actin depolymerisation. Without disassembly, the F-actin 
network localised directly beneath the invading bacterium would present itself as a 
significant physical barrier preventing complete internalisation. In C. trachomatis 
species, the effector CT166 may play a role in promoting the relatively rapid 
disassembly of F-actin by inactivating Rac and Cdc42 (Thalmann et al., 2010). 
Another candidate may the EB-associated effector, CT694, which interacts and co-
localises with the host protein AHNAK and may play a role in actin depolymerisation 
(Hower et al., 2009). Finally, a surprising observation was the co-localisation of EB1 
to invading C. caviae GPIC. This protein is a microtuble (MT) plus end binding 
protein and a commonly used marker for polymerising microtubules (Tirnauer et al., 
2002). Interestingly, Mital et al. found that C. caviae does not exhibit microtubule-
dependent trafficking to or association with the MTOC (Mital et al., 2010). In a study 
investigating focal adhesion dynamics in motile cells, Rid et al. noted that 
microtubule targeting potentiated the dissolution of anterior adhesions (Rid et al., 
2005). The investigators propose that MTs can transduce signals to release tension 
at focal adhesions resulting from linkage to the actin cytoskeleton. An exciting 
possibility, therefore, is that the Chlamydia-induced focal adhesion-like complex, 
potentially anchored to the actin cytoskeleton through vinculin, recruits MTs to 
ultimately induce a disassembly event. The mobilised MTs could localise through 
their capacity to bind actin microfilaments. Nonetheless, with the knowledge that all 
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Chlamydia species encode for the MT destabilizing effector CopN (Archuleta et al., 
2011), it is clear that further study is required to delineate MT involvement during 
chlamydial invasion.  
 
A striking feature of Chlamydia is its remarkable array of strategies to mobilise actin. 
Multiple invasion strategies make evolutionary sense for an obligate intracellular 
pathogen to ensure access to the protective intracellular niche. Actin nucleation, the 
subversion of FAK or vinculin activities and tyrosine phosphorylation are all 
recognised pathogenic mechanisms to remodel the host actin cytoskeleton. 
Remarkably, Chlamydia TarP has been distinctly engineered to induce most or, in 
the case of C. trachomatis, all of these pathogenic strategies through its diverse 
collection of modules. Interestingly, TarP is retained on the nascent inclusion for 
several hours after entry, suggesting that it also plays a role in some early events 
that do not require de novo chlamydial protein synthesis. The results presented in 
this report suggesting a post-invasion for TarP are preliminary. We propose that, 
through the TarP LD domain, Chlamydia have evolved unique a strategy to directly 
modulate FAK signalling beyond invasion. The significance of this relates to 
Chlamydia’s known capacity to circumvent apoptosis induction. However, several 
questions remain including determination of FAK requirement for the redistribution of 
adhesion components and whether this redistribution leads to an increase in cellular 
adhesion and/or dissolution of cell-cell contact. Most immediately, a western blot 
approach probing for post-invasion FAK phosphoactivation could be carried out to 
support observations of pY397-FAK involvement by immunofluorescence.  From 
here, FAK requirement could be analysed in HaCaT cells treated with the specific 
FAK inhibitor PF 573882. We would expect there to be a reduction in the 
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redistribution of markers for cell-cell or cell-matrix adhesions in the absence of FAK. 
Furthermore, it is important that these observations made regarding alterations to 
adhesion profiles are correlated to differences in cellular mechanics. The detachment 
assay described by Haraguchi et al. could be used to measure changes in cell 
adhesion strength (Haraguchi et al., 2008). In this assay, Uninfected (Ui)/ Untreated 
(Utr), Ui/ PF 573882-treated (PF-Tr), Infected (If)/Utr or If/PF-Tr HaCaT cells are 
plated on 24-well plates and incubated for 24 h. Cells are then dissociated from the 
culture plate by incubation with 0.025% trypsin/0.02 mM EDTA at 37°C for different 
lengths of time. DMEM containing 10% FBS is then added to the cells to inhibit 
trypsin. Following removal of the detached cells, the remaining cells are fixed in 70% 
ethanol and stained with crystal violet for 30 min. After extensive washing, 0.5% 
Triton X is added to lyse cells. The absorbance is then measured at 595 nm. The 
data can be presented as a percentage of detached cells relative to detachment 
observed in control cells. Using this approach, we can establish if Chlamydia 
infection enhances cellular adherence. If this is the case, then we can also get 
information on whether this enhancement requires FAK. 
 
One strategy to assess the integrity of intercellular junctions is to monitor the 
transepithelial cell resistance (TER) of the infected monolayer. This approach has 
been used to show that pathogens such as Salmonella and adherent-invasive E. coli 
(AIEC) target the epithelial barrier (Sherman et al., 2005, Kohler et al., 2007). T84 
cells are widely used in this system, as they form mature adhesion junctions resulting 
in high electrical resistance. In both cases, infection was found to significantly 
decrease TER. A number of studies interrogating cell-cell integrity of invasive cancer 
cells, however, refer to the hanging drop adhesion assay (Foty, 2011). This is 
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rationalised by the fact that cells within a tissue are typically encased within a closely 
packed tissue mass, which enables cells to establish a number of intimate 
connections. The struggle has been to design an approach that advances beyond 
monolayer cultures adherent to rigid structures. In addition, cells respond to matrices 
of diverse physical and biochemical properties in 3D tissue that are fundamentally 
different from those experienced in cells grown in monolayer culture. The hanging 
drop culture method is represents a simple technique to generate true 3D spheroids 
in which cells are in direct contact with each other and with ECM components. In 
essence, small drops of cell suspension (20ul) are seeded onto the inner surface lid 
of a petri dish and incubated at 37°C for the desired time. The lid is then inverted and 
the cluster sizes quantified. Using this approach, we would expect Chlamydia-
infected cells to exhibit reduced aggregation in comparison to uninfected cells.  
 
Under normal conditions, many of the biological processes that are regulated by FAK 
are also regulated by Src. Indeed, FAK is an important binding partner for SFKs, 
vvvwhere the autophosphorylation site creates high-affinity binding site for the SH2 
domain of Src (reviewed in: Mitra et al., 2005). Interestingly, FAK can be activated 
through distinct activation mechanisms in response to different physiological stimuli. 
Seong et al. observed that PDGF-induced FAK activation is mediated and 
maintained by Src activity. In contrast, FAK activation is upstream and, in fact, 
essential for Src activation in intergrin-mediated processes (Seong et al., 2011). 
Through the LD motif (Integrin-like activation) and tyrosine-rich repeat domain 
(PDGF-like activation), C. trachomatis may be able to employ both strategies, which 
could represent a highly efficient strategy to subvert the FAK-Src signalling axis. In 
addition, elevations in Src activity is sufficient to induce the assembly of integrin–
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adhesion complexes, which could further potentiate FAK signalling. Of interest, 
therefore, is whether "1-integrin is upregulated following C. trachomatis infection, 
which may represent a strategy to promote cell-matrix adherence. In the non-human 
Chlamydial species such as C. caviae, the role of SKFs is less clear. Interestingly, 
Mital et al. found C. caviae and C. muridarum to be growth restricted by the activities 
of SFKs, depletion of which triggered an 800% increase in infectious progeny 
production at 24 h.p.i. (Mital et al., 2010). From the perspective of the infected host, 
however, it is not known if there was a concomitant disruption of cellular adhesion 
and/or migration. These issues can be addressed by pre-treating HaCaT with PP2, a 
Src and Abl family tyrosine kinase inhibitor, and analysing these cells in the 
adherence and migration assays described above. It is conceivable that in SFY (Src, 
Yes and Fyn) null mutant cells, there is more emphasis on the other signalling 
molecules that can bind the FAK autophosphorylation site, including PI3-Kinase 
(PI3K), PLC* and Grb2. Interestingly, PI3K has been shown to function in the 
regulation of a number of processes including cell motility, survival and cytoskeletal 
dynamics. Finally, without a system in place to genetically modify Chlamydia, it is not 
possible to assess a role for TarP in modulating cellular integrity. To further 
complicate matters, it is possible that other chlamydial effectors are involved in this 
process. To gain further insight, Chloramphenicol can be used as it specifically 
inhibits the function of bacterial 50S ribosomal subunits, giving an indication as to 
whether de novo protein synthesis is required.  In this report, preliminary 
experimentation was limited to looking at the phenotypic consequences of TarP 
overexpression and comparing them to infected cells. To progress from here, we can 
investigate whether endogenous TarP associates with adhesion components through 
western blot and microscopy approaches.  Little, however, is known about TarP 
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stability at the early post-invasion stages.  A number of substrates including host and 
chlamydial proteins have been reported to be the target of the chlamydial protease 
CPAF. Recently, Joregensen et al. found recombinant CPAF to cleave GST-TarP in 
a manner that was sensitive to the proteasome inhibitor lactacystin. However, in vivo, 
a cell-permeable anti-CPAF peptide was found to only partially block the degradation 
of TarP in pulse-chase experiments, suggesting that TarP may be a target for other 
host or bacterial proteases (Jorgensen et al., 2011). While it is clear that TarP 
stability is targeted during infection, further work is needed to determine if this is due 
to degradation or specific cleavage events. Interestingly, the SipA effector of 
Salmonella is cleaved and subsequently divided into two functional domains during 
infection of intestinal epithelial cells (Srikanth et al., 2010).  Having shown in this 
study that TarP-LD alone can localise to adhesion structures, an exciting possibility is 
that TarP can also be cleaved into functional determinants. This can be addressed 
by engineering a TarP fusion protein harbouring two different tags, one at the N-
terminus and the other at the C-terminus. This fusion protein can then be 
overexpressed in uninfected or infected cells. An advantage to using this approach is 
that we can assess the stability of TarP in the absence of infection. In addition, the 
use of a double-tagged protein can give insight into the origin of the cleavage event 
(i.e. N-terminal or C-terminal). Finally, cells could be pre-treated with lactacystin to 
elucidate CPAF involvement.  
 
Overall, the data presented in this study identifies a new pan-chlamydial invasion 
mechanism, which is the TarP-mediated exploitation of FA signalling (Figure 7.1A). 
Interestingly, this signalling mechanism appears to have a post-invasion function 
(Figure 7.1B). 
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Figure 7.1- Proposed model for focal adhesion signalling involvement during chlamydial 
infection.  A) Chlamydiae enter cells in an actin-dependent fashion. Invasion also requires Rac and/or 
Cdc42 and the Arp2/3 complex. In C. trachomatis, the T3S effector TarP is tyrosine phosphorylated by 
host Src family tyrosine kinases, leading to the recruitment of GEFs (Sos and Vav2) that target Rac. 
The activation of Rac leads to Arp2/3-dependent actin polymerisation. The LD domain conserved in all 
TarP orthologues represents a pan-chlamydial strategy to subvert actin in an Arp2/3 and, thus, 
signalling-dependent fashion. Under normal conditions, signals through FAK to Rac play a role in 
modulating actin polymerisation.  Rac is a downstream target of the DOCK180-Cas-Crk complex that 
assembles following FAK activation. DOCK180 is a Rac nucleotide exchange factor DOCK180. FAK 
tyrosine phosphorylation as position 397 presents a number of signalling components including PI3-
kinase (PI3K), which in turn activates Cdc42/Rac (Chen et al., 1996a, Krasilnikov, 2000). Signaling 
emanating from an EB-activated PDGFR has also been proposed to converge on Rac to regulate 
actin polymerisation. TarP can associate with actin directly or indirectly through Actin Binding Domains 
(ABD) or Vinculin Binding Domains (VBD) respectively. In C. trachomatis TarP, which possesses only 
1 functional ABD, an oligomerisation event is required to bring multiple ABDs into close proximity. The 
VBD recruits the actin binding protein vinculin, which provides a link to the actin cytoskeleton and has 
also shown to have depolymerising activity (Bourdet-Sicard et al., 1999). Association of the secreted 
effector CT694 with AHNAK may function as actin-severing machinery, whilst in some Chlamydia 
species, the putative toxin (Ct166) may play a role in rapid F-actin disassembly by inactivating Rac 
and Cdc42. Dashed arrows represent author’s speculation in the model. TJ, Tight Junction; AJ, 
Adherens Junction; FA, Focal Adhesion; BM, Basement Membrane. B) Chlamydia tactics to reinforce 
adherence of infected cell to basement membrane. Chlamydia infection leads to an upregulation of 
the focal adhesion (FA) profile and the loss of the intercellular junction marker, "-catenin, from cell-cell 
contacts. In addition, FA structures of infected cells appear stable and not of the dynamic nature 
observed in motile cells. Interestingly, TarP or the FAK-interacting LD domain localised to FA 
structures, and overexpression resulted in an increase in FA numbers.  These results propose a 
model in which Chlamydia reinforces the adherence of infected epithelial cells to the basement 
membrane, possibly through TarP-mediated subversion of FAK signalling. Cell–cell junctions can 
function as signalling structures that can protect cells from apoptosis (Dejana, 2004). It is, therefore, 
conceivable that Chlamydia-induced disruption of junctional organisation compromises the epithelial 
barrier by causing the release of neighbouring uninfected that have lost their cell-cell contact-
dependent survival signals.   
 
 
We obtained valuable insight into TarP functionality by optimising a previously 
defined genetically tractable heterologous system (Campellone et al., 2004). Using 
this approach, we were able to artificially replicate the membrane-localised higher-
ordered configuration thought to be adopted by TarP in vivo.  In addition, this robust 
and reproducible system allows for the signalling efficiency of ectopically expressed 
of TarP or its derivatives to be determined. Importantly, our findings using the EPEC-
based system were consistent with the signalling kinetics observed via live cell 
imaging of invading EBs. This includes the transient recruitment of actin and FAK to 
membrane-localised TarP and the seemingly more stable association with vinculin. 
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Intriguingly, fixed-sample microscopy found that vinculin continues to stain EBs at 
120 min post-infection. It is possible that there is a stable EB-vinculin association 
through to post-invasion stages, although this has not been explored.  
 
Carrying on from here, it will be of interest to determine how the TarP-mediated 
signalling associates with the functions of other emerging chlamydial effectors. For 
instance, do the actin polymerizing signals from TarP cooperate with the indirect 
depolymerising actions of CT694 and/or CT166 during invasion? Salmonella, for 
example, employs a careful balance of effectors during invasion to promote actin 
nucleation (SopE) and to revert and repair the host actin cytoskeleton (SptP). At 
post-invasion stages, we have begun to address the manner in which chlamydiae are 
able to maintain the cell in state that can support the replication cycle. We show for 
the first time that infected cells exhibit a modulated adhesion profile, which suggests 
that Chlamydia have evolved strategies to circumvent cell exfoliation and apoptosis. 
Our mechanistic approach focused on TarP, although it is likely that other effectors 
are involved at different stages. Over the years, evidence has supported the notion 
that TarP also participates in early post-invasion activities. As such, we propose that 
the identification of TarP interactions through the EPEC-based system can be an 
efficient approach to better understanding aspects of chlamydial pathogenesis. 
Indeed, our finding that TarP usurps FA components such as FAK and vinculin 
allowed us to draw parallels with other bacterial pathogens, leading to further 
characterisation of the invasion process. In addition, this subversion proved to be the 
catalyst for our interrogation into whether Chlamydia modulates FA dynamics post-
invasion.  
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Overall,TarP is an intriguing protein because of its apparent multifunctionality, and 
the presence of a number of mammalian-like signalling motifs, including the SH2-
recognised phosphodomain, the WAVE homology 2-like actin binding domain, the LD 
motif and the vinculin binding domain.  Harbouring multiple signalling motifs indicates 
multi-functionality potentially through the combined actions of the different domains. 
In addition, this multi-domain nature of TarP raises the possibility of multiple levels of 
regulation that fine-tunes TarP activity in different situations (i.e. invasion ((Lane et 
al., 2008), actin remodelling ((Jewett et al., 2006)), apoptosis inhibition (Mehlitz et al., 
2010)).  
 
The origins of these motifs remain a mystery. Acquisition of TarP itself may have 
occurred through horizontal gene transfer (HGT), possibly though the fusion of 
functional effector modules to create a proto-TarP variant. Seeing as TarP is missing 
in all chlamydiae other than the Chlamydiaceae (Collingro et al., 2011), its acquisition 
is likely to have occurred after the divergence between the traditional Chlamydiaceae 
species and the Parachlamydiaceae (Figure 7.2).  
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Figure 7.2- Evolutionary relationship between different chlamydial species highlighting TarP 
emergence. The genera that have acquired the invasion-associated effector TarP are highlighted in 
red.  
 
It is conceivable that the duplication of certain domains facilitated mutations of a 
convergent nature and contributed to the pathoadaptive evolution of TarP. The LD 
domain, for instance, appears to be mutated duplications of the actin binding domain 
that is highly conserved, suggesting that it confers a evolutionary advantage (Figure 
7.3).  
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Figure 7.3- Did a duplication event facilitate the evolution of functional specialisation? ClustalW 
sequence alignment of the putative acting binding domains (ABD) and LD domains present in TarP. 
Arrows indicate the LD domains (bold), which were previously characterised as ABDs (Jewett et al., 
2010). Numbers indicate the amino acid residue of the amino terminus. Identical amino acids are in 
red. Similar residues are in blue. The consensus sequences shown are based on homology greater 
than 50%. An 8-residue consensus motif (XXDILAAV) was generated by aligning the actin binding 
domains for comparison to the TarP LD consensus (LEXLLPXL). Identical amino acids are in red, ‘x’ 
dictates any amino acid.  
 
 
The multidomain and multifunctional nature of TarP may be a strategy to expand the 
functional landscape of the proteome, thus, in effect maximizing the coding capacity 
of the relatively small genome.  However, this multidomain aspect also raises the 
potential for more complex regulation of function, where the activation of various 
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pathways originating from these domains coordinated temporally and spatially (i.e. 
cell and tissue tropism). In addition, there are likely other TarP binding partners yet to 
be identified, with possible post-invasion functions.  
 
It is becoming clear that TarP signalling is very complex. The complete 
understanding of TarP and its significance to Chlamydia pathogenesis requires the 
full characterisation of its interactome and its function, the coordination of protein 
binding and signalling, the functional interactions between domains, and post-
translational modifications, such as phosphorylation. Further studies should also 
consider signalling crosstalk between TarP and other host cell receptors implicated in 
the early stages of Chlamydia infection (Chen et al., 1994, Swanson et al., 1998, 
Wuppermann et al., 2001, Conant et al., 2007, Elwell et al., 2008, Ajonuma et al., 
2010). Only then will we fully appreciate the breadth of the subversive strategies 
mediated by TarP.  A detailed characterisation of TarP may reveal surprising and 
novel aspects of Chlamydia-host interactions. 
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